CURRICULUM VITAE

Updated: January 27, 2025

Md. Imtaiyaz Hassan, Ph.D., FRSB., FRSC.

Professor
Group Leader: Structural Biology Laboratory
Scopus ID: 7401625549
ORCID: 0000-0002-3663-4940

Publication Statistics

Total Research Book Chapters Total Citations H-Index I10 Index

publications
541 34 19,419 67 378
Center for Interdisciplinary Research in
Contact Information Basic Sciences, Jamia Millia Islamia
Jamia Nagar 110 025, New Delhi, India
A Telefax +91-11-26983409
Cell +91-9990323217; +91-9311323414
E-mail [email protected]; [email protected]
Web page https://hassanlab.org
 Drug design and discovery
B Research Interests  Protein folding and dynamics
 Structural Bioinformatics
Highlights  Identification and validation of potential drug targets.
C  Design and development of potent and selective kinase inhibitors.
of the Lab  Understanding the mechanism of folding and dynamic behavior of drug targets.
Personal Information
D Year of Birth 1980
Marital status Married
Education
B. Sc. in Chemistry (2001) from Aligarh Muslim University, Aligarh with First Class.
E M. Sc. in Biotechnology (2003) from Aligarh Muslim University. (Gold Medal).
Ph.D. in Structural Biology (2007) from Department of Biophysics, AIIMS, New Delhi
(Gold Medal).
Details of Employment
2023-till date Professor, Jamia Millia Islamia, New Delhi, India
2020-2023 Associate Professor, Jamia Millia Islamia, New Delhi, India
2018-2020 Assistant Professor (Stage 3), Jamia Millia Islamia, New Delhi, India
F 2009- 2018 Assistant Professor (Stage 1 & 2), Jamia Millia Islamia, New Delhi.
Fellow of Indo-US Science and Technology Forum at Saint Louis
2011-2011
University, Saint Louis, Missouri, USA
2007-2009 Young Scientist, Jamia Millia Islamia, New Delhi, India
2005-2007 Senior Research Fellow, AIIMS, New Delhi India

1 Hassan’s CV
 2003-2005 Junior Research Fellow, AIIMS, New Delhi India
Research Experience
G Cell and Molecular Biology, Biophysics, Molecular Spectroscopy, X-Ray Crystallography, Protein
Folding Kinetics, X-ray crystallography, Structural Bioinformatics, and Medicinal Chemistry.
Teaching Experience 17 years
H Molecular Cell Biology, Bioinformatics, Biochemistry, Molecular Biology, Genomics and
Proteomics, Structural Biology, Experimental Techniques, Drug design and discovery
I Ph. D. Thesis/Post doc Supervised
Post-doctoral Mentorship 10
Ph.D. Degree Awarded under main supervision 10
Ph.D. Degree Awarded under Co-supervision 18
Ph.D. Students registered under main supervision 7
Ph.D. Students registered under Co-supervision 8
Dissertations supervised at UG and PG level: 240 Students
J (Six Months dissertation)
Award and Honors
2023 Selected among top 2% scientist from the last 5 years.
2022 Prof. Rita Mulherkar Lecture Award for year 2020.
2021 Selected among top 2% scientists of the world.
2019 Elected as a Fellow of Royal Society of Chemistry (UK).
2019 Elected as a Fellow of Royal Society of Biology (UK).
2019 Best oral presentation in the 2nd Asia-Pacific CardioMetabolic Syndrome Congress
Seoul, Korea.
2018 Selected as an ‘OUTSTANDING RESEARCHER in Biophysics’ by VIHA 2018
K
2018 Top 10 “Most outstanding Researchers” in the field of Biochemistry, Genetics and
Molecular Biology by Carreer360.
2017 Received ICMR International Fellowship for Indian Biomedical Scientists.
2016 Elected as member of National Academy of Science India, Allahabad.
2011 Received Indo-US fellowship from IUCSSF, DST India.
2009 Ph.D. gold medal from All India Institute of Medical Sciences
2007 Department of Science and Technology (DST)- Young Scientist award
2003 University gold medal for scoring highest marks in M.Sc.
2003 OBAID BIN SAYEED GOLD MEDAL in M.Sc. Biotechnology
Members of Scientific Societies
Indian Biophysical Society (Vice-President)
Protein Society (General Secretary)
Bioinformatics and Drug Design Society (Joint Secretary)
L
Indian Academy of Biomedical Sciences. (Life Member)
Indian Crystallography Association (Life Member)
Indian Science Congress (Life Member)
Society for Biological Chemists, India (Life Member)
Indian Society of Cell Biology (Life Member)

2 Hassan’s CV
 The Biotech Research Society, India (Life Member)
Proteomics Society India (Life Member)
National Academy of Biological Sciences (Life Member)
American Chemical Society
M Invited talk/Oral presentations
1. 2011 National symposium on Biomolecular drug targets, Aligarh Muslim university, Aligarh
on March 7-9, 2011
2. 2012 Annual Meeting of the Indian Biophysical Society held on January 19 – 21, 2012 at
Madras University, Chennai.
3. 2012 5th International Symposium on Recent Trends in Macromolecular Structure and
Function (ISRTMSF-2012) on January 23 – 25, 2012 at Madras University, Chennai
4. 2012 National Conference on Biology and Bioinformatics of Economically Important Plant
and microbes (BBCon2012) at University of North Bengal, Siliguri, February 17-19, 2012.
5. 2012 National Symposium on Bimolecular Interaction and Drug Discovery & Workshop on
Current Trends in Bioinformatics, AMU, Aligarh, March 21-22, 2012.
6. 2012 81st Annual meeting of the Society of Biological chemists (India) to be held during
November 8-11 at Kolkata.
7. 2013 International Conference on “Emerging Trends in Biomarker Research – Prospects &
Challenges” September 13th and 14th, 2013 Organized by Jawaharlal Nehru Institute of
Advanced Studies, Secunderabad.
8. 2014 National Seminar on “Plant Biotechnology: Challenges and Opportunities in 21 st
Century” to be held from March 3rd& 4th, 2014, Jamia Hamdard, New Delhi
9. 2014 9th International Symposium on Fuels and Lubricants organized by the Indian Oil
Corporation Limited, Faridabad 121007, Haryana, India during 15-17 April 2014.
10. 2014 Bioworld2014, Protein Structure and Function Organized by Kusuma School of
Biological Sciences, Indian Institute of Technology Delhi New Delhi.
11. 2015 6th World Congress on Biotechnology, October 05-07, 2015, New Delhi.
12. 2015 Recent Developments in Medical Biotechnology and Structure-Based Drug Designing
2015 (RDMBSBDD-2015)” held at the Department of Biosciences and Bioengineering,
Indian Institute of Technology Guwahati during December 6-7, 2015.
13. 2016 Workshop on “Bioinformatics in Drug Discovery” as part of the ICMR Bio-Medical
Informatics activity on Feb 2 – 3, 2016, organized by the Department of Biophysics, All
India Institute of Medical Sciences, New Delhi
14. 2016 Annual Meeting of Indian Biophysical Society: Molecules in living cells: basis of
function, during 8-10 February 2016 at the Indian Institute of Science, Bangalore.
15. 2016 1st International Conference on Human Implications of Biotechnology Centre for
Biological Sciences, Central University of South Bihar February 12-14, 2016 in Patna.
16. 2016 International Conference on “Emerging Trends in Biomedical Sciences” (ETBS-2016) to
be held on March 6-8, 2016, organized by Department of Biochemistry, Aligarh Muslim
University, Aligarh-202002 (UP), India
17. 2016 National Symposium cum Bioinformatics Workshop on Macromolecular Structure,
Function, Interaction and Prediction held during March 29-30, 2016, organized by the
Interdisciplinary Biotechnology Unit, Aligarh Muslim University, Aligarh
18. 2016 DeMon2016 Workshop, 4-7 May 2016 at Henan University, Zhengzhou, China.
19. 2017 International Conference on “Structure and Dynamics of Biomolecules” during January
27-28, 2017 at DDU, Gorakhpur.
20. 2017 9th National Symposium cum Workshop – SBCADD’2017, Feb 14-17, 2017, Department
of Bioinformatics, Alagappa University, Karaikudi- 630004.

3 Hassan’s CV
21. 2017 National Seminar on Biotechnology in Health Care: Challenges and Opportunities
organized by the Department of Biotechnology, Jamia Hamdard on March 18-19, 2017.
22. 2017 National Symposium cum Bioinformatics Workshop on Current Trends in Proteomics
and Bioinformatics organized by the Interdisciplinary Biotechnology Unit, Aligarh
Muslim University, Aligarh on 16-17 March 2017.
23. 2017 4th International Conference on Emerging Trends in Protein Science & Proteomics:
GenoPro2017 organized by the Invertis University, Bareilly.
24. 2018 10th National Symposium cum Workshop on “Recent Trends in Structural
Bioinformatics and Computer Aided Drug Design” [SBCADD’2018] organized by the
Department of Bioinformatics, Alagappa University, Karaikudi scheduled to be held
during 20th –23rd February 2018.
25. 2018 3rd International Conference on Nutraceuticals and Chronic Diseases (September 14 -
16,2018) Cancer Research Institute, Himalayan Institute of Medical Sciences, Swami
Rama Himalayan University, Dehradun, India
26. 2018 International Conference on Bioinformatics organized by Jawaharlal Nehru University,
New Delhi on 26-28 September 2018.
27. 2018 International Congress of Diabetes and Metabolism organized by the Koran Diabetes
Association on 11-13 October 2018 at Grand Hilton Seoul Hotel, Seoul, South Korea
28. 2019 11th National Symposium cum Workshop on “Recent Trends in Structural
Bioinformatics and Computer Aided Drug Design and 2 nd Annual Meeting of
Bioinformatics and Drug Discovery Society [BIDDS] from 12 th – 15th February 2019,
Alagappa University, Karaikudi, TN.
29. 2019 The 2nd APCMS (Asia-Pacific CardioMetabolic Syndrome) Congress (APCMS 2019) will
be held on February 22-23, 2019 at the Grand Hilton Hotel, Seoul, Korea.
30. 2019 Recent Advancements in Biochemical Engineering and Biotechnology organized by
School of Biochemical Engineering, IIT (BHU) Varanasi during 15-16 March 2019.
31. 2019 National Conference on “Emerging Trends in Disease Model Systems” during March
25-26, 2019 organized by National Centre for Cell Science, Pune.
32. 2019 National Seminar on “Biotechnology Research in India-Current Status and Future
Prospects”, held at Jamia Hamdard, New Delhi on 26th -27th March 2019.
33. 2019 7th Biennial Congress of the Asian-Pacific Hepato-Pancreato-Biliary Association (A-
PHPBA 2019) Held during September 4-7, 2019 at Coex, Seoul, South Korea.
34. 2019 8th International Congress on Lipid & Atherosclerosis (IcoLA 2019) and 8 th Conference
of the Korean Society of Lipid & Atherosclerosis, held at the Conrad Hotel in Seoul,
Korea from September 5 to 7, 2019.
35. 2019 National Conference on Insect-Plant Biology in 21st Century” held on November 4-5,
2019 at Deshbandhu College, Delhi University
36. 2019 Seminar on drug design and discovery organized by the Department of Biotechnology,
PGDAV College, Muzaffarnagar on 8th November 2019.
37. 2019 Recent advances and current trends in Biological sciences, organized jointly by PG
department of Zoology and Botany, M. S. College, Motihari on 11-12th November 2019.
38. 2019 National Conference on Translational Research Current and Future Perspectives
Gautam Buddha University, Greater Noida on 16-17th November 2019.
39. 2020 International Conference on “Contemporary Islamic Thought and Societal Reforms
through Education” on February 1-2, 2020 at the Constitution Club of India, New Delhi
40. 2020 International Conference on Corona Viral Genomics organized by Bengaluru Genomics
Center (BGC) and Sarvasumana Association from 7th June to 10th June 2020.

4 Hassan’s CV
41. 2020 Virtual conference The World After- From Things to life organized by Dassault
Systèmes, USA.
42. 2020 Coronavirus Pandemic and its Impact on Human Life organized by Department of Life
Sciences, Central University of Karnataka, Kalaburagi 585311, Karnataka, INDIA
43. 2020 2nd World Conference on Advances in COVID-19 organized by Bengaluru Genomics
Center, Bengaluru, India and High Altitude Pulmonary and Pathology Institute (HAPPI-
IPPA), Bolivia, South America during 28-30 August 2020.
44. 2020 Refresher Course in “Life Sciences” organized by UGC-HRDC, MANUU on 19th
September 2020.
45. 2020 International Seminar on COVID-19 challenges before mankind: Victory beyond the
defeat. Organized by the Netaji Suchash Chandra Bose Government Girls PG College,
Aliganj, Lucknow on October 10, 2020.
46. 2020 Bio-Illumination: Talk 9 scheduled on 31st October 2020 at Department of Biological
Sciences, Aliah University, Kolkata.
47. 2020 International Symposium on Bioinformatics and Artificial Intelligence in Covid-19 era
and beyond organized by the Centre for Computational Biology and Bioinformatics,
Amity Institute of Biotechnology, Amity University Noida, held on November 24-25,
2020.
48. 2020 One Week Workshop on Research Methodology organized by UGC-Human Resource
Development Centre, Jamia Millia Islamia New Delhi on Interdisciplinary Research on
22.12.2020.
49. 2020 International Bioinformatics E-Workshop organized by Department of Biotechnology
Delhi Technological University on 18.12.2020.
50. 2020 Seminar on structure-based drug design and discovery organized by Government
Degree College, Baramula.
51. 2021 UGC-Human Resource Development Centre, Jamia Millia Islamia, “Interdisciplinary
Research” in the online 3rd One Month Faculty Induction Programme. 25.02.2021
52. 2021 DBT Sponsored National Workshop Under Star College Scheme on MOLECULAR
DOCKING held on 31st March. Organized by the Department of Microbiology, Ram Lal
Anand College, Delhi University.
53. 2021 Structure based drug designing and discovery Workshop held on 22nd March.
Organized by the Department of Microbiology, Institute of Home Economics, Delhi
University.
54. 2021 National Webinar on Genomics and Proteomics organized by Department of
Biotechnology, Kalinga University, Raipur on 28th August 2021. Basic concept of Drug
design and discovery.
55. 2021 Biology Department Seminar Series on Therapeutic Targeting of Human Kinases, A
structure-based approach at UAE University, Al-Ain. October 14, 2021.
56. 2021 Design and development of high affinity kinase inhibitors: From theory to therapy
organized in Azadi Ka Amrit Mahotsav by Department of Microbiology, Tripura
University on 30th October 2021.
57. 2021 National Workshop on Advanced Research Techniques for Cellular and Molecular
Systems in Neuroscience. Concept of docking in drug discovery on 14th December 2021.
Organized by Jamia Hamdard, New Delhi.
58. 2021 Faculty Development Activity. Methods for Data Analysis and Paper Writing Skills on
14th December 2021 organized by General Studies Department, Royal Commission of
Jubail and Yanbu, KSA.

5 Hassan’s CV
59. 2021 Workshop on “Computational Biology and Network Pharmacology: New Horizon in
Drug Discovery” on 22nd December 2021, organized by DBT-Bioinformatics Centre,
Department of Pharmaceutical Sciences and Drug Research, Punjabi University, Patiala,
Punjab.
60. 2021 Online lecture on ‘Interdisciplinary and collaborative research projects’ on 27.12.2021 to
the participants of 7th online One Month Faculty Induction Programme from 10
December 2021 to 08 January 2022 organised by the UGC-Human Resource
Development Centre, Jamia Millia Islamia, New Delhi.
61. 2 2022 Online lecture on ‘Interdisciplinary Research’ on 04.03.2022 to the 8th One month
0 Faculty Induction Program organised by the UGC-Human Resource Development
Centre, Jamia Millia Islamia, New Delhi.
62. 2022 Synergistic Training program Utilizing the Scientific and Technological Infrastructure
(STUTI) Program on 10th March 2022, organized by Jamia Hamdard, New Delhi
63. 2022 Annual Fest SYNAPSE 2022, Organized by Synergia Life Science Society, Deshbandhu
College, University of Delhi, New Delhi.
64. 2022 1st International Conference on Genomics of Animal Gut Microbes on 22nd June 2022
organized by National Institute for Genomics Advanced Biotechnology (NIGAB),
National Agricultural Research Centre, (NARC), Islamabad.
65. 2022 9th Online Faculty Induction Programme, on 25th June 2022 organized by Human
Resource Development Centre, Jamia Millia Islamia, New Delhi.
66. 2022 Biotech Innovation Ignition School-12 (BIIS-12), 30th June 2022, organized by BIRAC
SITARE-BIIS program, Society for Research and Initiatives for Sustainable Technologies
and Institutions, Ahmedabad, Gujarat.
67. 2022 3rd Online 2-Week Refresher Course in Basic Sciences from August 2 to 18, 2022.
Organized by The Human Resource Development Centre, Jamia Millia Islamia on
6.08.2022.
68. 2022 Webinar On Structure-Based Drug Design and Development: Computational Methods
And Protocols organized by JIS Institute of Advanced Studies and Research Kolkata, on
27.08.2022.
69. 2022 Computational Methods in Advancing Agricultural Research 11th October 2022
organized by National Institute for Genomics Advanced Biotechnology (NIGAB),
National Agricultural Research Centre, (NARC), Islamabad.
70. 2022 11th Online Faculty Induction Programme from 01 November to 29 November, 2022
organized by UGC-Human Resource Development Centre, Jamia Millia Islamia, New
Delhi.
71. 2022 2nd International Conference cum workshop on “Recent Trends in Structural
Bioinformatics and Computer Aided Drug Design" (ICSBCADD’2022) during 21st –
25th, November 2022 organized by the Department of Bioinformatics, Alagappa
University
Karaikudi, Tamil Nadu, India.
72. 2022 Hands-on training under DST-STUTI Program from 20th – 26th December, 2022 in Dept.
of Toxicology, School of Chemical Life Sciences.
73. 2023 Workshop on Data Science in Drug Discovery organized by Bioinformatics Facility,
NCCS Pune on 5th February 2023.
74. 2023 International Conference on Unani Medicine as part of celebrations of Unani Day 2023,
in hybrid mode on February 10-11, 2023 at Vigyan Bhawan, New Delhi by Central
Council for Research in Unani Medicine (CCRUM), Ministry of AYUSH, Government of
India.

6 Hassan’s CV
75. 2023 5-days Faculty Development Programme (FDP) under the theme “Innovation in Health
Sciences: Challenges and Future Trends” from February 13-17, 2023, by Faculty of Allied
Health Sciences (FAHS) SGT University, Gurugram.
76. 2023 Talks on Research Innovation organized by School of Life Sciences, Manipur University
on 11th February 2023.
77. 2023 Climate Change Impacts and Sustainable Development in a conference on India and G20
Summit: Setting the agenda for Inclusive Future” held on 19th August 2023 at Institute
of Objective Studies, New Delhi.
78. 2023 International Conference on Structural Biology and Drug Discovery (ICSBDD-2023) 11-
12th October, 2023 organized by School of Biotechnology, Gautam Buddha University,
Greater NOIDA, Gautam Budha Nagar, Uttar Pradesh-201312 (INDIA)
79. 2023 Three days online workshop entitled "Protein Modelling: A Rational Tool for Drug
Discovery and Development" organized by DBT-Bioinformatics Centre, Department of
Pharmaceutical Sciences and Drug Research, Punjabi University, Patiala, Punjab on 31st
October 2023.
80. 2023 5-Day FDP (Faculty Development Program) on "Advances and Innovations in
Biotechnology" during 27 Nov - 1st Dec 2023, organized by Centre for Bio-Separation
and Technology, Vellore Institute of Technology (VIT), Vellore
81. 2023 Global Bio-India (GBI) 2023 from 4-6 December 2023 at Bharat Mandapam, Pragati
Maidan, New Delhi on “Transforming Lives-Biosciences to Bioeconomy”.
82. 2023 Structural dynamics of protein in faculty induction program organized by Department
of Veterinary Biochemistry, Sher-e-Kashmir University of Agricultural Sciences and
Technology of Kashmir, Srinagar on 12th December 2023.
83. 2024 Current Trends in Research and Research Paradigms in the online 2-Week Refresher
Course in Teacher Education organized by HRDC, Jamia Millia Islamia, New Delhi on
9th January, 2024.
84. 2024 Keynote speaker at the RSG-India's CBInd 2023-24 Symposium, organized by
Department of Biophysics, University of Delhi South Campus, New Delhi, India on 10th
January, 2024.
85. 2024 International Conference on Microbial Technologies for Sustainable Bioeconomies
organized by Department of Biochemistry, Central University of Rajasthan on January
31, 2024.
86. 2024 Hands-on Training workshop in Bioinformatics focusing on Genomics, Metagenomics
and Proteomics Analysis organized by the School of Allied Sciences, Dev Bhoomi
Uttarakhand University on February 3, 2024.
87. 2024 National Workshop 2024 on Capacity Building of AYUSH professionals organized by
the Centre of Excellence in Unani Medicine, Jamia Hamdard, on February 23-25, 2024.
88. 2024 SERB-sponsored workshop (KARYASHALA) “Advanced hands-on workshop on
recombinant protein production, structural and functional studies”, held at Amity
University Rajasthan, India, from 11-17 March 2024.
89. 2024 Three-day workshop entitled "BIC and NNP workshop on Big Data Analysis and
Machine Learning" at the National Institute of Plant Genome Research (NIPGR), New
Delhi on March 13-15, 2024.
90. 2024 Hands-on Training on 18th April 2024 in One Week SNCI-STUTI Workshop on
“Translational Neuroscience: Bridging Gap between Bench to Bedside” organized by the
Society for Neurochemistry India (SNCI) Delhi at Jamia Hamdard, New Delhi.
91. 2024 Online One-month Faculty Induction Programme from 01 February to 01 March 2024 at
The Malaviya Mission Teacher Training Centre, Jamia Millia Islamia.

7 Hassan’s CV
 92. 2024 The 12th Online Faculty Induction Programme, from 01 February to 28 February 2023,
was organized by The Malaviya Mission Teacher Training Centre, Jamia Millia Islamia.
93. 2024 Whole Exome sequencing in clinical settings - Hands-on workshop organized by CMR-
National Institute of Cancer Prevention and Research on September 24, 2024.
94. 2024 Short Term Course on Bioinformatics: Basic to Advance organized by Department of
Zoology, Bhaskaracharya College of Applied Sciences, Delhi University on October 1,
2024.
95. 2024 8 Days The Malaviya Mission Teacher Training Centre organized Online Training
Programme on NEP Orientation & Sensitization Programme, Jamia Millia Islamia on
23.09.2024.
96. 2024 A one-week workshop on Advanced Drug Designing and Computational Biology by the
Department of Chemistry, Jamia Millia Islamia, New Delhi, on September 26, 2024.
97. 2024 Online 2-Week Refresher Course in Basic Science (Interdisciplinary) Programme
organized by The Malaviya Mission Teacher Training Centre Jamia Millia Islamia on
01.11.2024.
98. 2024 Breakthroughs in Drug Design: The Synergy of Machine Learning and HPC," jointly
hosted by Prescience Insilico and School of Physical Sciences, JNU during 29th- 30th
November 2024.
99. 2024 Workshop on “Alternative Models in Toxicological Research” from 9th December 2024
to 11th December 2024 in Dept. of Toxicology, School of Chemical and Life Sciences.
100. 2024 4th Asian Congress for Alternatives to Animal Experiments (4ACAAE) and the 7th
Annual Conference of the Society for Alternatives to Animal Experiments (SAAE)- India
at Jamia Hamdard, New Delhi, India on 12-24 December 2024.
101. 2024 Workshop on Computational Biology Methods in Toxicity testing under the aegis of
Alternatives to Animal Experiments at Jamia Hamdard, New Delhi, India on 16th
December 2024.
102. 2025 Residential one month Faculty Induction Programme organized by The Malaviya
Mission Teacher Training Centre, Jamia Millia Islamia. 02.01.2025.
Member of Editorial Board
Journal of Biomolecular Structure and Dynamics (Associate Editor, Since 2020)
Journal of Protein and Proteomics (Associate Editor, Since 2018)
Oxidative Medicine and Cellular Longevity (Editor, Since 2021)
Journal of Alzheimer’s Disease (Associate Editor, Since 2024)
F1000Research (Senior Advisor for Cell & Molecular Biology Gateway)
Scientific Reports (Editor)
PloS-ONE (Academic Editor)
N Brain Research (Guest Editor)
Frontiers in Molecular Biosciences (Associate Editor)
Frontiers in Immunology (Guest Editor)
Brain Research (Guest Editor)
Frontiers in Oncology (Guest Editor)
Molecules (Guest Editor)
Briefings in Functional Genomics (Guest Editor)
Current Topics in Medicinal Chemistry (Guest Editor)
Frontiers in Biosciences (Guest Editor)
J Natural Science Biology and Medicine (Editor)

8 Hassan’s CV
O Research Projects and Grants
i. Folding and Stability of Naturally Truncated Photosynthetic
Pigment, C-Phycoerythrin from Cyanobacteria Phormidium DST Completed
tenue (39.40 L)
ii. The critical role of five N-terminal residues in the folding and
DST Completed
stability of Yeast iso-1 cytochrome c (AS CO-PI) (49.50 L)
iii. Structural and biophysical characterization of cyt-c; a
DST Completed
component of mitochondrial respiration (13.75L)
iv. Compilation of useful information for Indian diseases through
an online data base management; A useful resource for UGC Completed
researcher and public awareness (15.2 L)
v. Structural and Functional Assignment to Hypothetical Proteins
ICMR Completed
from Common Indian Pathogens. (29.6 L)
vi. Mechanism of survival of ethanol producing organisms: Role of
Cellular Compatible Osmolytes in Counteracting the
CSIR Completed
Deleterious Effects of Ethanol on Structure, Stability and
Function of Protein (AS CO-PI) (24.36 L)
vii. Design and synthesis of selective inhibitors against human
carbonic anhydrase VA to search potential anti- obesity agent: CSIR Completed
A QSAR and crystallographic approach (24.10 L)
viii. Identification of a high affinity selective inhibitor of
calcium/calmodulin-dependent protein kinase IV by a ICMR Completed
combined experimental and computational approach (52.70 L)
ix. In Silico (Molecular Dynamic Simulation) and In Vitro
Approaches to Understand Counteraction of Urea’s Effects on ICMR Completed
Proteins by Kidney Osmolytes (Co-PI) (46.39 L)
x. Design and Synthesis of Potential Inhibitors of
MAP/Microtubule Affinity-Regulating Kinase 4 to Fight DST Completed
Against Diabetes and Cancer (31.90 L)
xi. Identification of MARK 4 inhibitors from bioactive
phytoconstituents of Bacopa Monnieri (Brahmi): Therapeutic NMPB-
Completed
management of Alzheimer’s disease and neuro-inflammation AYUSH
animal model (22.20 L)
xii. Elucidation of neurodegenerative tauopathies through MARK4
inhibitors: Design and evaluation of MARK4 inhibitors using in
ICMR Completed
silico and in vitro approaches and investigation of their role to
cure hyper phosphorylation of tau proteins (Co-PI) (36.39 L)
xiii. Structure-based Design and Development of Selective
Sphingosine Kinase 1 Inhibitors to Combat Idiopathic ICMR Completed
Pulmonary Fibrosis (36.45 L)
xiv. Systems Regulatory Networks of Autophagy Proteins in
ICMR Ongoing
Leishmania: Implications towards Drug Design (Co-PI) (34.39 L)
xv. Selective Pharmacological Inhibition of the Transcriptional
DHR Ongoing
Anti-terminator Protein, RfaH of Klebsiella pneumoniae (64.78 L)
xvi. Targeting Alzheimer disease by a mixture of Unani plant AYUSH
Ongoing
extract via modulation of human kinase (49.90 L) CCRUM

9 Hassan’s CV
xvii. Developing small molecule inhibitors to target non-genomic
androgen signaling and elucidating the role of GPR56 in DST Completed
Prostate Cancer (As Co-PI) (43.10 L)
xviii. Development of Pim-1 Kinase-Specific Inhibitors as Preclinical
CSIR Completed
Lead for Prostate Cancer Therapy (42.60 L)
xix. Targeting two diseases with one stone Inhibition of enzyme
India-Serbia
modulators of androgen receptor function in prostate cancer Ongoing
by SERB
and COVID-19
xx. Effect of Unani formulations against mitochondria-mediated
AYUSH
cellular mechanism: Strategy to combat Alzheimer’s disease Ongoing
CCRUM
Co-PI (43.50 L)

P PUBLICATIONS
I.F.
541 Asrani P, Eapen MS, Hassan MI, Sohal SS. Implications of the second wave of
38.73
COVID-19 in India. Lancet Respiratory Medicine 2021, 9(9):e93-e94.
540 Rao S, Yang X, Ohshiro K, Zaidi S, Wang Z, Shetty K, Xiang X, Hassan MI,
Mohammad T, Mishra L. et al. β2-spectrin (SPTBN1) as a therapeutic target for diet-
19.36
induced liver disease and preventing cancer development. Science Translational
Medicine 2021, 13(624): eabk2267.
539 Queen A, Bhutto HN, Yousuf M, Syed MA, Hassan MI. Carbonic anhydrase IX: A
tumor acidification switch in heterogeneity and chemokine regulation. Seminar in 17.06
Cancer Biology 2022, 86(Pt 3):899-913.
538 Gu S, Zaidi S, Hassan MI, Mohammad T, Malta TM, Noushmehr H, Nguyen B,
Mishra B, Obias V, Lin P, Nguyen B, Yao M, Yao R, King CH, Mazumder R, Rao S,
and Mishra L (2020) Mutated CEACAMs Disrupt Transforming Growth Factor Beta 22.88
Signaling and Alter the Intestinal Microbiome to Promote Colorectal
Carcinogenesis. Gastroenterology 158(1):238-252.
537 Anwar S, Shamsi A, Mohammad T, Islam A, Hassan MI. (2021) Targeting pyruvate
dehydrogenase kinase signaling in the development of effective cancer therapy. 11.20
Biochim Biophys Acta Rev Cancer 1876(1):188568.
536 Upadhyay S, Khan S, Hassan MI. Exploring the diverse role of pyruvate kinase M2
in cancer: Navigating beyond glycolysis and the Warburg effect. Biochim Biophys 11.20
Acta Rev Cancer. 2024 Mar 6;1879(3):189089.
535 Mohammad T, Mathur Y, Hassan MI (2021). InstaDock: A Single-click Graphical
User Interface for Molecular Docking-based Virtual High-throughput Screening. 10.99
Briefings in Bioinformatics 22(4):bbaa279.
534 Basheer N, Smolek T, Hassan I, Liu F, Iqbal K, Zilka N, Novak P. Does modulation
of tau hyperphosphorylation represent a reasonable therapeutic strategy for
14.15
Alzheimer's disease? From preclinical studies to the clinical trials. Mol Psychiatry.
2023 Jun;28(6):2197-2214.
533 Singh A, Meena M, Kumar D, Dubey AK and Hassan MI (2015) Structural and
functional analysis of various globulin proteins from soy seed. Critical Reviews in 11.21
Food Science and Nutrition 55(11):1491-502.
532 Kumar D, Hassan MI. Targeted protein degraders march towards the clinic for
13.10
neurodegenerative diseases. Ageing Res Rev. 2022, 78:101616.

10 Hassan’s CV
531 Khan T, Waseem R, Shahid M, Ansari J, Ahanger IA, Hassan I, Islam A. Recent
advancement in therapeutic strategies for Alzheimer's disease: Insights from clinical 13.10
trials. Ageing Res Rev. 2023 Dec;92:102113.
530 Khan S, Hassan MI, Shahid M, Islam A. Nature's toolbox against tau aggregation:
12.5
An updated review of current research. Ageing Res Rev. 2023, 87:101924.
529 Prabha S, Sajad M, Hasan GM, Islam A, Hassan MI, Thakur SC. Recent
advancement in understanding of Alzheimer's disease: Risk factors, subtypes, and 12.5
drug targets and potential therapeutics. Ageing Res Rev. 2024 Aug 31;101:102476.
528 Singh S, Khan S, Shahid M, Sardar M, Hassan MI, Islam A. Targeting tau in
Alzheimer’s and beyond: Insights into pathology and therapeutic strategies. Ageing 12.5
Research Reviews 2025 104 102639.
527 Iram F, Shahid M, Ansari J, Ashraf GM, Hassan MI, Islam A. Navigating the Maze
of Alzheimer's disease by exploring BACE1: Discovery, current scenario, and future 12.5
prospects. Ageing Res Rev. 2024 Jul;98:102342. doi: 10.1016/j.arr.2024.102342.
526 Bashir S, Aiman A, Shahid M, Chaudhary AA, Sami N, Basir SF, Hassan I, Islam A
Professor. Amyloid-induced neurodegeneration: A comprehensive review through
12.5
aggregomics perception of proteins in health and pathology. Ageing Res Rev. 2024
Mar 16;96:102276.
525 Alrouji, M., Anwar, S., Venkatesan, K., Shahwan, M., Hassan, M.I., Islam, A.,
Shamsi, A., 2024. Iron homeostasis and neurodegeneration in the ageing brain: 12.5
Insight into ferroptosis pathways. Ageing Research Reviews 102, 102575.
524 Prabha S, Islam A, Hassan MI, Thakur SC. Understanding of Alzheimer's Disease
Pathophysiology for Therapeutic Implications of Natural Products as 12.5
Neuroprotective Agents. Ageing Res Rev. 2025
523 Taiyab A, Ashraf A, Sulaimani MN, Rathi A, Shamsi A, Hassan MI. Role of MTH1
in oxidative stress and therapeutic targeting of cancer. Redox Biol. 2024 Oct 10.7
11;77:103394. doi: 10.1016/j.redox.2024.103394.
522 Lu W, Teoh A, Waters M, Haug G, Shakeel I, Hassan I, Shahzad AM, Callerfelt AL,
Piccari L, Sohal SS. Pathology of idiopathic pulmonary fibrosis with particular focus
12.0
on vascular endothelium and epithelial injury and their therapeutic potential.
Pharmacol Ther. 2025 Jan;265:108757.
521 Yang X, Bhowmick K, Rao S, Xiang X, Ohshiro K, Amdur RL, Hassan MI,
Mohammad T, Crandall K, Cifani P, Shetty K, Lyons SK, Merrill JR, Vegesna AK,
John S, Latham PS, Crawford JM, Mishra B, Dasarathy S, Wang XW, Yu H, Wang Z, 9.6
Huang H, Krainer AR, Mishra L. Aldehydes alter TGF-β signaling and induce
obesity and cancer. Cell Rep. 2024 Sep 24;43(9):114676.
520 Zaidi S, Islam A, Hassan MI, Ahmad F (2014) The role of key residues in structure
7.7
and stability of cytochrome c. Cellular and Molecular Life Sciences 71(2):229-55
519 Hassan, M. I., Waheed, A and Ahmad F. (2009) Prolactin Inducible protein in
cancer, structure, functions and its clinical implications. Cellular and Molecular Life 7.7
Sciences 66: 447-459
518 Alam M, Ali S, Ashraf GM, Bilgrami AL, Yadav DK, Hassan MI. Epigallocatechin 3-
8.5
gallate: From green tea to cancer therapeutics. Food Chem. 2022, 379:132135.
517 Kumar D, Md Ashraf G, Bilgrami AL, Imtaiyaz Hassan M. Emerging therapeutic
developments in neurodegenerative diseases: A clinical investigation. Drug Discov 8.37
Today. 2022, 18:S1359-6446(22)00275-6.
516 Hussain A, Jairajpuri DS, Anwar S, Choudhury A, Hawwal MF, Firdous A, Alajmi
MF, Hassan MI. Apigenin-mediated MARK4 inhibition: a novel approach in 3.8
advancing Alzheimer's disease therapeutics. Mol Divers. 2025 Jan 22.

11 Hassan’s CV
515 Mustafa M, Abbas K, Ahmad W, Ahmad R, Islam S, Khan H, Moinuddin, Hassan
MI, Parveen S, Habib S. A Promising Druggable Target for Translational Therapy of
Ovarian Cancer: A Molecular Profiling of Therapeutic Innovations, Extracellular 3.9
Vesicle Acquired Resistance, and Signaling Pathways. Curr Med Chem. 2025 Jan 14.
doi: 10.2174/0109298673331849240930140120.
514 Taufeeq M, Choudhury A, Hussain A, Alajmi MF, Mohammad T, Shamsi A,
Hassan MI. Discovering potential ERK1 inhibitors from natural products for
4.2
therapeutic targeting of Alzheimer's disease. J Alzheimers Dis. 2025 Jan
15:13872877241309592. doi: 10.1177/13872877241309592.
513 Hussain A, Mohammad T, Gulzar M, Alajmi MF, Yadav DK, Hassan MI.
Phytochemicals Withanolide N and Dryobalanolide as Potential Bioactive Leads for
3.9
Developing Anticancer Drugs Targeting Tyrosine-Protein Kinase Mer. OMICS. 2025
Jan 10. doi: 10.1089/omi.2024.0192.
512 Rathi A, Noor S, Sulaimani MN, Ahmed S, Taiyab A, AlAjmi MF, Khan FI, Hassan
MI, Haque MM. FDA-approved drugs as PIM-1 kinase inhibitors: A drug
8.02
repurposed approach for cancer therapy. Int J Biol Macromol. 2024 Dec
23;292:139107. doi: 10.1016/j.ijbiomac.2024.139107.
511 Atre R, Obukhov AG, Majmudar CY, Nair K, White FA, Sharma R, Siddiqi F, Faisal
SM, Varma VP, Hassan MI, Mohammad T, Darwhekar GN, Baig MS. Dorzolamide
4.2
intermediates with potential anti-inflammatory activity. Eur J Pharmacol. 2025 Jan
15;987:177160. doi: 10.1016/j.ejphar.2024.177160.
510 Prabha S, Sajad M, Anjum F, Hassan MI, Shamsi A, Thakur SC. Investigating gene
expression datasets of hippocampus tissue to discover Alzheimer's disease- 4.2
associated molecular markers. J Alzheimers Dis. 2024 Dec;102(4):994-1016.
509 Mustafa M, Ahmad R, Tantry IQ, Ahmad W, Siddiqui S, Alam M, Abbas K,
Moinuddin, Hassan MI, Habib S, Islam S. Apoptosis: A Comprehensive Overview
4.6
of Signaling Pathways, Morphological Changes, and Physiological Significance and
Therapeutic Implications. Cells. 2024 Nov 6;13(22):1838. doi: 10.3390/cells13221838.
508 Chauhan K, Vijayan V, Pant P, Sharma S, Hassan MI, Ganguly NK, Sharma P, Rana
R. Identifying potential inhibitors against galectin-3-binding protein (LGALS3BP) 3.8
for therapeutic targeting of glioma. J Biomol Struct Dyn. 2024 Nov 26:1-13.
507 Jeong GJ, Khan F, Kim DK, Cho KJ, Tabassum N, Choudhury A, Hassan MI, Jung
WK, Kim HW, Kim YM. Marine polysaccharides for antibiofilm application: A 8.02
focus on biomedical fields. Int J Biol Macromol. 2024 Dec;283(Pt 4):137786.
506 Ashraf A, Choudhary A, Khan MA, Noor S, Hussain A, Alajmi MF, Hassan MI.
Targeting transcriptional regulatory protein RfaH with natural compounds to
3.6
develop novel therapies against Klebsiella pneumoniae. J Biomol Struct Dyn. 2024
Nov 14:1-13. doi: 10.1080/07391102.2024.2427376.
505 Zehra, Anjum F, Jawaid T, Ishrat R, Hassan MI. Investigating the inhibitory
potential of natural bioactive compounds against cyclin-dependent kinase 13:
2.2
virtual high throughput screening and MD simulation studies to target CDK
signaling. J Recept Signal Transduct Res. 2024 Aug;44(4):140-150.
504 Saeed MU, Ahmed S, Choudhury A, Hussain A, Alajmi MF, Mohammad T, Hassan
MI. Discovering novel inhibitors of RfaH from Klebsiella pneumoniae to combat 2.3
antimicrobial resistance. Arch Microbiol. 2024 Nov 20;206(12):472.
503 Taiyab, A., Mohammad, T., Sulaimani, M. et al. Structure-guided identification of
potential MTH1 inhibitors from natural compounds: toward therapeutic targeting 2.4
of oxidative DNA damage in cancer. Chem. Pap. (2025).

12 Hassan’s CV
502 Rais A, Husain A, Hasan GM, Hassan MI. A review on regulation of cell cycle by
8.02
extracellular matrix. Int J Biol Macromol. 2023 Jan 25;232:123426.
501 Neha, Anwar S, Pinky, Hassan MI, Parvez S. Ropinirole reverses the effects of
neuroinflammation, and cellular demise by downregulating the MARK4-NFκβ
8.02
signaling system in Alzheimer's disease. Int J Biol Macromol. 2024 Jun;271(Pt
1):132425. doi: 10.1016/j.ijbiomac.2024.132425.
500 Alotaibi BS, Hakami MA, Anwar S, Mawkili W, Albaqami A, Hassan MI. Structure-
based investigation of pyruvate dehydrogenase kinase-3 inhibitory potential of
8.02
thymoquinone, targeting lung cancer therapy. Int J Biol Macromol. 2024 Mar
20;265(Pt 2):131064.
499 Jairajpuri DS, Khan S, Anwar S, Hussain A, Alajmi MF, Hassan I. Investigating the
role of thymol as a promising inhibitor of pyruvate dehydrogenase kinase 3 for 8.02
targeted cancer therapy. Int J Biol Macromol. 2024 Feb;259(Pt 2):129314.
498 Yousuf M, Khan S, Hussain A, Alajmi MF, Shamsi A, Haque QMR, Islam A, Hassan
MI. Exploring therapeutic potential of Rutin by investigating its cyclin-dependent
8.02
kinase 6 inhibitory activity and binding affinity. Int J Biol Macromol. 2024 Mar
6;264(Pt 2):130624.
497 Taiyab A, Choudhury A, Haidar S, Yousuf M, Rathi A, Koul P, Chakrabarty A,
Islam A, Shamsi A, Hassan MI. Exploring MTH1 inhibitory potential of
7.56
Thymoquinone and Baicalin for therapeutic targeting of breast cancer. Biomed
Pharmacother. 2024 Apr;173:116332.
496 Shakeel I, Haider S, Khan S, Ahmed S, Hussain A, Alajmi MF, Chakrabarty A, Afzal
M, MI. Thymoquinone, artemisinin, and thymol attenuate proliferation of lung
7.56
cancer cells as Sphingosine kinase 1 inhibitors. Biomed Pharmacother. 2024
Aug;177:117123. doi: 10.1016/j.biopha.2024.117123.
495 Singh Y, Ahmad R, Raza A, Warsi MS, Mustafa M, Khan H, Hassan MI, Khan R,
Moinuddin, Habib S. Exploring the effects of 4-chloro-o-phenylenediamine on
7.6
human fibrinogen: A comprehensive investigation via biochemical, biophysical and
computational approaches. Int J Biol Macromol. 2024 Sep 21;280(Pt 2):135825.
494 Rathi A, Chaudhury A, Anjum F, Ahmad S, Haider S, Khan ZF, Taiyab A,
Chakrabarty A, Islam A, Hassan MI, Haque MM. Targeting prostate cancer via
7.6
therapeutic targeting of PIM-1 kinase by Naringenin and Quercetin. Int J Biol
Macromol. 2024 Sep;276(Pt 2):133882. doi: 10.1016/j.ijbiomac.2024.133882.
493 Sharma B, Dhiman C, Hasan GM, Shamsi A, Hassan MI. Pharmacological Features
and Therapeutic Implications of Plumbagin in Cancer and Metabolic Disorders: A 5.6
Narrative Review. Nutrients. 2024 Sep 8;16(17):3033. doi: 10.3390/nu16173033.
492 Mustafa M, Abbas K, Alam M, Habib S, Zulfareen, Hasan GM, Islam S, Shamsi A,
Hassan I. Investigating underlying molecular mechanisms, signaling pathways,
5.6
emerging therapeutic approaches in pancreatic cancer. Front Oncol. 2024 Jul
17;14:1427802. doi: 10.3389/fonc.2024.1427802.
491 Anwar S, Ahmed A, Sarli V, Hassan I. Editorial: Protein kinase inhibitors in
neurodegeneration and cancer targeted therapies. Front Cell Dev Biol. 2024 Apr 5.8
18;12:1413293. doi: 10.3389/fcell.2024.1413293.
490 Naz F, Arish M, Hassan I. Editorial: Sphingolipids in infections, diseases, and
6.5
disorders. Front Immunol. 2024 Mar 14;15:1392055.
489 Khan S, Upadhyay S, Hassan MI. Novel prospects in targeting neurodegenerative
4.5
disorders via autophagy. Eur J Pharmacol. 2024 Oct 18;984:177060.
488 Singh P, Tabassum G, Masood M, Anwar S, Syed MA, Dev K, Hassan MI, Haque
3.5
MM, Dohare R, Singh IK. Investigating the role of prognostic mitophagy-related

13 Hassan’s CV
 genes in non-small cell cancer pathogenesis via multiomics and network-based
approach. 3 Biotech. 2024 Nov;14(11):273. doi: 10.1007/s13205-024-04127-y.
487 Habib I, Sulaimani MN, Jairajpuri DS, Hussain A, Mohammad T, Alajmi MF,
Shamsi A, Hassan MI. Identification of potential bioactive phytochemicals for the
4.5
inhibition of platelet-derived growth factor receptor β: a structure-based approach
for cancer therapy. Front Mol Biosci. 2024 Oct 15;11:1492847.
486 Rathi A, Noor S, Khan S, Khan F, Anjum F, Ashraf A, Taiyab A, Islam A, Hassan
MI, Haque MM. Investigating pH-induced conformational switch in PIM-1: An
3.8
integrated multi spectroscopic and MD simulation study. Comput Biol Chem. 2024
Oct 28;113:108265. doi: 10.1016/j.compbiolchem.2024.108265.
485 Alam M, Gulzar M, Akhtar MS, Zulfareen, Tanuja, Rashid S, Shamsi A, Hassan MI.
Epigallocatechin-3-gallate therapeutic potential in human diseases: molecular
6.1
mechanisms and clinical studies 2024, Molecular Biomedicine.
DOI : 10.1186/s43556-024-00223-w.
484 Prasad K, Hassan MI, Raghuvanshi S, Kumar V. Understanding the relationship
between cerebellum and the frontal-cortex region of C9orf72-related amyotrophic
3.6
lateral sclerosis: A comparative analysis of genetic features. PLoS One. 2024 May
16;19(5):e0301267. doi: 10.1371/journal.pone.0301267.
483 Sulaimani MN, Ahmed S, Anjum F, Mohammad T, Shamsi A, Dohare R, Hassan
MI. Structure-guided identification of mitogen-activated protein kinase-1 inhibitors 3.6
towards anticancer therapeutics. PLoS One. 2025 Jan 24;20(1):e0311954.
482 Khan ZF, Rathi A, Khan A, Anjum F, Shamsi A, Hassan MI. Exploring PDK3
inhibition in lung cancer through drug repurposing for potential therapeutic 3.8
interventions. Scientific Reports. DOI : 10.1038/s41598-024-78022-0.
481 Aazad, Choudhury A, Hussain A, AlAjmi MF, Mohammad T, Prabha S, Sharma
MK, Shamsi A, Hassan MI. Exploring Phytochemical Inhibitors of Protein Kinase C
4.2
Alpha (PKCa) for therapeutic targeting of Alzheimer's disease. Journal of
Alzheimer’s Disease. 2024 Oct.
480 Mustafa M, Habib S, Imtiyaz K, Tufail N, Ahmad R, Hamim B, Abbas K, Ahmad W,
Khan S, Moinuddin, Rizvi MMA, Hassan MI, Siddiqui SA. Characterization of
structural, genotoxic, and immunological effects of methyl methanesulfonate 7.6
(MMS) induced DNA modifications: Implications for inflammation-driven
carcinogenesis. Int J Biol Macromol. 2024 May;268(Pt 1):131743.
479 Anwar S, Khan S, Hussain A, Alajmi MF, Shamsi A, Hassan MI. Investigating
Pyruvate Dehydrogenase Kinase 3 Inhibitory Potential of Myricetin Using
4.2
Integrated Computational and Spectroscopic Approaches. ACS Omega. 2024 Jun
26;9(27):29633-29643. doi: 10.1021/acsomega.4c03001.
478 Ahmed S, Queen A, Irfan I, Siddiqui MN, Abdulhameed Almuqdadi HT, Setia N,
Ansari J, Hussain A, Hassan MI, Abid M. Vanillin-Isatin Hybrid-Induced MARK4
4.2
Inhibition As a Promising Therapeutic Strategy against Hepatocellular Carcinoma.
ACS Omega. 2024 Jun 5;9(24):25945-25959. doi: 10.1021/acsomega.4c00661.
477 Bhakta A, Mukhtar S, Anwar S, Haider S, Alahmdi MI, Parveen H, Alsharif MA,
Wani MY, Chakrabarty A, Hassan MI, Ahmed N. Design, synthesis, molecular
docking and anti-proliferative activity of novel phenothiazine containing 4.3
imidazo[1,2-a]pyridine derivatives against MARK4 protein. RSC Med Chem. 2024
Apr 19;15(6):1942-1958. doi: 10.1039/d4md00059e.
476 Noor S, Choudhury A, Islam KU, Yousuf M, Raza A, Ansari MA, Ashraf A,
4.2
Hussain A, Hassan MI. Investigating the chemo-preventive role of noscapine in

14 Hassan’s CV
 lung carcinoma via therapeutic targeting of human aurora kinase B. Mol Cell
Biochem. 2024 Jun 3. doi: 10.1007/s11010-024-05036-7.
475 Ashraf A, Hassan MI. Microbial Endocrinology: Host metabolism and appetite
hormones interaction with gut microbiome. Mol Cell Endocrinol. 2024 Oct 4.6
1;592:112281. doi: 10.1016/j.mce.2024.112281.
474 Shafie A, Ashour AA, Anwar S, Anjum F, Hassan MI. Exploring molecular
mechanisms, therapeutic strategies, and clinical manifestations of Huntington's 6.2
disease. Arch Pharm Res. 2024 Jun;47(6):571-595. doi: 10.1007/s12272-024-01499-w.
473 Elasbali AM, Anjum F, Al-Ghabban BA, Shafie A, Mohammad T, Hassan MI.
Phytochemicals Neogitogenin and Samogenin Hold Potentials for Hepatocyte
4.2
Growth Factor Receptor-Targeted Cancer Treatment. OMICS. 2024 Oct 10. doi:
10.1089/omi.2024.0169.
472 Sharma N, Yadav D, Kumari S, Ghosh D, Shandilya M, Hassan MI, Srivastava CM,
Majumder S, Exploring Nano-Protein Corona Dynamics: Tracing the Hard-to-Soft
3.3
Corona Transition with Trypsin and Graphene Oxide in a Silver Nanocomposite
Model. Chemistry Select 9 (36), e202402816.
471 Sharma N, Yadav D, Hassan MI, Srivastava CM, Majumder S. A review on
exploring the impact of graphene oxide-based nanomaterials on structures and 5.3
bioactivity of proteins. Journal of Molecular Liquids. 2024;404:124980.
470 Zehra, Hussain A, AlAjmi MF, Ishrat R, Hassan MI. Enriching Anticancer Drug
Pipeline with Potential Inhibitors of Cyclin-Dependent Kinase-8 Identified from 4.2
Natural Products. OMICS. 2024 Sep;28(9):478-488. doi: 10.1089/omi.2024.0128.
469 Qamar W, Gulia S, Athar M, Ahmad R, Imam MT, Chandra P, Singh BP, Haque R,
Hassan MI, Rahman S. An insight into impact of nanomaterials toxicity on human 3.2
health. PeerJ. 2024 Sep 30;12:e17807. doi: 10.7717/peerj.17807.
Salsbury FR Jr, Adnan M, Bishop TC, Chaires JB, Hassan MI. Editorial: aims and
3.6
scope update. J Biomol Struct Dyn. 2024 Aug 8:1-2.
468 Sumaira S, Vijayarathna S, Hemagirri M, Adnan M, Hassan MI, Patel M, Gupta R,
Shanmugapriya, Chen Y, Gopinath SCB, Kanwar JR, Sasidharan S. Plant bioactive
compounds driven microRNAs (miRNAs): A potential source and novel strategy 3.2
targeting gene and cancer therapeutics. Noncoding RNA Res. 2024 Jun 8;9(4):1140-
1158. doi: 10.1016/j.ncrna.2024.06.003.
467 Mustafa, Mohd, Rizwan Ahmad, Irfan Qadir Tantry, Waleem Ahmad, Sana
Siddiqui, Mudassir Alam, Kashif Abbas, Moinuddin, Md. Imtaiyaz Hassan, Safia
Habib, and et al. 2024. "Apoptosis: A Comprehensive Overview of Signaling 5.6
Pathways, Morphological Changes, and Physiological Significance and Therapeutic
Implications" Cells 13, no. 22: 1838. https://doi.org/10.3390/cells13221838
466 Singh NK, Awasthi P, Gupta A, Anand N, Giri BS, Hassan MI, Hasan S, Identifying
Porphyromonas gingivalis- Infected Hub Genes and Molecular Mechanisms of Oral 1.6
Squamous Cell Carcinoma Pathogenesis. Discover Applied Sciences 2024
465 Mustafa M, Abbas K, Ahmad R, Ahmad W, Tantry IQ, Islam S, M, Alam M,
HASSAN MI, Usmani N, Usmani N, et al: Unmasking vulnerabilities in the age of 2.9
COVID‑19 (Review). World Acad Sci J 7: 2, 2025.
464 Elasbali AM, Al-Soud WA, Anwar S, Alhassan HH, Adnan M, Hassan MI. A review
on mechanistic insights into structure and function of dystrophin protein in
8.02
pathophysiology and therapeutic targeting of Duchenne muscular dystrophy. Int J
Biol Macromol. 2024 Feb 29;264(Pt 1):130544.
463 Anwar S, Choudhury A, Hussain A, AlAjmi MF, Hassan MI, Islam A. Harnessing
8.02
memantine in Alzheimer's disease therapy through inhibition of microtubule

15 Hassan’s CV
 affinity-regulating kinase: Mechanistic insights. Int J Biol Macromol. 2024
Mar;262(Pt 2):130090.
462 Eapen MS, Lu W, Dey S, Chia C, Hardikar A, Hassan MI, Bhattarai P, Gaikwad AV,
Das S, Hansbro PM, Singhera GK, Hackett TL, Sohal SS. Differential expression of
3.6
mast cells in the small airways and alveolar septa of current smokers and patients
with small airway disease and COPD. ERJ Open Res. 2024 Mar 18;10(2):00579-2023.
461 Khan T, Waseem R, Shahid M, Ansari J, Hassan MI, Shamsi A, Islam A.
Understanding the Modulation of α-Synuclein Fibrillation by N-Acetyl Aspartate: 4.2
A Brain Metabolite. ACS Omega. 2024 Feb 29;9(10):12262-12271.
460 Bashir S, Aiman A, Chaudhary AA, Khan N, Ahanger IA, Sami N, Almugri EA, Ali
MAM, Khan S, Shahid M, Basir SF, Hassan MI, Islam A, Probing protein
aggregation through spectroscopic insights and multimodal approaches: A 4.0
comprehensive review for counteracting neurodegenerative disorders, Heliyon,
2024, 10 (7): e27949.
459 Shafie, A.; Ashour, A.A.; Anjum, F.; Shamsi, A.; Hassan, M.I. Elucidating the Impact
of Deleterious Mutations on IGHG1 and Their Association with Huntington’s 4.6
Disease. J. Pers. Med. 2024, 14.
458 Ahmed S, Chaudhury A, Saeed MU, Mohammad T, Hussain A, AlAjmi MF, Hassan
MI, Structure-guided computational identification of interleukin-2-inducible T-cell 4.4
kinase modulators, Journal of Biomolecular Structure & Dynamics, 2024.
457 Ahmed, S; Queen, A; Irfan, I; Siddiqui, MN; Abdulhameed, H; Setia, N; Ansari, J;
Hussain, A; Hassan, MI; Abid, M. Vanillin-Isatin hybrids-induced MARK4-
4.6
inhibition as a promising therapeutic strategy against hepatocellular carcinoma.
ACS Omega 2024.
456 Batra S, Jahan S, Ashraf A, Alharby B, Jawaid T, Islam A, Hassan I. A review on
cyclin-dependent kinase 5: An emerging drug target for neurodegenerative 8.02
diseases. Int J Biol Macromol. 2023 Mar 1;230:123259.
455 Hasan GM, Anwar S, Shamsi A, Sohal SS, Hassan MI. The neuroprotective potential
of phytochemicals in traumatic brain injury: mechanistic insights and 5.6
pharmacological implications. Front Pharmacol. 2024 Jan 4;14:1330098.
454 A. Rathi, A. Khan, S. Haider, S. Roy, A. Taiyab, S. Mahendru, Hassan MI, Exploring
the potential of baicalin and resveratrol as PIM-1 kinase inhibitors: Therapeutic
6.0
targeting of prostate and breast cancers Journal of Molecular Liquids 2024; 396:
124026
453 Elasbali AM, Al-Soud WA, Adnan M, Alhassan HH, Mohammad T, Hassan MI.
Discovering Promising Biomarkers and Therapeutic Targets for Duchenne 5.5
Muscular Dystrophy: a Multiomics Meta-Analysis Approach. Mol Neurobiol. 2024.
452 Shakeel I, Ashraf A, Afzal M, Sohal SS, Islam A, Kazim SN, Hassan MI. The
Molecular Blueprint for Chronic Obstructive Pulmonary Disease (COPD): A New
7.5
Paradigm for Diagnosis and Therapeutics. Oxid Med Cell Longev. 2023 Dec
21;2023:2297559.
451 Noor S, Choudhury A, Raza A, Ashraf A, Islam KU, Hussain A, Imtiyaz K, Islam A,
Hassan MI. Probing Baicalin as potential inhibitor of Aurora kinase B: A step 8.2
towards lung cancer therapy. Int J Biol Macromol. 2023 Dec 18;258(Pt 1):128813.
450 Gulzar M, Noor S, Hasan GM, Hassan MI. The role of serum and glucocorticoid-
regulated kinase 1 in cellular signaling: Implications for drug development. Int J 8.2
Biol Macromol. 2023 Dec 12;258(Pt 1):128725.
449 Ashraf A, Ahmad M, Mariadasse R, Khan MA, Noor S, Islam A, Hassan MI.
4.2
Integrated spectroscopic and MD simulation approach to decipher the effect of pH

16 Hassan’s CV
 on the structure function of Staphylococcus aureus thymidine kinase. J Biomol
Struct Dyn. 2023 Dec 15:1-12.
448 Azhar MK, Anwar S, Hasan GM, Shamsi A, Islam A, Parvez S, Hassan MI.
Comprehensive Insights into Biological Roles of Rosmarinic Acid: Implications in
5.7
Diabetes, Cancer and Neurodegenerative Diseases. Nutrients. 2023 Oct
9;15(19):4297.
447 I. Shakeel, M. Afzal, A. Islam, S. S. Sohal and M. I. Hassan, Idiopathic pulmonary
fibrosis: Pathophysiology, cellular signaling, diagnostic and therapeutic --
approaches. Medicine in Drug Discovery 2023: 100167.
446 Khan T, Waseem R, Zehra Z, Aiman A, Bhardwaj P, Ansari J, Hassan MI, Islam A.
Mitochondrial Dysfunction: Pathophysiology and Mitochondria-Targeted Drug 6.23
Delivery Approaches. Pharmaceutics. 2022 Nov 30;14(12):2657.
445 Alam M, Hasan GM, Eldin SM, Adnan M, Riaz MB, Islam A, Khan I, Hassan MI.
Investigating regulated signaling pathways in therapeutic targeting of non-small 7.41
cell lung carcinoma. Biomed Pharmacother. 2023 May;161:114452.
444 A Alam M, Rashid S, Fatima K, Adnan M, Shafie A, Akhtar MS, Ganie AH, Eldin
SM, Islam A, Khan I, Hassan MI. Biochemical features and therapeutic potential of
7.41
α-Mangostin: Mechanism of action, medicinal values, and health benefits. Biomed
Pharmacother. 2023 May 2;163:114710. doi: 10.1016/j.biopha.2023.114710.
443 Adnan M, DasGupta D, Anwar S, Shamsi A, Siddiqui AJ, Snoussi M, Bardakci F,
Patel M, Hassan MI. Mechanistic insights into MARK4 inhibition by galantamine
5.2
toward therapeutic targeting of Alzheimer's disease. Front Pharmacol. 2023 Sep
19;14:1276179.
442 Azhar MK, Anwar S, Hasan GM, Shamsi A, Islam A, Parvez S, Hassan MI (2023)
Comprehensive insight into biological roles of Rosmarinic acid in
6.6
Disease therapeutics: Implications in Diabetes, Neurodegenerative diseases
and Cancer. Nutrients (In Press)
441 Shakeel I, Khan S, Roy S, Sherwani F, Ahmad SF, Sohal SS, Afzal M, Hassan MI.
Investigating potential of cholic acid, syringic acid, and mangiferin as cancer
8.2
therapeutics through sphingosine kinase 1 inhibition. Int J Biol Macromol. 2023 Oct
1:127036. doi: 10.1016/j.ijbiomac.2023.127036.
440 Hasan GM, Shamsi A, Sohal SS, Alam M, Hassan MI. Structure-Based Identification
of Natural Compounds as Potential RET-Kinase Inhibitors for Therapeutic
4.8
Targeting of Neurodegenerative Diseases. J Alzheimers Dis. 2023 Sep 11. doi:
10.3233/JAD-230698.
439 Jairajpuri DS, Mohammad T, Hussain A, Alajmi MF, Yadav DK, Hassan MI.
Identification of High-Affinity Inhibitors of TANK-Binding Kinase 1 (TBK1): A
2.1
Promising Frontier for Controlling Inflammatory Signaling in Cancer. Discov Med.
2024 Jan;36(180):129-139.
438 T. Mohammad, A. Hussain, M. F. Alajmi, S. Hasan, D. K. Yadav and M. I. Hassan,
Identifying potential inhibitors of phosphatidylinositol 4,5-bisphosphate 3-kinase:
2.2
Molecular dynamic insights into the interaction and inhibitory mechanism.
Chemical Physics Impact 2024, 8: 100458
437 Alam J, Kalash A, Hassan MI, Rahman SZ. Agents at the Peak of US FDA Approval
2.4
for the Treatment of Alzheimer's Disease. Neurol Res. 2024 Jan 10:1-8.
Saifi S, Ashraf A, Hasan GM, Shamsi A, Hassan MI. Insights into the preventive
actions of natural compounds against Klebsiella pneumoniae infections and drug 3.6
resistance. Fitoterapia. 2023 Dec 31;173:105811.

17 Hassan’s CV
436 Jairajpuri DS, Mohammad T, Hussain A, Amir S, Fatima U, AlAjmi MF, Yadav DK,
Hassan MI. An integrated docking and molecular dynamics simulation approach to
2.4
discover potential inhibitors of activin receptor-like kinase 1. J Mol Recognit. 2023
Dec 6:e3069.
435 Gaur T, Ali A, Sharma D, Gupta SK, Gota V, Bagal B, Platzbeckar U, Mishra R, Dutt
A, Khattry N, Mills K, Hassan MI, Sandur S, Hasan SK. Mitocurcumin utilizes
4.5
oxidative stress to upregulate JNK/p38 signaling and overcomes Cytarabine
resistance in acute myeloid leukemia. Cell Signal. 2024 Feb;114:111004.
434 Ahmed S, Nadeem M, Hussain I, Fatima S, Anwar S, Rizvi MA, Hassan MI, Tabish
M. Preparation of nanoformulation of 5-fluorouracil to improve anticancer efficacy:
4.2
integrated spectroscopic, docking, and MD simulation approaches. J Biomol Struct
Dyn. 2023 Oct 18:1-14.
433 Alam M, Ahmed S, Abid M, Hasan GM, Islam A, Hassan MI. Therapeutic targeting
of microtubule affinity-regulating kinase 4 in cancer and neurodegenerative 4.6
diseases. J Cell Biochem. 2023 Sep;124(9):1223-1240. doi: 10.1002/jcb.30468.
432 Banerjee P, Chandra A, Mohammad T, Singh N, Hassan MI, Qamar I. Identification
of high-affinity pyridoxal kinase inhibitors targeting cancer therapy: an integrated
5.2
docking and molecular dynamics simulation approach. J Biomol Struct Dyn. 2023
Aug 14:1-18. doi: 10.1080/07391102.2023.2246580.
431 Hasan GM, Hassan MI, Sohal SS, Shamsi A, Alam M. Therapeutic Targeting of
Regulated Signaling Pathways of Non-Small Cell Lung Carcinoma. ACS Omega. 4.7
2023 Jul 17;8(30):26685-26698. doi: 10.1021/acsomega.3c02424.
430 Voura M, Anwar S, Sigala I, Parasidou E, Fragoulidou S, Hassan MI, Sarli V.
Synthesis, Structural Modification, and Bioactivity Evaluation of Substituted
6.0
Acridones as Potent Microtubule Affinity-Regulating Kinase 4 Inhibitors. ACS
Pharmacol Transl Sci. 2023 Jul 4;6(7):1052-1074. doi: 10.1021/acsptsci.3c00084.
429 Kumar D, Noor S, Alam M, Hassan MI. Editorial: Molecular dynamics of cognitive-
motor impairment in neurodegenerative diseases. Front Mol Neurosci. 2023 Jun 4.8
22;16:1237769. doi: 10.3389/fnmol.2023.1237769.
428 Waseem R, Khan T, Shamsi A, Shahid M, Kazim SN, Hassan MI, Islam A.
Inhibitory potential of N-acetylaspartate against protein glycation, AGEs formation
8.2
and aggregation: Implication of brain osmolyte in glycation-related complications.
Int J Biol Macromol. 2023 Jul 31;244:125405. doi: 10.1016/j.ijbiomac.2023.125405.
427 Anwar S, Mohammad T, Azhar MK, Fatima H, Alam A, Hasan GM, Islam A, Kaur
P, Hassan MI. Investigating MARK4 inhibitory potential of Bacopaside II: Targeting 8.2
Alzheimer's disease. Int J Biol Macromol. 2023 Aug 1;245:125364.
426 Hassan MI. Multi-omics approaches to therapeutic target identification. Brief Funct
4.32
Genomics. 2023 Apr 13;22(2):75. doi: 10.1093/bfgp/elac058.
425 Khan MA, Mohammad T, Malik A, Hassan MI, Domashevskiy AV. Iron response
elements (IREs)-mRNA of Alzheimer's amyloid precursor protein binding to iron
4.23
regulatory protein (IRP1): a combined molecular docking and spectroscopic
approach. Sci Rep. 2023 Mar 28;13(1):5073.
424 Sharma, P., Kumari, S., Ghosh, D., Kumar, J., Vij, A., Brajpuriya, R., Rawat, P.,
Srivastava, C., Saini, S., Sharma, V., Hassan, M. & Majumder, S. (2023). Structural
morphological, and thermal properties of nano bentonite and α-Fe2O3/bentonite 1.2
nanocomposite. Zeitschrift für Physikalische Chemie. https://doi.org/10.1515/zpch-
2022-0073
423 Raina, N., Singh, E., Ahanger, I.A., Shahid, M., Israil, Hassan, M.I., Ahmad, F.,
6.09
Singh, A.K., and Islam, A. (2023). Polyethylene glycol induced structural

18 Hassan’s CV
 modulation of holo alpha-lactalbumin: In vitro and in vivo approach towards
protein stability. Journal of Molecular Liquids 382, 121909.
422 Ahmad S, Hassan MI, Gupta D, Dwivedi N, Islam A. Design and evaluation of
pyrimidine derivatives as potent inhibitors of ABCG2, a breast cancer resistance 3.2
protein. 3 Biotech. 2022 Sep;12(9):182. doi: 10.1007/s13205-022-03231-1.
421 Ali T, Anjum F, Choudhury A, Shafie A, Mohammad T, Hassan MI, Identification
of natural product-based effective inhibitors of spleen tyrosine kinase (SYK)
5.2
through virtual screening and molecular dynamics simulation approaches. J
Biomol Struct Dyn. 2023 (In press)
420 Kumar D, Hasan GM, Islam A, Hassan MI. Therapeutic targeting of Huntington's
disease: Molecular and clinical approaches. Biochem Biophys Res Commun. 2023 3.57
May 7;655:18-24. doi: 10.1016/j.bbrc.2023.02.075.
419 Khan A, Bealy MA, Alharbi B, Khan S, Alharethi SH, Al-Soud WA, Mohammad T,
Hassan MI, Alshammari N, Ahmed Al-Keridis L. Discovering potential inhibitors
of Raf proto-oncogene serine/threonine kinase 1: a virtual screening approach 5.2
towards anticancer drug development. J Biomol Struct Dyn. 2023 Apr 27:1-12. doi:
10.1080/07391102.2023.2204380.
418 Elasbali AM, Al-Soud WA, Elfaki EM, Alanazi HA, Alharbi B, Alharethi SH, Anwer
K, Mohammad T, and Hassan MI. (2023) Identification of novel c-Kit inhibitors
5.2
from natural sources using virtual screening and molecular dynamics simulations.
Journal of Biomolecular Structure & Dynamics (In press)
417 Singh P, Rathi A, Minocha R, Sinha A, Haque MM, Hassan MI, Dohare R. Breast
Cancer Prognostic Hub Genes Identified by Integrated Transcriptomic and
3.98
Weighted Network Analysis: A Road Toward Personalized Medicine. OMICS. 2023
May 8. doi: 10.1089/omi.2023.0033.
416 Ali N, Aiman A, Shamsi A, Hassan I, Shahid M, Gaur NA, Islam A. Identification of
Thermostable Xylose Reductase from Thermothelomyces thermophilus: A
4.02
Biochemical Characterization Approach to Meet Biofuel Challenges. ACS Omega.
2022 Nov 17;7(48):44241-44250.
415 Waseem R, Shamsi A, Khan T, Anwer A, Shahid M, Kazim SN, Hassan MI, Islam A.
Characterization of advanced glycation end products and aggregates of irisin:
4.23
Multispectroscopic and microscopic approaches. J Cell Biochem. 2023
Jan;124(1):156-168.
414 Ali N, Zehra Z, Shamsi A, Beg MA, Parray ZA, Israil, Imam MA, Gaur NA, Hassan
MI, Chaudhary AA, Rudayni HA, Alghonaim MI, Alsalamah SA, Islam A.
4.23
Elucidating the Role of Santalol as a Potent Inhibitor of Tyrosinase: In Vitro and In
Silico Approaches. Molecules. 2022 Dec 15;27(24):8915.
413 Mann GS, Azum N, Khan A, Rub MA, Hassan MI, Fatima K, Asiri AM. Green
Composites Based on Animal Fiber and Their Applications for a Sustainable Future. 4.23
Polymers (Basel). 2023 Jan 24;15(3):601.
412 Naqvi AAT, Rizvi SAM, Hassan MI. Pan-cancer analysis of Chromobox (CBX)
genes for prognostic significance and cancer classification. Biochim Biophys Acta 6.63
Mol Basis Dis. 2023 Jan 1;1869(1):166561.
411 Parray ZA, Naqvi AAT, Ahanger IA, Shahid M, Ahmad F, Hassan MI, Islam A.
Measuring Structural Changes in Cytochrome c under Crowded Conditions Using 4.36
In Vitro and In Silico Approaches. Polymers (Basel). 2022 Nov 9;14(22):4808.
410 Anwar S, Shahwan M, Hasan GM, Islam A, Hassan MI. Microtubule-affinity
regulating kinase 4: A potential drug target for cancer therapy. Cell Signal. 2022 4.2
Aug 9;99:110434. doi: 10.1016/j.cellsig.2022.110434.

19 Hassan’s CV
409 Bouali N, Hammouda MB, Ahmad I, Ghannay S, Thouri A, Dbeibia A, Patel H,
Hamadou WS, Hosni K, Snoussi M, Adnan M, Hassan MI, Noumi E, Aouadi K,
Kadri A. Multifunctional Derivatives of Spiropyrrolidine Tethered Indeno-
4.2
Quinoxaline Heterocyclic Hybrids as Potent Antimicrobial, Antioxidant and
Antidiabetic Agents: Design, Synthesis, In Vitro and In Silico Approaches.
Molecules. 2022 Oct 25;27(21):7248.
408 Adnan M, Shamsi A, Elasbali AM, Siddiqui AJ, Patel M, Alshammari N, Alharethi
SH, Alhassan HH, Bardakci F, Hassan MI. Structure-Guided Approach to Discover
3.8
Tuberosin as a Potent Activator of Pyruvate Kinase M2, Targeting Cancer Therapy.
Int J Mol Sci. 2022 Oct 29;23(21):13172.
407 Mushtaq A, Singh P, Tabassum G, Mohammad T, Hassan MI, Syed MA, Dohare R.
Unravelling hub genes as potential therapeutic targets in lung cancer using
5.2
integrated transcriptomic meta-analysis and in silico approach. J Biomol Struct Dyn.
2022 Nov 1:1-14.
406 Khatoon F, Ali S, Kumar V, Elasbali AM, Alhassan HH, Alharethi SH, Islam A,
Hassan MI. Pharmacological features, health benefits and clinical implications of 5.2
honokiol. J Biomol Struct Dyn. 2022 Sep 12:1-23.
405 Adnan M, Anwar S, DasGupta D, Patel M, Elasbali AM, Alhassan HH, Shafie A,
Siddiqui AJ, Bardakci F, Snoussi M, Hassan MI. Targeting inhibition of microtubule
8.02
affinity regulating kinase 4 by Harmaline: Strategy to combat Alzheimer's disease.
Int J Biol Macromol. 2022 Oct 17:S0141-8130(22)02361-3.
404 Yousuf M, Shamsi A, Khan S, Khan P, Shahwan M, Elasbali AM, Haque QMR,
Hassan MI. Naringenin as a potential inhibitor of human cyclin-dependent kinase
8.02
6: Molecular and structural insights into anti-cancer therapeutics. Int J Biol
Macromol. 2022 Jul 31;213:944-954.
403 Alam M, Ansari MM, Noor S, Mohammad T, Hasan GM, Kazim SN, Hassan MI.
Therapeutic targeting of TANK-binding kinase signaling towards anticancer drug
8.02
development: Challenges and opportunities. Int J Biol Macromol. 2022 May
15;207:1022-1037. doi: 10.1016/j.ijbiomac.2022.03.157.
402 Noor S, Mohammad T, Ashraf GM, Farhat J, Bilgrami AL, Eapen MS, Sohal SS,
Yadav DK, Hassan MI. Mechanistic insights into the role of serum-glucocorticoid
8.02
kinase 1 in diabetic nephropathy: A systematic review. Int J Biol Macromol. 2021
Oct 26:S0141-8130(21)02322-9. doi: 10.1016/j.ijbiomac.2021.10.165.
401 Yousuf, M., Alam, M., Shamsi, A., Khan, P., Hasan, G. M., Rizwanul Haque, Q. M.,
and Hassan, M. I. (2022) Structure-guided design and development of cyclin-
8.02
dependent kinase 4/6 inhibitors: A review on therapeutic implications, International
Journal of Biological Macromolecules. https://doi.org/10.1016/j.ijbiomac.2022.07.156
400 Fatima U, Roy S, Ahmad S, Al-Keridis LA, Alshammari N, Adnan M, Islam A,
Hassan MI. Investigating neuroprotective roles of Bacopa monnieri extracts:
7.41
Mechanistic insights and therapeutic implications. Biomed Pharmacother. 2022
Sep;153:113469.
399 Kumar D, Ashraf GM, Hassan MI. Therapeutic integrity of microbiome-based
medicines in neurodegenerative disorders. Current Neuropharmacology 2022 Feb 7.70
14. doi: 10.2174/1570159X20666220214113816.
398 Noor S, Mohammad T, Rub MA, Raza A, Azum N, Yadav DK, Hassan MI, Asiri
AM. Biomedical features and therapeutic potential of rosmarinic acid. Arch Pharm 6.01
Res. 2022 Apr;45(4):205-228. doi: 10.1007/s12272-022-01378-2.
397 Uddin A, Gupta S, Mohammad T, Shahi D, Hussain A, Alajmi MF, El-Seedi HR,
5.98
Hassan I, Singh S, Abid M. Target-Based Virtual Screening of Natural Compounds

20 Hassan’s CV
 Identifies a Potent Antimalarial With Selective Falcipain-2 Inhibitory Activity.
Frontiers in Pharmacology 2022 Apr 6;13:850176. doi: 10.3389/fphar.2022.850176.
396 Aggarwal S, Bhadana K, Singh B, Rawat M, Mohammad T, Al-Keridis LA,
Alshammari N, Hassan MI, Das SN. Cinnamomum zeylanicum Extract and its
5.98
Bioactive Component Cinnamaldehyde Show Anti-Tumor Effects via Inhibition of
Multiple Cellular Pathways. Front Pharmacol. 2022 Jun 2;13:918479.
395 Alam M, Ashraf GM, Sheikh K, Khan A, Ali S, Ansari MM, Adnan M, Pasupuleti
VR, Hassan MI. Potential Therapeutic Implications of Caffeic Acid in Cancer 5.98
Signaling: Past, Present, and Future. Front Pharmacol. 2022 Mar 9;13:845871.
394 Shamsi A, DasGupta D, Alhumaydhi FA, Khan MS, Alsagaby SA, Al Abdulmonem
W, Hassan MI, Yadav DK. Inhibition of MARK4 by serotonin as an attractive
3.4
therapeutic approach to combat Alzheimer's disease and neuroinflammation. RSC
Medicinal Chemistry 2022 Apr 20;13(6):737-745.
393 Alotaibi BS, Joshi J, Hasan MR, Khan MS, Alharethi SH, Mohammad T,
Alhumaydhi FA, Elasbali AM, Hassan MI. Identifying Isoononin and Candidissiol
as Rho-associated protein kinase 1 (ROCK1) inhibitors: a combined virtual 5.2
screening and MD simulation approach. J Biomol Struct Dyn. 2022 Aug 13:1-10. doi:
10.1080/07391102.2022.2111362.
392 Fatima U, Roy S, Ahmad S, Ali S, Elkady WM, Khan I, Alsaffar RM, Adnan M,
Islam A, Hassan MI. Pharmacological attributes of Bacopa monnieri extract: 6.5
Current updates and clinical manifestation. Front Nutr. 2022 Aug 18;9:972379.
391 Khan T, Waseem R, Zehra Z, Aiman A, Bhardwaj P, Ansari J, Hassan MI, Islam A.
Mitochondrial Dysfunction: Pathophysiology and Mitochondria-Targeted Drug 6.5
Delivery Approaches. Pharmaceutics. 2022; 14(12):2657.
390 Ali N, Zehra Z, Shamsi A, Beg MA, Parray ZA, Israil, Imam MA, Gaur NA, Hassan
MI, Chaudhary AA, Rudayni HA, Alghonaim MI, Alsalamah SA, Islam A (2022)
4.2
Elucidating the role of santalol as a potent inhibitor of tyrosinase:
In vitro and In silico approaches. Molceuls (In Press)
389 Hassan MI, Anjum D, Mohammad T, Alam M, Khan MS, Shahwan M, Shamsi A,
Yadav DK (2022) Integrated virtual screening and MD simulation study to discover
5.2
potential inhibitors of Lyn-kinase: targeting cancer therapy. Journal of Biomolecular
Structure & Dynamics (In Press)
388 Xue B, Chaddha M, Elasbali AM, Zhu Z, Jairajpuri DS, Alhumaydhi FA,
Mohammad T, Abdulmonem WA, Sharaf SE, Hassan MI. Death-Associated Protein
3.98
Kinase 3 Inhibitors Identified by Virtual Screening for Drug Discovery in Cancer
and Hypertension. OMICS. 2022 Jul;26(7):404-413.
387 Xue B, DasGupta D, Alam M, Khan MS, Wang S, Shamsi A, Islam A, Hassan MI.
Investigating binding mechanism of thymoquinone to human transferrin, targeting 4.48
Alzheimer's disease therapy. Journal of Cellular Biochemistry 2022 Jun 20.
386 Baig MH, Yousuf M, Khan MI, Khan I, Ahmad I, Alshahrani MY, Hassan MI, Dong
JJ. Investigating the Mechanism of Inhibition of Cyclin-Dependent Kinase 6
5.73
Inhibitory Potential by Selonsertib: Newer Insights Into Drug Repurposing.
Frontiers in Oncology 2022 May 26;12:865454.
385 Mohammad T, Singh P, Jairajpuri DS, Al-Keridis LA, Alshammari N, Adnan M,
Dohare R, Hassan MI. Differential Gene Expression and Weighted Correlation
5.73
Network Dynamics in High-Throughput Datasets of Prostate Cancer. Frontiers in
Oncology 2022 Jun 1;12:881246. doi: 10.3389/fonc.2022.881246.

21 Hassan’s CV
384 Ahmed S, Mobashir M, Al-Keridis LA, Alshammari N, Adnan A, Abid M and
Hassan MI. A network-guided approach to discover phytochemical-based
5.73
anticancer therapy targeting MARK4 for hepatocellular carcinoma. Front. Oncol.
2022, doi: 10.3389/fonc.2022.914032
383 Azeem, K., Ahmed, M., Mohammad, T., Uddin, A., Shamsi, A., Hassan, M. I., Singh,
S., Patel, R., and Abid, M. A multi-spectroscopic and computational simulations
5.2
study to delineate the interaction between antimalarial drug hydroxychloroquine
and human serum albumin, Journal of Biomolecular Structure and Dynamics, 1-17.
382 Alam M, Alam S, Shamsi A, Adnan M, Elasbali AM, Al-Soud WA, Alreshidi M,
Hawsawi YM, Tippana A, Pasupuleti VR, Hassan MI. Bax/Bcl-2 Cascade Is
5.73
Regulated by the EGFR Pathway: Therapeutic Targeting of Non-Small Cell Lung
Cancer. Front Oncol. 2022 Mar 25;12:869672. doi: 10.3389/fonc.2022.869672.
381 Alam M, Ahmed S, Elasbali AM, Adnan M, Alam S, Hassan MI, Pasupuleti VR.
Therapeutic Implications of Caffeic Acid in Cancer and Neurological Diseases. 5.73
Front Oncol. 2022 Mar 10;12:860508. doi: 10.3389/fonc.2022.860508.
380 Singh M, Jayant K, Bhutani S, Bhasin S, Mehra A, Poddar NK, Chaudhary A,
Adnan M, Siddiqui AJ, Hassan MI, Khan FI, Lai D and Khan S, Withania somnifera
(L.) Dunal (Ashwagandha) for the possible therapeutics and clinical management of 6.03
SARS-CoV-2 infection: Plant-based drug discovery and targeted therapy. Frontiers
in Cellular and Infection Microbiology 2022.
379 Rustagi V, Bajaj M, Tanvi, Singh P, Aggarwal R, AlAjmi MF, Hussain A, Hassan MI,
Singh A, Singh IK. Analyzing the Effect of Vaccination Over COVID Cases and
6.03
Deaths in Asian Countries Using Machine Learning Models. Front Cell Infect
Microbiol. 2022 Feb 8;11:806265. doi: 10.3389/fcimb.2021.806265.
378 Parray ZA, Ahmad F, Chaudhary AA, Rudayni HA, Al-Zharani M, Hassan MI,
Islam A. Size-Dependent Interplay of Volume Exclusion Versus Soft Interactions:
6.11
Cytochrome c in Macromolecular Crowded Environment. Front Mol Biosci. 2022
May 25;9:849683. doi: 10.3389/fmolb.2022.849683.
377 Allai FM, Dar BN, Gul K, Adnan M, Ashraf SA, Hassan MI, Pasupuleti VR, Azad
ZRAA. Development of Protein Rich Pregelatinized Whole Grain Cereal Bar
6.5
Enriched With Nontraditional Ingredient: Nutritional, Phytochemical, Textural, and
Sensory Characterization. Front Nutr. 2022 Apr 8;9:870819.
376 Yadav M, Pandey J, Chakraborty A, Hassan MI, Kundu JK, Roy A, Singh IK, Singh
A. A Comprehensive Analysis of Calmodulin-Like Proteins of Glycine max
6.62
Indicates Their Role in Calcium Signaling and Plant Defense Against Insect Attack.
Front Plant Sci. 2022 Mar 9;13:817950. doi: 10.3389/fpls.2022.817950.
375 Waseem R, Shamsi A, Khan T, Hassan MI, Kazim SN, Shahid M, Islam A.
Unraveling the Binding Mechanism of Alzheimer's Drugs with Irisin:
6.2
Spectroscopic, Calorimetric, and Computational Approaches. Int J Mol Sci. 2022
May 25;23(11):5965. doi: 10.3390/ijms23115965.
374 Baig MH, Gupta P, Khan MI, Alajmi MF, Hussain A, Hassan MI, Dong JJ. Probing
the interaction of Selonsertib with human serum albumin: In silico and in vitro 3.57
approaches. Curr Top Med Chem. 2022 Mar 29.
373 Cheke RS, Patil VM, Firke SD, Ambhore JP, Ansari IA, Patel HM, Shinde SD,
Pasupuleti VR, Hassan MI, Adnan M, Kadri A, Snoussi M. Therapeutic Outcomes
5.2
of Isatin and Its Derivatives against Multiple Diseases: Recent Developments in
Drug Discovery. Pharmaceuticals (Basel). 2022 Feb 22;15(3):272.
372 Yousuf M, Ali A, Khan P, Anjum F, Elasbali AM, Islam A, Yadav DK, Shafie A,
4.92
Rizwanul Haque QM, Hassan MI. Insights into the Antibacterial Activity of

22 Hassan’s CV
 Prolactin-Inducible Protein against the Standard and Environmental MDR Bacterial
Strains. Microorganisms. 2022 Mar 9;10(3):597.
371 Guhe V, Anjum F, Shafie A, Hassan MI, Pasupuleti VR, Singh S. Infection Dynamics
of ATG8 in Leishmania: Balancing Autophagy for Therapeutics. Molecules. 2022 4.92
May 13;27(10):3142. doi: 10.3390/molecules27103142.
370 Yang C, Alam A, Alhumaydhi FA, Khan MS, Alsagaby SA, Al Abdulmonem W,
Hassan MI, Shamsi A, Bano B, Yadav DK. Bioactive Phytoconstituents as Potent
4.92
Inhibitors of Tyrosine-Protein Kinase Yes (YES1): Implications in Anticancer
Therapeutics. Molecules. 2022 May 10;27(10):3060. doi: 10.3390/molecules27103060.
369 Waseem R, Shamsi A, Mohammad T, Hassan MI, Kazim SN, Chaudhary AA,
Rudayni HA, Al-Zharani M, Ahmad F, Islam A. FNDC5/Irisin: Physiology and 4.92
Pathophysiology. Molecules. 2022 Feb 8;27(3):1118.
368 Choudhury A, Mohammad T, Anjum F, Shafie A, Singh IK, Abdullaev B,
Pasupuleti VR, Adnan M, Yadav DK, Hassan MI. Comparative analysis of web-
3.75
based programs for single amino acid substitutions in proteins. PLoS One. 2022
May 4;17(5):e0267084. doi: 10.1371/journal.pone.0267084.
367 Alam M, Hasan GM, Ansari MM, Sharma R, Yadav DK, Hassan MI. Therapeutic
implications and clinical manifestations of thymoquinone. Phytochemistry. 2022 4.00
Aug;200:113213. doi: 10.1016/j.phytochem.2022.113213.
366 Anjum F, Sulaimani MN, Shafie A, Mohammad T, Ashraf GM, Bilgrami AL,
Alhumaydhi FA, Alsagaby SA, Yadav DK, Hassan MI. Bioactive phytoconstituents
4.03
as potent inhibitors of casein kinase-2: dual implications in cancer and COVID-19
therapeutics. RSC Adv. 2022 Mar 10;12(13):7872-7882.
365 Habib I, Anjum F, Mohammad T, Sulaimani MN, Shafie A, Almehmadi M, Yadav
DK, Sohal SS, Hassan MI. Differential gene expression and network analysis in 3.85
head and neck squamous cell carcinoma. Mol Cell Biochem. 2022, 477(5):1361-1370.
364 Anjum F, Mohammad T, Asrani P, Shafie A, Singh S, Yadav DK, Uversky VN,
Hassan MI. Identification of intrinsically disorder regions in non-structural proteins
3.85
of SARS-CoV-2: New insights into drug and vaccine resistance. Mol Cell Biochem.
2022 May;477(5):1607-1619. doi: 10.1007/s11010-022-04393-5.
363 Mathur Y, Mohammad T, Anjum F, Shafie A, Elasbali AM, Uversky VN, Hassan
MI. PyPAn: An automated graphical user interface for protein sequence and 1.92
structure analyses. Protein Pept Lett. 2022, 29(4):306-312.
362 Waseem M, Kaushik P, Dutta S, Chakraborty R, Hassan MI, Parvez S. Modulatory
Role of Quercetin in Mitochondrial Dysfunction in Titanium Dioxide Nanoparticle- 4.12
Induced Hepatotoxicity. ACS Omega. 2022 Jan 21;7(4):3192-3202.
361 Idrees, D., Naqvi, A. A. T., Hassan, M. I., Ahmad, F., and Gourinath, S. Insight into
the Conformational Transitions of Serine Acetyl Transferase Isoforms in E.
4.12
histolytica: Implications for Structural and Functional Balance, ACS Omega. 2022,
https://doi.org/10.1021/acsomega.2c02467
360 Ali S, Alam M, Khatoon F, Fatima U, Elasbali AM, Adnan M, Islam A, Hassan MI,
Snoussi M, De Feo V. Natural products can be used in therapeutic management of
7.4
COVID-19: Probable mechanistic insights. Biomed Pharmacother. 2022 Jan
20;147:112658.
359 Adnan M, Jairajpuri DS, Chaddha M, Khan MS, Yadav DK, Mohammad T, Elasbali
AM, Abu Al-Soud W, Hussain Alharethi S, Hassan MI. Discovering Tuberosin and
3.50
Villosol as Potent and Selective Inhibitors of AKT1 for Therapeutic Targeting of
Oral Squamous Cell Carcinoma. Journal of Personalized Medicine. 2022; 12(7):1083.

23 Hassan’s CV
358 Khan, S., Alhumaydhi, F.A., Khan, M.S., Sharaf, S.E., Al Abdulmonem, W., Hassan,
M.I., Shamsi, A., and Kumar Yadav, D. Exploring binding mechanism of naringenin
to human transferrin using combined spectroscopic and computational methods: 6.63
Towards therapeutic targeting of neurodegenerative diseases. Journal of Molecular
Liquids 2022, 356, 119001.
357 Anjum, F.; Joshia, N.; Mohammad, T.; Shafie, A.; Alhumaydhi, F. A.; Aljasir, M. A.;
Shahwan, M. J. S.; Abdullaev, B.; Adnan, M.; Elasbali, A. M.; Pasupuleti, V. R.;
Hassan, M. I., Impact of Single Amino Acid Substitutions in Parkinsonism- 3.50
Associated Deglycase-PARK7 and Their Association with Parkinson’s
Disease. Journal of Personalized Medicine 2022, 12.
356 Yousuf M, Shamsi A, Anjum F, Shafie A, Islam A, Haque QMR, Elasbali AM, Yadav
DK, Hassan MI. Effect of pH on the structure and function of cyclin-dependent 3.75
kinase 6. PLoS One. 2022 Feb 11;17(2):e0263693.
Yousuf, M., Shamsi, A., Mohammad, T., Azum, N., Alfaifi, S. Y. M., Asiri, A. M.,
355 Mohamed Elasbali, A., Islam, A., Hassan, M. I., and Haque, Q. M. R. Inhibiting
4.12
Cyclin-Dependent Kinase 6 by Taurine: Implications in Anticancer Therapeutics,
ACS Omega, 2022. https://doi.org/10.1021/acsomega.2c03479
354 Waseem R, Anwar S, Khan S, Shamsi A, Hassan MI, Anjum F, Shafie A, Islam A,
Yadav DK. MAP/Microtubule Affinity Regulating Kinase 4 Inhibitory Potential of
6.20
Irisin: A New Therapeutic Strategy to Combat Cancer and Alzheimer's Disease. Int
J Mol Sci. 2021 Oct 12;22(20):10986. doi: 10.3390/ijms222010986.
353 Shafie A, Khan S, Zehra, Mohammad T, Anjum F, Hasan GM, Yadav DK, Hassan
MI. Identification of Phytoconstituents as Potent Inhibitors of Casein Kinase-1
6.52
Alpha Using Virtual Screening and Molecular Dynamics Simulations.
Pharmaceutics. 2021 Dec 15;13(12):2157.
352 Anwar S, Khan S, Anjum F, Shamsi A, Khan P, Fatima H, Shafie A, Islam A, Hassan
MI. Myricetin inhibits breast and lung cancer cells proliferation via inhibiting 4.48
MARK4. J Cell Biochem. 2022, 123(2):359-374.
351 Wahiduzzaman, Kumar V, Anjum F, Shafie A, Elasbali AM, Islam A, Ahmad F,
Hassan MI. Delineating the Aggregation-Prone Hotspot Regions (Peptides) in the 4.12
Human Cu/Zn Superoxide Dismutase 1. ACS Omega. 2021 Dec 3;6(49):33985-33994.
350 Naqvi AAT, Anjum F, Shafie A, Badar S, Elasbali AM, Yadav DK, Hassan MI.
Investigating host-virus interaction mechanism and phylogenetic analysis of viral 3.75
proteins involved in the pathogenesis. PLoS One. 2021 Dec 16;16(12):e0261497.
349 Kumar D, Hassan MI. Neurodegenerative brain models vs. cell replacement or
restoration therapy: A review on promises and pitfalls. Biochem Biophys Res 3.56
Commun. 2021, 31;585:124-131.
348 Khatoon F, Kumar V, Shafie A, Naz F, Adnan M, Hassan MI, Frustration analysis of
TBK1 missense mutations reported in ALS/FTD and cancer patients. 3 Biotech 2022, 2.89
DOI: 10.1007/s13205-022-03240-0.
347 Khan FI, Ali S, Chen W, Anjum F, Shafie A, Hassan MI, Lai D. High-resolution MD
simulation studies to get mechanistic insights into the urea-induced denaturation of
3.57
human Sphingosine kinase 1. Curr Top Med Chem. 2021 Nov 4. doi:
10.2174/1568026621666211105095731.
346 Adnan M, Siddiqui AJ, Hamadou WS, Ashraf SA, Hassan MI, Snoussi M, Badraoui
R, Jamal A, Bardakci F, Awadelkareem AM, Sachidanandan M, Patel M. Functional
and Structural Characterization of Pediococcus pentosaceus-Derived Biosurfactant 5.22
and Its Biomedical Potential against Bacterial Adhesion, Quorum Sensing, and
Biofilm Formation. Antibiotics. 2021; 10(11):1371.

24 Hassan’s CV
345 Asrani P, Tiwari K, Eapen MS, McAlinden KD, Haug G, Johansen MD, Hansbro
PM, Flanagan KL, Hassan MI, Sohal SS. Clinical features and mechanistic insights
5.62
into drug repurposing for combating COVID-19. Int J Biochem Cell Biol. 2021 Nov
5:106114. doi: 10.1016/j.biocel.2021.106114.
344 Alam, M.; Ali, S.; Ahmed, S.; Elasbali, A.M.; Adnan, M.; Islam, A.; Hassan, M.I.;
Yadav, D.K. Therapeutic Potential of Ursolic Acid in Cancer and Diabetic 6.20
Neuropathy Diseases. International Journal of Molecular Sciences 2021, 22.
343 Raina N, Hassan MI, Ahmad F, Islam A, Singh AK. PEG mediated destabilization of
holo α-lactalbumin probed by in silico and in vitro studies: deviation from excluded 5.22
volume effect. J Biomol Struct Dyn. 2021 Nov 2:1-13.
342 AlAjmi, M.F.; Khan, S.; Choudhury, A.; Mohammad, T.; Noor, S.; Hussain, A.; Lu,
W.; Eapen, M.S.; Chimankar, V.; Hansbro, P.M.; et al. Impact of Deleterious
Mutations on Structure, Function and Stability of Serum/Glucocorticoid Regulated 6.11
Kinase 1: A Gene to Diseases Correlation. Frontiers in Molecular Biosciences 2021,
8.
341 Kumar D, Yadav DK, Hassan MI (2021) Topical insights into the post-approval
5.98
controversies of Aducanumab. Frontiers in Pharmacology, 12:787303.
340 Kumar D, Hassan MI. Ultra-sensitive techniques for detecting neurological
biomarkers: Prospects for early diagnosis. Biochem Biophys Res Commun. 2021 3.56
Nov 2;584:15-18.
339 Mohammad T, Choudhury A, Habib I, Asrani P, Mathur Y, Umair M, Anjum F,
Shafie A, Yadav DK, Hassan MI. Genomic Variations in the Structural Proteins of
6.11
SARS-CoV-2 and Their Deleterious Impact on Pathogenesis: A Comparative
Genomics Approach. Front Cell Infect Microbiol. 2021 Oct 13;11:765039.
338 Shafie A, Khan S, Batra S, Anjum F, Mohammad T, Alam S, Yadav DK, Islam A,
Hassan MI. Investigating single amino acid substitutions in PIM1 kinase: A 3.75
structural genomics approach. PLoS One. 2021 Oct 22;16(10):e0258929.
337 Roy RK, Sharma U, Wasson MK, Jain A, Hassan MI, Prakash H. Macrophage
Activation Syndrome and COVID 19: Impact of MAPK Driven Immune-Epigenetic 8.78
Programming by SARS-Cov-2. Front Immunol. 2021 Oct 1;12:763313.
336 Alam M, Ali S, Mohammad T, Hasan GM, Yadav DK, Hassan MI. B Cell
Lymphoma 2: A Potential Therapeutic Target for Cancer Therapy. Int J Mol Sci. 6.20
2021 Sep 28;22(19):10442. doi: 10.3390/ijms221910442.
335 Alam S, Mohammad T, Padder RA, Hassan MI, Husain M. Thymoquinone and
quercetin induce enhanced apoptosis in non-small cell lung cancer in combination 4.46
through the Bax/Bcl2 cascade. J Cell Biochem. 2022, 123(2):259-274.
334 Raman C, Qayyum S, Mohammad T, Hassan MI, Slominski R, (2021). Vitamin D
and lumisterol novel metabolites can inhibit SARS-COV-2 replication machinery
5.96
enzymes. American Journal of Physiology-Endocrinology and Metabolism
321(2):E246-E251.
333 Rathi A, Kumar D, Hasan GM, Haque MM, Hassan MI. Therapeutic targeting of
PIM KINASE signaling in cancer therapy: Structural and clinical prospects. Biochim 4.11
Biophys Acta Gen Subj. 2021 Aug 26;1865(11):129995.
332 Anjum F, Mohammad T, Almalki AA, Akhtar O, Abdullaev B, Hassan MI.
Phytoconstituents and Medicinal Plants for Anticancer Drug Discovery:
3.98
Computational Identification of Potent Inhibitors of PIM1 Kinase. OMICS. 2021,
25(9):580-590.

25 Hassan’s CV
331 Ali S, Alam M, Hasan GM, Hassan MI. Potential therapeutic targets of Klebsiella
pneumoniae: a multi-omics review perspective. Brief Funct Genomics. 2022, 4.25
21(2):63-77.
330 Ahmad Parray Z, Naqvi AAT, Ahmad F, Hassan MI, Islam A. (2021)
Characterization of different intermediate states in myoglobin induced by
polyethylene glycol: a process of spontaneous molecular self-organization foresees 6.63
the energy landscape theory via in vitro and in silico approaches. Journal of
Molecular Liquids.117502.
329 Anwar, S., DasGupta, D., Shafie, A., Alhumaydhi, F.A., Alsagaby, S.A., Shahwan,
M., Anjum, F., Al Abdulmonem, W., Sharaf, S.E., and Imtaiyaz Hassan, M.
Implications of tempol in pyruvate dehydrogenase kinase 3 targeted anticancer 6.63
therapeutics: Computational, spectroscopic, and calorimetric studies. Journal of
Molecular Liquids 2022, 350, 118581.
328 Anwar, S., DasGupta, D., Azum, N., Alfaifi, S.Y.M., Asiri, A.M., Alhumaydhi, F.A.,
Alsagaby, S.A., Sharaf, S.E., Shahwan, M., and Hassan, M.I. Inhibition of PDK3 by
6.63
artemisinin, a repurposed antimalarial drug in cancer therapy. Journal of Molecular
Liquids 2022, 355, 118928.
327 Moyad S, Fahad AA, Ameen SSA, Aljasir MA, Alsagaby SA, Abdulmonem WA,
Hassan MI, Islam A, (2021) Spectroscopic, Calorimetric and In silico Insight into the
8.02
Molecular Interactions of Memantine with Human Transferrin: Implications of
Alzheimer’s drugs. Int J Biol Macromol. 190:660-666.
326 Alhumaydhi, F. A., Aljasir, M. A., Aljohani, A. S. M., Alsagaby, S. A., Alwashmi, A.
S. S., Shahwan, M., Hassan, M. I., Islam, A. & Shamsi, A. (2021). Probing the
6.63
interaction of memantine, an important Alzheimer's drug, with human serum
albumin: In silico and in vitro approach. Journal of Molecular Liquids, 116888.
325 Anwar S, Khan S, Shamsi A, Anjum F, Shafie A, Islam A, Ahmad F, Hassan MI. (2021)
Structure-based investigation of MARK4 inhibitory potential of Naringenin for
4.46
therapeutic management of cancer and neurodegenerative diseases. J Cell Biochem.
122(10):1445-1459. doi: 10.1002/jcb.30022. PMID: 34121218.
324 Alam M, Hasan GM, Hassan MI. (2021) A review on the role of TANK-binding kinase
8.02
1 signaling in cancer. Int J Biol Macromol. 183:2364-2375.
323 Singh A, Panwar R, Mittal P, Hassan MI, Singh IK. (2021) Plant cytochrome P450s:
Role in stress tolerance and potential applications for human welfare. Int J Biol 8.02
Macromol. 24;184:874-886.
322 Ahmed A, Shamsi A, Mohammad T, Hasan GM, Islam A, Hassan MI. (2021) Aurora
B kinase: a potential drug target for cancer therapy. J Cancer Res Clin Oncol. 4.32
147(8):2187-2198. doi: 10.1007/s00432-021-03669-5.
321 Khairat SHM, Omar MA, Ragab FAF, Roy S, Turab Naqvi AA, Abdelsamie AS,
Hirsch AKH, Galal SA, Hassan MI, El Diwani HI. Design, synthesis, and biological
2.59
evaluation of novel benzimidazole derivatives as sphingosine kinase 1 inhibitor.
Arch Pharm 354(9):e2100080.
320 Khan, M.S., Husain, M.F., Alhumaydhi, F.A., Alwashmi, A.S.S., Rehman, M. T.,
Alruwetei, A.M., Hassan, M.I., Islam, A. and Shamsi, A. (2021) Exploring the
6.63
molecular interactions of Galantamine with human Transferrin: In-silico and in
vitro insight. Journal of Molecular Liquids, 335, 116227.
319 Parray, Z.A., Ahmad, F., Hassan, M.I., Ahmed, A., Almajhdi, F.N., Malik, A.,
Hussain, T. and Islam, A. (2021) Structural Refolding and Thermal Stability of
4.98
Myoglobin in the Presence of Mixture of Crowders: Importance of Various
Interactions for Protein Stabilization in Crowded Conditions. Molecules 26, 2807.

26 Hassan’s CV
318 Habib I, Khan S, Mohammad T, Hussain A, Alajmi MF, Rehman T, Anjum F,
Hassan MI. Impact of non-synonymous mutations on the structure and function of 5.2
telomeric repeat binding factor 1. J Biomol Struct Dyn. 2021 May 13:1-14.
317 Choudhury A, Mohammad T, Samarth N, Hussain A, Rehman MT, Islam A, Alajmi
MF, Singh S, Hassan MI. Structural genomics approach to investigate deleterious
4.37
impact of nsSNPs in conserved telomere maintenance component 1. Sci Rep. 2021
May 13;11(1):10202.
316 Yousuf M, Shamsi A, Queen A, Shahbaaz M, Khan P, Hussain A, Alajmi MF,
Rizwanul Haque QM, Hassan MI. Targeting cyclin‑dependent kinase 6 by vanillin
4.48
inhibits proliferation of breast and lung cancer cells: combined computational and
biochemical studies. J Cell Biochem. 2021, 122(8):897-910.
315 Gupta D, Tiwari P, Haque MA, Sachdeva E, Hassan MI, Ethayathulla AS, Kaur P.
2021. Structural insights into the transient closed conformation and pH dependent
4.01
ATPase activity of S. Typhi GyraseB N- terminal domain. Archives of Biochemistry
and Biophysics 701:108786.
314 Khan A, Khan F, Shahwan M, Khan MS, Husain FM, Rehman MT, Hassan MI,
Islam A, Shamsi A. 2021. Mechanistic insight into the binding of graphene oxide
4.01
with human serum albumin: Multispectroscopic and molecular docking approach.
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 256:119750.
313 Gupta, P.; Taiyab, A.; Hussain, A.; Alajmi, M.F.; Islam, A.; Hassan, M.I. (2021)
Targeting Sphingosine Kinase/Sphingosine-1-Phosphate Signaling Axis in Drug 6.63
Discovery for Cancer Therapy. Cancers 13(8):1898.
312 Ali S, Liu X, Sen L, Lan D, Wang J, Hassan MI, Wang Y. (2021) Sequence and
structure-based method to predict diacylglycerol lipases in protein sequence. 8.02
International Journal of Biological Macromolecules 182:455-463.
311 Shamsi A, Mohammad T, Anwar S, Amani S, Khan MS, Husain FM, Rehman MT,
Islam A, Hassan MI. Potential drug targets of SARS-CoV-2: From genomics to 8.02
therapeutics. International Journal of Biological Macromolecules 177:1-9.
310 Nazam F, Shaikh S, Nazam N, Alshahrani AS, Hasan GM, Hassan MI. Mechanistic
insights into the pathogenesis of neurodegenerative diseases: towards the 3.85
development of effective therapy. Mol Cell Biochem. 476(7):2739-2752.
309 Nasreen K, Parray ZA, Shamsi A, Ahmad F, Ahmed A, Malik A, Lakhrm NA,
Hassan MI, Islam A. Crowding Milleu stabilizes apo-myoglobin against chemical-
8.02
induced denaturation: Dominance of hardcore repulsions in the heme devoid
protein. International Journal of Biological Macromolecules 181:552-560.
308 Verma P, Hassan MI, Singh A, Singh IK (2021) Design and development of novel
inhibitors of aldo-ketoreductase 1C1 as potential lead molecules in treatment of 3.85
breast cancer. Mol Cell Biochem 476(8):2975-2987
307 Waseem R, Shamsi A, Mohammad T, Alhumaydhi FA, Kazim SN, Hassan MI,
Ahmad F, Islam A. Multispectroscopic and Molecular Docking Insight into
4.25
Elucidating the Interaction of Irisin with Rivastigmine Tartrate: A Combinational
Therapy Approach to Fight Alzheimer's Disease. ACS Omega. 6(11):7910-7921.
306 Shamsi A, Shahwan M, Khan MS, Husain FM, Alhumaydhi FA, Aljohani ASM,
Rehman MT, Hassan MI, Islam A. Elucidating the Interaction of Human Ferritin
with Quercetin and Naringenin: Implication of Natural Products in 4.25
Neurodegenerative Diseases: Molecular Docking and Dynamics Simulation Insight.
ACS Omega 6(11):7922-7930.
305 Bashir S, Ahanger IA, Shamsi A, Alajmi MF, Hussain A, Choudhry H, Ahmad F,
6.06
Hassan MI, Islam A. (2021) Trehalose Restrains the Fibril Load towards α-

27 Hassan’s CV
 Lactalbumin Aggregation and Halts Fibrillation in a Concentration-Dependent
Manner. Biomolecules 11(3):414.
304 Roy S, Khan S, Jairajpuri DS, Hussain A, AlAjmi MF, Islam A, Luqman S, Parvez S,
Hassan MI (2021) Investigation of sphingosine kinase 1 inhibitory potential
5.2
cinchonine and colcemid targeting anti-cancer therapy. Journal of Biomolecular
Structure and Dynamics (In Press)
303 Parray ZA, AlAjmi MF, Hassan MI, Hussain A, Ahmad F and Islam A (2021)
Interaction of polyethylene glycol with cytochrome c investigated via various in vitro
4.37
and in silico approaches provides crucial information to fight cancer using crowding-
induced alternative modes. Scientific Reports 11(1):6475.
302 Naiyer A, Khan B, Hussain A, AlAjmi MF, Hassan MI, Islam A, Sundd M, Ahmad F,
(2021) Stability of uniformly labeled (13C and 15N) cytochrome c and its L94G mutant. 4.37
Scientific Reports 11(1):6804.
301 Ahanger IA, Bashir S, Parray ZA, Alajmi MF, Hussain A, Ahmad F, Hassan MI, Islam
A, Sharma A. (2021) Rationalizing the Role of Monosodium Glutamate in the Protein
5.15
Aggregation Through Biophysical Approaches: Potential Impact on
Neurodegeneration. Front Neurosci 15:636454.
Sharma, P., Yadav, V., Kumari, S., Ghosh, D., Rawat, P., Vij, A., Srivastava, C., Saini,
S., Sharma, V., Hassan, M. I., and Majumder, S. (2021) Deciphering the potent
300 3.67
application of nanobentonite and α-Fe2O3/bentonite nanocomposite in dye removal:
revisiting the insights of adsorption mechanism, Applied Nanoscience. (In Press)
Ahanger IA, Parray ZA, Nasreen K, Ahmad F, Hassan MI, Islam A, Sharma A. (2021)
Heparin Accelerates the Protein Aggregation via the Downhill Polymerization
299 4.25
Mechanism: Multi-Spectroscopic Studies to Delineate the Implications on
Proteinopathies. ACS Omega. 6(3):2328-2339.
Jairajpuri DS, Hussain A, Nasreen K, Mohammad T, Anjum F, Rehman T, Mustafa
Hasan G, Alajmi MF, Hassan MI. (2021) Identification of natural compounds as
298 4.2
potent inhibitors of SARS-CoV-2 main protease using combined docking and
molecular dynamics simulations. Saudi J Biol Sci. doi: 10.1016/j.sjbs.2021.01.040.
Asrani P, Nasreen K, Hussain A, Amir S, AlAjmi MF, Sohal SS and Hassan MI (2021).
Guidelines and safety considerations in the laboratory diagnosis of SARS-CoV-2
297 3.2
infection: A prerequisite study for health professionals. Risk Management and
Healthcare Policy 2021, 379—389.
Asrani P, Eapen MS, Chia C, Haug G, Weber HC, Hassan MI, Sohal SS. (2020)
296 Diagnostic approaches in COVID-19: clinical updates. Expert Rev Respir Med. 4.3
15(2):197-212.
Asrani P, and Hassan MI (2020) SARS-CoV-2 mediated lung inflammatory responses
295 in host: targeting the cytokine storm for therapeutic interventions. Molecular and 3.87
Cellular Biochemistry 476(2):675-687.
Shakeel I, Basheer N, Hasan GM, Afzal M, Hassan MI (2021) Polo-like Kinase 1 as an
294 emerging drug target: Structure, function and therapeutic implications. J Drug Target 5.12
29(2):168-184.
Fatima U, Rizvi SSA, Raina S, Fatima S, and Hassan MI (2021) Therapeutic
293 management of COVID-19 patients: Clinical manifestation and limitations. Current 3.11
Pharmaceutical Design. 27(41):4223-4231.
Singh A, Kumari P, Hasan GM, Singh IK, Hassan MI. (2021) Emerging therapeutic
292 3.11
approaches to COVID-19. Current Pharmaceutical Design 27(31):3370-3388.
Naiyer, A., Khan, B., Islam, A., Hassan, M.I., Sundd, M., and Ahmad, F. (2022). Heme-
291 5.2
iron ligand (M80-Fe) in cytochrome c is destabilizing: combined in vitro and in silico

28 Hassan’s CV
 approaches to monitor changes in structure, stability and dynamics of the protein on
mutation. Journal of Biomolecular Structure and Dynamics 40(9):4122-4139.
Shamsi A, Anwar S, Mohammad T, Hassan MI, Ahmad F and Islam A (2022) Insight
into the binding of PEG-400 with eye protein alpha-crystallin: Multi spectroscopic
290 5.2
and computational approach: Possible therapeutics targeting eye diseases. Journal
of Biomolecular Structure and Dynamics 40(10):4496-4506.
Khan S, Fakhar Z, Hussain A, Ahmad A, Jairajpuri DS, Alajmi MF, Hassan MI. (2022)
289 Structure-based identification of potential SARS-CoV-2 main protease inhibitors. 5.2
Journal of Biomolecular Structure & Dynamics 40(8):3595-3608.
Mahapatra AD, Queen A, Khan P, Yousuf M, Hussain A, AlAjmi MF, Rehman MT,
Datta B and Hassan MI (2022) Design and Development of 5-(4H)-oxazolones as
288 potential Inhibitors of Human Carbonic Anhydrase VA: Towards Therapeutic 5.2
Management of Diabetes and Obesity. Journal of Biomolecular Structure & Dynamics
40(7):3144-3154.
Almary, K.A., Srivastava, S., Shahbaaz, M., Gupta, P., Khan, P., Syed, S. B., Azum,
N., Asiri, A. M., Islam, A., Ahmad, F., and Hassan, M. I. (2021) Unravelling the
287 5.2
unfolding pathway of human Fas-activated serine/threonine kinase by urea-induced
denaturation. Journal of Biomolecular Structure and Dynamics 39(15):5516-5525.
Naqvi AAT, Jairajpuri DS, Hussain A, Hasan GM, Alajmi MF, Hassan MI (2021)
Impact of glioblastoma multiforme associated mutations on the structure and
286 5.2
function of MAP/Microtubule affinity regulating kinase 4. Journal of Biomolecular
Structure and Dynamics 39(5):1781-1794.
Kumar B, Mohammad T, Uddin A, Hussain A, Islam A, Ahmad F, Alajmi MF, Singh
S, Pandey KC, Hassan MI, Abid M. (2021) Targeting metacaspase-3 from
285 Plasmodium falciparum towards antimalarial therapy: A combined approach of in- 5.2
silico and in-vitro investigation. Journal of Biomolecular Structure and Dynamics
39(2):421-430.
Amir M, Ahamad S, Mohammad T, Jairajpuri DS, Hasan GM, Dohare R, Islam A,
Ahmad F, Hassan M (2021) Investigation of conformational dynamics of Tyr89Cys
284 5.2
mutation in protection of telomeres 1 gene associated with familial melanoma.
Journal of Biomolecular Structure and Dynamics 39(1):35-44.
Mohammad T, Arif K, Alajmi MF, Hussain A, Islam A, Rehman MT, Hassan I. (2020)
Identification of high-affinity inhibitors of pyruvate dehydrogenase kinase-3:
283 5.2
towards therapeutic management of cancer. Journal of Biomolecular Structure and
Dynamics 39(2):586-594.
Khan A, Mohammad T, Shamsi A, Hussain A, AlAjmi MF, Husain SA, Iqbal MA and
282 Hassan MI (2021) Identification of Plant-based Hexokinase 2 Inhibitors: Combined 5.2
Molecular Docking and Dynamics Simulation Studies. J Biomol Struct Dyn. (In Press)
Galal SA, Omar MA, Khairat SMH, Ragab FAF, Naqvi AAT, Hassan MI, Diwani HI
281 (2021) Design and synthesis of new pyrazolylbenzimidazoles as sphingosine 1-kinase 2.3
inhibitors, Medicinal Chemistry Research 30, 1614–1634.
Umair M, Khan S, Mohammad T, Shafie A, Anjum F, Islam A, Hassan MI. (2021)
280 Impact of single amino acid substitution on the structure and function of TANK- 4.48
binding kinase-1. J Cell Biochem 122(10):1475-1490.
Mohammad T, Amir M, Prasad K, Batra S, Kumar V, Hussain A, Rehman MT, AlAjmi
MF, Hassan MI. (2020) Impact of amino acid substitution in the kinase domain of
279 8.02
Bruton tyrosine kinase and its association with X-linked agammaglobulinemia. Int J
Biol Macromol 164:2399-2408.

29 Hassan’s CV
 Kumari S, Sharma P, Ghosh D, Shandilya M, Rawat P, Hassan MI, Moulick RG,
Bhattacharya J, Srivastava C, Majumder S. Time-dependent study of graphene oxide-
278 8.02
trypsin adsorption interface and visualization of nano-protein corona. Int J Biol
Macromol. 163:2259-2269.
Asrani P, Hasan GM, Sohal SS and Hassan MI (2020) Molecular Basis of Pathogenesis
277 of Coronaviruses: A Comparative Genomics Approach to Planetary Health 3.87
to Prevent Zoonotic Outbreaks in the 21st Century. OMICS 24(11):634-644.
Peerzada, M.N., Khan, P., Khan, N.S., Avecilla, F., Siddiqui, S.M., Hassan, M.I., and
Azam, A. (2020). Design and Development of Small-Molecule Arylaldoxime/5-
276 4.25
Nitroimidazole Hybrids as Potent Inhibitors of MARK4: A Promising Approach for
Target-Based Cancer Therapy. ACS Omega 5(36):22759-22771.
Peerzada, M.N., Khan, P., Khan, N.S., Gaur, A., Avecilla, F., Hassan, M.I., and Azam,
A. (2020). Identification of morpholine based hydroxylamine analogues: Selective
275 3.59
inhibitors of MARK4/Par-1d causing cancer cell death through apoptosis. New
Journal of Chemistry 44, 16626-16637.
Roy, S., Mohammad, T., Gupta, P., Dahiya, R., Parveen, S., Luqman, S., Hasan, G.M.
274 and Hassan, M.I., 2020. Discovery of Harmaline as a Potent Inhibitor of Sphingosine 4.25
Kinase-1: A Chemopreventive Role in Lung Cancer. ACS Omega 5(34):21550-21560.
Kumari P, Singh A, Ngasainao MR, Shakeel I, Kumar S, Lal S, Singhal A, Sohal SS,
273 Singh IK, Hassan MI. (2020) Potential diagnostics and therapeutic approaches in 3.78
COVID-19. Clin Chim Acta. 510:488-497.
Parray ZA, Ahmad F, Hassan MI, Islam A. (2020) Conformational changes in
cytochrome c directed by ethylene glycol accompanying complex formation: Protein-
272 4.01
solvent preferential interaction or/and kosmotropic effect. Spectrochim Acta A Mol
Biomol Spectrosc 242:118788.
Raina N, Singh AK, Hassan MI, Ahmad F, Islam A. (2020) Concentration dependent
effect of ethylene glycol on the structure and stability of holo α-lactalbumin:
271 8.02
Characterization of intermediate state amidst soft interactions. International Journal
of Biological Macromolecules 164:2151-2161.
Ahmad, S. I., Ahmad, R., Khan, M. S., Kant, R., Shahid, S., Gautam, L., Hasan, G. M.,
and Hassan, M. I. (2020) Chitin and its derivatives: Structural properties and
270 8.02
biomedical applications, International Journal of Biological Macromolecules 164, 526-
539.
Khan F. I., Gupta P., Almary, K.A., Azum, N., Asiri, A. M., Lai, D., and Hassan, M. I.
269 (2020) Mechanistic the urea-induced denaturation of human sphingosine kinase 1. 8.02
International Journal of Biological Macromolecules 161:1496-1505.
Uddin A, Singh V, Irfan I, Mohammad T, Singh Hada R, Hassan MI, Abid M, Singh
S. (2020) Identification and structure-activity relationship (SAR) studies of carvacrol
268 5.52
derivatives as potential anti-malarial against Plasmodium falciparum falcipain-2
protease. Bioorg Chem. 103:104142.
Mohammad, T., Shamsi, A., Anwar, S., Hussain, A., Rehman, M. T., AlAjmi, M. F.,
Islam, A., and Hassan, M. I. (2020) Identification of high-affinity inhibitors of SARS-
267 5.2
CoV-2 main protease: Towards the development of effective COVID-19 therapy,
Virus Research 288:198102.
Shamsi A, Anwar S, Shahbaaz M, Mohammad T, AlAjmi MF, Hussain A, Hassan MI,
Ahmad F and Islam A (2020) Evaluation of binding of Rosmarinic acid with human
266 transferrin and its impact on protein structure: Targeting polyphenolic acid-induced 7.31
protection of neurodegenerative disorders. Oxidative Medicine and Cellular
Longevity. 2020:1245875.

30 Hassan’s CV
 Anwar, S., Shamsi, A., Kar, R. K., Queen, A., Islam, A., Ahmad, F., and Hassan, M. I.
(2020) Structural and biochemical investigation of MARK4 inhibitory potential of
265 8.02
cholic acid: Towards therapeutic implications in neurodegenerative diseases. Int J
Biol Macromol 161, 596-604.
Fatima U, Rizvi SSA, Fatima S, and Hassan MI (2020) Impact of
264 Hydroxychloroquine/chloroquine in COVID-19 therapy: Two sides of the coin. 3.65
Journal of Interferon and Cytokine Research 40(10):469-471.
Naqvi AAT, Fatima K, Mohammad T, Fatima U, Singh IK, Singh A, Atif SM,
Hariprasad G, Hasan GM, Hassan MI. (2020) Insights Into SARS-CoV-2 Genome,
263 6.63
Structure, Evolution, Pathogenesis and Therapies: Structural Genomics Approach.
Biochim Biophys Acta Mol Basis Dis. 1866(10):165878.
Amir M, Alam A, Ishrat R, Alajmi MF, Hussain A, Rehman T, Islam A, Ahmad F,
Hassan I, Dohare R. (2020) A Systems View of the Genome Guardians: Mapping the
262 3.87
Signaling Circuitry Underlying Oligonucleotide/Oligosaccharide-Binding Fold
Proteins. OMICS 24(9):518-530.
Gupta, P., Khan, S., Fakhr, Z., Hussain, A., Alajmi, M. F., Rehman, M. T., Islam, A.,
Ahmad, F., and Hassan, M. I. (2020) Identification of Potential inhibitors of
261 7.31
Calcium/calmodulin-dependent Protein Kinase IV from Bioactive Phytoconstituents.
Oxidative Medicine and Cellular Longevity 2020, 2094635.
Dahiya, R.; Mohammad, T.; Alajmi, M.F.; Rehman, M.T.; Hasan, G.M.; Hussain, A.;
260 Hassan, M.I. Insights into the Conserved Regulatory Mechanisms of Human and 6.06
Yeast Aging. Biomolecules 2020, 10, 882.
Singh, S.; Tyagi, C.; Rather, I.A.; Sabir, J.S.; Hassan, M.I.; Singh, A.; Singh, I.K.
259 Molecular Modeling of Chemosensory Protein 3 from Spodoptera litura and Its 6.20
Binding Property with Plant Defensive Metabolites. Int. J. Mol. Sci. 2020, 21, 4073.
Roy, S.; Mahapatra, A.D.; Mohammad, T.; Gupta, P.; Alajmi, M.F.; Hussain, A.;
Rehman, M.T.; Datta, B.; Hassan, M.I. Design and Development of Novel Urea,
258 5.86
Sulfonyltriurea, and Sulfonamide Derivatives as Potential Inhibitors of Sphingosine
Kinase 1. Pharmaceuticals 2020, 13, 118.
Shamsi, A.; Anwar, S.; Mohammad, T.; Alajmi, M.F.; Hussain, A.; Rehman, M.T.;
Hasan, G.M.; Islam, A.; Hassan, M.I. MARK4 Inhibited by AChE Inhibitors,
257 6.06
Donepezil and Rivastigmine Tartrate: Insights into Alzheimer’s Disease
Therapy. Biomolecules, 10, 789.
Shamsi, A.; Mohammad, T.; Anwar, S.; Alajmi, M.F.; Hussain, A.; Rehman, M.T.;
Islam, A.; Hassan, M.I. (2020) Glecaprevir and Maraviroc are high-affinity inhibitors
256 4.84
of SARS-CoV-2 main protease: Possible therapeutic implication in COVID-
19. Bioscience Report 40 (6): BSR20201256.
Jairajpuri D, Mohammad T, Adhikari K, Gupta P, Hasan GM, Alajmi MF, Rehman
MT, Hussain A, and Hassan, MI (2020) Identification of Sphingosine kinase-1
255 4.25
inhibitors from bioactive natural products targeting cancer therapy. ACS Omega
5(24):14720-14729.
Parray, Z. A., Ahmad, F., Hassan, M. I., Hasan, I., and Islam, A. (2020) Effects of
Ethylene Glycol on the Structure and Stability of Myoglobin Using Spectroscopic,
254 4.25
Interaction, and In Silico Approaches: Monomer Is Different from Those of Its
Polymers. ACS Omega 5, 13840-13850.
Anwar, S., Shamsi, A., Shahbaaz, M., Queen, A., Khan, P., Hasan, G. M.,
Islam, A., Alajmi, M. F., Hussain, A., Ahmad, F., and Hassan, M. I. (2020)
253 4.36
Rosmarinic Acid Exhibits Anticancer Effects via MARK4 Inhibition. Sci Re p
10, 10300.

31 Hassan’s CV
 Khan NS, Khan P, Inam A, Ahmad K, Yousuf M, Islam A, Ali S, Azam A, Husain M,
and Hassan MI (2020) Discovery of 4-(2-(dimethylamino) ethoxy) benzo-hydrazide
252 4.36
derivatives as prospective microtubule affinity regulating kinase 4 inhibitors. RSC
Advances 10, 20129-20137.
Khan, S. H., Prakash, A., Pandey, P., Islam, A., Hassan, M. I., Lynn, A. M., & Ahmad,
F. (2020). Effects of natural mutations (L94I and L94V) on the stability and mechanism
251 of folding of horse cytochrome c: A combined in vitro and molecular dynamics 8.02
simulations approach. International Journal of Biological Macromolecules 159:976-
985.
Shahbaaz, M., Potemkin, V., Bisetty, K., Hassan, M. I., & Hussien, M. A. (2020).
Classification and functional analyses of putative virulence factors of Mycobacterium
250 3.73
tuberculosis: A combined sequence and structure-based study. Computational
Biology and Chemistry 87:107270.
Anwar, S.; Mohammad, T.; Shamsi, A.; Queen, A.; Parveen, S.; Luqman, S.; Hasan,
G.M.; Alamry, K.A.; Azum, N.; Asiri, A.M.; Hassan, M.I. (2020) Discovery of
249 6.08
Hordenine as a Potential Inhibitor of Pyruvate Dehydrogenase Kinase 3: Implication
in Lung Cancer Therapy. Biomedicines 8(5): E119.
Yousuf M, Shamsi A, Khan P, Shahbaaz M, AlAjmi MF, Hussain A, Hasan GM, Islam
A, Haque QMR and Hassan MI (2020) Ellagic Acid Controls Cell Proliferation and
248 6.02
Induces Apoptosis in Breast Cancer Cells via inhibition of Cyclin-Dependent Kinase
6. International Journal of Molecular Sciences 21(10): E3526.
Amir M, Mohammad T, Dohare R, Islam A, Ahmad F and Hassan MI (2020)
247 Structure, function and therapeutic implications of OB-fold proteins: A lesson from 4.24
past to present. Briefings in Functional Genomics 19(5-6):377-389.
Aneja B, Queen A, Khan P, Shamsi S, Hasan P, Rizvi MA, Daniliuc CG, Hassan MI
and Abid M (2020) Design, synthesis & biological evaluation of ferulic acid-based
246 3.64
inhibitors targeting tumor-associated carbonic anhydrase IX. Bioorganic and
Medicinal Chemistry 28, 115424.
Shamsi F, Hasan P, Hussain A, Khan PK, Zeya B, King H, Rana S, Garrison J, Queen
A, AlAjmi MF, Rizvi MA, Zahid M, Hassan MI, Abid M (2020) Synthesis and SAR
245 5.27
studies of novel 1,2,4-oxadiazole-sulfonamide based compounds as potential
anticancer agents for colorectal cancer therapy. Bioorganic Chemistry 98, 103754.
Nasreen K, Parray ZA, Ahamad S, Ahmed A, Alamery SF, Ahmad F, Hassan MI,
Islam A. (2020) Interactions under Crowding Milleu: Chemical-induced denaturation
244 6.06
of myoglobin is determined by the extent of heme dissociation on interaction with
crowders. Biomolecules 10(3) E490.
Mohammad T, Siddiqui S, Shamsi A, Alajmi MF, Hussain A, Islam A, Ahmad F,
Hassan MI. (2020) Virtual Screening Approach to Identify High-Affinity Inhibitors of
243 4.98
Serum and Glucocorticoid-Regulated Kinase 1 among Bioactive Natural Products:
Combined Molecular Docking and Simulation Studies. Molecules 25(4).
Parray ZA, Ahmad F, Alajmi MF, Hussain A, Hassan MI, Islam A. (2020) Formation
of molten globule state in horse heart cytochrome c under physiological conditions:
242 8.02
Importance of soft interactions and spectroscopic approach in crowded milieu.
International Journal of Biological Macromolecules 148:192-200.
Bansal R, Haque MA, Hassan MI, Ethayathulla AS, Kaur P. (2020) Structural and
conformational behavior of MurE ligase from Salmonella enterica serovar Typhi at
241 8.02
different temperature and pH conditions. International Journal of Biological
Macromolecules 150:389-399.

32 Hassan’s CV
 Amir, M.; Khan, P.; Queen, A.; Dohare, R.; Alajmi, M.F.; Hussain, A.; Islam, A.;
Ahmad, F.; Hassan, I. Structural Features of Nucleoprotein CST/Shelterin Complex
240 7.66
Involved in the Telomere Maintenance and Its Association with Disease Mutations.
Cells 2020, 9, 359.
Shamsi A, Mohammad T, Anwar S, Alajmi MF, Hussain A, Hassan MI, Ahmad F,
Islam A. (2020) Probing the interaction of Rivastigmine Tartrate, an important
239 8.02
Alzheimer's drug, with serum albumin: Attempting treatment of Alzheimer's
disease. International Journal of Biological Macromolecules 148:533-542.
Turab Naqvi AA, Hasan GM, Hassan MI. (2020) Targeting tau
238 hyperphosphorylation via kinase inhibition- Strategy to address Alzheimer’s disease. 3.29
Current Topics in Medicinal Chemistry 20(12):1059-1073.
Anwar S, Kar RK, Haque MA, Dahiya R, Gupta P, Islam A, Ahmad F, Hassan MI.
(2020) Effect of pH on the structure and function of pyruvate dehydrogenase kinase
237 8.02
3: Combined spectroscopic and MD simulation studies. International Journal of
Biological Macromolecules 147:768-777.
Shamsi A, Mohammad T, Anwar S, Hassan MI, Ahmad F, Hasan I, Islam A (2020)
236 Biophysical insight into implications of PEG-400 on alpha-crystallin structure: Multi 4.25
spectroscopic and microscopic approach. ACS Omega 5(30):19210-19216.
Gupta P, Khan FI, Ambreen D, Lai D, Alajmi F, Hussain A, Islam A, Ahmad F and
Hassan MI (2020) Investigation of Guanidinium chloride-induced Unfolding
235 8.02
Pathway of Sphingosine kinase 1. International Journal of Biological
Macromolecules 147:177-186.
Parray ZA, Hassan MI, Ahmad F, Islam A. (2020) Amphiphilic nature of polyethylene
234 4.28
glycols and their role in medical research. Polymer Testing 82:106316.
Gupta P, Khan FI, Dahiya R, Roy S, Anwar S, Alajmi F, Hussain A, Dakun L, Hassan
MI (2020) Functional implications of pH-induced conformational changes in the
233 4.09
sphingosine kinase 1. Spectrochimica Acta Part A: Molecular and Biomolecular
Spectroscopy 225:117453.
Alsharif MA, Khan D, Ahmed N, Mukhtar S, Khan P, Hassan MI, Almalki AS, Obaid
RJ. Pharmacological Activities of Novel Chromene Derivatives as
232 2.1
Calcium/Calmodulin Dependent Protein Kinase IV (CAMKIV) Inhibitors. Chemistry
Select 5(2):498-505.
Qausain S, Khan FI, Lai D, Hassan MI, Basheeruddin M, Ahmed N, Khan MKA.
(2020) Mechanistic Insights into the Urea-Induced Denaturation of a Non-Seleno
231 8.02
Thiol Specific Antioxidant Human Peroxiredoxin 6. International Journal of
Biological Macromolecules 161:1171-1180.
Wahiduzzaman, Hassan MI, Islam A and Ahmad F. (2020) Urea Stress: Myo-
inositol's efficacy to counteract destabilization of TIM-β-globin complex by urea is as
230 8.02
good as that of the methylamine. International Journal of Biological
Macromolecules 151:1108-1115.
Ghosh S, Shahid S, Raina N, Ahmad F, Hassan MI and Islam A (2020) Molecular and
macromolecular crowding-induced stabilization of proteins: Effect of dextran and its
229 8.02
building block alone and their mixtures on stability and structure of lysozyme.
International Journal of Biological Macromolecules 150:1238-1248.
Shahbaaz, M., Potemkin, V., Grishina, M., Bisetty, K. and Hassan, M.I. (2020) The
structural basis of acid resistance in Mycobacterium tuberculosis: Insights from
228 5.2
multiple pH regime molecular dynamics simulations. Journal of Biomolecular
Structure and Dynamics 38(15):4483-4492.

33 Hassan’s CV
 Naiyer A, Islam A, Hassan MI, Ahmad F, Sundd M (2020) Backbone and side chain
227 1H, 15N and 13C chemical shift assignments of the molten globule state of L94G 0.74
mutant of horse cytochrome-c. Biomol NMR Assign 14(1):37-44.
Amir, M., Mohammad, T., Prasad, K., Mustafa Hasan, G., Kuma, V., Dohare, R.,
Islam, A., Ahmad, F. and Hassan, I. (2020) Virtual high-throughput screening of
226 5.2
natural compounds in-search of potential inhibitors for protection of telomeres 1
(POT1). Journal of Biomolecular Structure and Dynamics 38(15):4625-4634
Fatima S, Mohammad T, Jairajpuri DS, Samim M, Ahmad FJ, Alajmi F, Hussain A,
Rehman MT, Hassan MI (2020) Identification and evaluation of glutathione
225 5.2
conjugate gamma-L-glutamyl-L-cysteine for improved drug-delivery to the brain.
Journal of Biomolecular Structure & Dynamics 38(12):3610-3620.
Naqvi AAT, Jairajpuri DS, Noman M, Alajmi F, Hussain A, Islam A, Ahmad F,
Hassan MI (2020) Evaluation of pyrazolopyrimidine derivatives as microtubule
224 affinity regulating kinase 4 inhibitors: Towards therapeutic management of 5.2
Alzheimer's disease. Journal of Biomolecular Structure & Dynamics 38(13):3892-
3907.
Amir M, Ahmad S, Ahamad S, Kumar V, Mohammad T, Dohare R, Alajmi MF,
Rehman MT, Hussain A, Islam A, Ahmad F, Hassan MI. (2020) Impact of Gln94Glu
223 mutation on the structure and function of Protection of telomere 1, a cause of 5.2
cutaneous familial melanoma. Journal of Biomolecular Structure & Dynamics
38(5):1514-1524
222 Gupta P, Mohammad T, Dahiya R, Roy S, Noman, A, Alajmi F, Hussain A, Hassan
MI (2019) Evaluation of binding and inhibition mechanism of dietary
4.36
phytochemicals with sphingosine kinase 1: Towards targeted anticancer therapy.
Scientific Reports, 9 (1), 18727.
221 Yousuf M, Khan P, Shamsi A, Shahbaaz M, Hasan GM, Haque QMR, Christoffels A,
Islam A and Hassan MI (2020) Inhibiting CDK6 activity by quercetin is an attractive 4.25
strategy for cancer therapy. ACS Omega 5(42):27480-27491.
220 Shahid S, Hasan I, Ahmad F, Hassan MI, Islam A (2019) Carbohydrate-Based
Macromolecular Crowding-Induced Stabilization of Proteins: Towards 6.06
Understanding the Significance of the Size of the Crowder. Biomolecules 9(9), 477.
219 Khan P, Queen A, Mohammad T, Smita NA, Nashrah NS, Zubair H, Hassan MI, Ali
S (2019) Identification of α-Mangostin as a Potential Inhibitor of Microtubule Affinity 4.85
Regulating Kinase 4. Journal of Natural Products 82(8):2252-2261.
218 Sharma, P., Dhiman, S., Kumari, S., Rawat, P., Srivastava, C., Sato, H., Akitsu, T.,
Kumar, S., Hassan MI, Majumder, S. (2019) Revisiting the physiochemical properties
1.62
of Hematite (α-Fe2O3) nanoparticle and exploring its bio-environmental application.
Materials Research Express 6, 095072
217 Shamsi A, Mohammad T, Shahwan M, Hassan MI, Ahmad F, Islam A (2019)
Unraveling binding mechanism of Alzheimer’s drug Rivastigmine tartrate with
6.06
human transferrin: Molecular docking and multi spectroscopic approach towards
neurodegenerative diseases. Biomolecules 9(9), 49.
216 Gupta P, Mohammad T, Khan P, Roy S, Alajmi F, Hussain A, Hassan MI (2019)
Evaluation of Ellagic Acid as an Inhibitor of Sphingosine Kinase 1: A Targeted
7.30
Approach towards Anticancer Therapy. Biomedicine & Pharmacotherapy
118:109245
215 Dahiya R, Mohammad T, Khan P, Roy S, Anwar S, Gupta P, Alajmi F, Hussain A,
Hassan MI (2019) Molecular interaction studies on ellagic acid for its anticancer 4.36
potential targeting pyruvate dehydrogenase kinase 3. RSC Advances 9, 23302-23315.

34 Hassan’s CV
214 Mehmankhah M, Bhat R, Anvar MS, Ali S, Alam A, Farooqui A, Hassan MI, Ishrat
R, Kazim SN (2019) Structure-guided approach to identify potential inhibitors of
7.35
large envelope protein to prevent hepatitis B virus infection. Oxidative Medicine and
Cellular Longevity 2019:1297484.
213 Amir, M., Mohammad, T., Kumar, V., Alajmi, M.F., Rehman, M.T., Hussain, A.,
Alam, P., Dohare, R., Islam, A., Ahmad, F. and Hassan MI (2019). Structural Analysis
6.16
and Conformational Dynamics of STN1 Gene Mutations Involved in Coat Plus
Syndrome. Frontiers in Molecular Biosciences 6, 41.
212 Rahman S, Rehman MT, Rabbani G, Khan P, AlAjmi MF, Hassan MI, Muteeb G, Kim
J. (2019) Insight of the Interaction between 2,4-thiazolidinedione and Human Serum
6.12
Albumin: A Spectroscopic, Thermodynamic and Molecular Docking Study.
International Journal of Molecular Sciences 20(11): E2727.
211 Dahiya R, Mohammad T, Roy S, Anwar S, Gupta P, Haque A, Khan P, Kazim SN,
Islam A, Ahmad F, Hassan MI. (2019) Investigation of inhibitory potential of
quercetin to the pyruvate dehydrogenase kinase 3: Towards implications in 8.02
anticancer therapy. International Journal of Biological Macromolecules 136:1076-
1085.
210 Naqvi AAT, Alajmi MF, Rehman T, Hussain A, Hassan MI. (2019) Effects of
Pro1266Leu mutation on structure and function of glycoprotein Ib binding domain 4.42
of von Willebrand factor. Journal of Cellular Biochemistry 120:17847‑17857.
209 Amir M, Kumar V, Dohare R, Rehman MT, Hussain A, Alajmi MF, Hassan HMA,
Islam A, Ahmad F, Hassan MI. (2019) Investigating architecture and structure-
function relationships in cold shock DNA-binding domain family using structural 8.02
genomics-based approach. International Journal of Biological Macromolecules
133:484-494
207 Voura M, Khan P, Thysiadis S, Katsamakas S, Queen A, Hasan GM, Sarli V, Hassan
MI. (2019) Probing the Inhibition of Microtubule Affinity Regulating Kinase 4 by a
4.36
Novel Class of N-Substituted Acridone Derivatives: Synthesis, Characterization and
Biological Evaluation. Scientific Reports 9(1):1676.
206 Dahiya R, Naqvi AAT, Mohammad T, Alajmi MF, Rehman MT, Hussain A, Hassan
MI. (2019) Investigating the structural features of chromodomain proteins in the
8.02
human genome and predictive impacts of their mutations in cancers. International
Journal of Biological Macromolecules 131:1101-1116.
205 Amir M, Kumar V, Dohare R, Hussain A, Rehman MT, Alajami MF, Islam A, Ahmad
F, Hassan MI. (2019) Structural and functional impact of non-synonymous SNPs in
4.84
the CST complex subunit TEN1: Structural genomics approach. Bioscience Reports
39(5): BSR20190312.
204 Manzoor O, Soleja N, Khan P, Hassan MI and Mohsin M (2019) Visualization of
thiamine in living cells using genetically encoded fluore scent nanosensor. 3.97
Biochemical Engineering Journal 146, 170-178.
203 Naz H, Tarique M, Ahamad S, Hussain A, Rehman MT, Alajami MF, Hassan MI.
(2019) Hesperidin-CAMKIV interaction and its impact on cell proliferation and
4.48
apoptosis in the human hepatic carcinoma and neuroblastoma cells. Journal of
Cellular Biochemistry 120(9):15119-15130.
202 Bashir S, Shamsi A, Ahmad F, Hassan MI, Kamal M, Islam A, (2020) Biophysical
elucidation of fibrillation inhibition by sugar osmolytes in α-lactalbumin:
4.25
Multispectroscopic and molecular docking approaches. ACS Omega 5(41):26871-
26882.

35 Hassan’s CV
201 Shamsi A, Hassan MI, Ahmad F, Islam A (2019) Spectroscopic, calorimetric and
molecular docking insight into the interaction of Alzheimer’s drug Donepezil with
5.2
human transferrin: Implications of Alzheimer’s drug. Journal of Biomolecular
Structure and Dynamics. Doi: 10.1080/07391102.2019.1595728.
200 Rahman S, Islam A, Hassan MI, Kim J, Ahmad F. (2019) Unfoldness of the denatured
state of proteins determines urea: Methylamine counteraction in terms of Gibbs free
8.02
energy of stabilization. International Journal of Biological Macromolecules 132:666-
676.
199 Afreen S, Idrees D, Khera R, Amir M, Hassan MI, Mishra S. (2019) Investigation of
role of central metal ion of Cyathus bulleri laccase 1 using guanidinium chloride-
8.02
induced denaturation. International Journal of Biological Macromolecules 132:994-
1000.
198 Furkan M, Siddiqi MK, Zakariya SM, Khan FI, Hassan MI, Khan RH. (2019) An In
Vitro elucidation of the antiaggregatory potential of Diosminover thermally induced
8.02
unfolding of hen egg white lysozyme; A preventive quest for lysozyme amyloidosis.
International Journal of Biological Macromolecules 29:1015-1023.
197 Anjum F, Ali F, Mohammad T, Shafie A, Akhtar O, Abdullaev B, Hassan MI (2021)
Discovery of natural compounds as potential inhibitors of human carbonic
3.87
anhydrase II: An integrated virtual screening, docking and MD simulation study.
OMICS: A Journal of Integrative Biology 25(8):513-524.
196 Kumar V, Wahiduzzaman, Prakash A, Tomar AK, Srivastava A, Kundu B, Lynn AM,
Hassan MI (2019) Exploring the aggregation-prone regions from structural domains 4.12
of human TDP-43. Biochim Biophys Acta Proteins Proteomics 1867(3):286-296.
195 Amir M, Kumar V, Dohare R, Hussain A, Rehman MT, Alajami MF, Islam A, Ahmad
F, Hassan MI. (2019) Investigation of deleterious effects of nsSNPs in POT1 gene: A
4.48
structural genomics-based approach to understand mechanism of cancer
development. Journal of Cellular Biochemistry 120(6):10281-10294.
194 Ali, S.; Khan, F.I.; Mohammad, T.; Lan, D.; Hassan, M.I.; Wang, Y. (2019)
Identification and Evaluation of Inhibitors of Lipase from Malassezia restricta using
6.16
Virtual High-Throughput Screening and Molecular Dynamics Studies. International
Journal of Molecular Sciences 20, 884.
193 Ali N, Amir M, Hassan MI, Ahmad F, Islam A. (2019) Purification, modeling and
structural insights of calmodulin-binding receptor like cytoplasmic kinase 2 from 8.02
Oroxylum Indicum. International Journal of Biological Macromolecules 123:704-712.
192 Shahid S, Ahmad F, Hassan MI, Islam A. (2019) Mixture of Macromolecular
Crowding Agents Has a Non-additive Effect on the Stability of Proteins. Applied 3.09
Biochemistry and Biotechnology 188(4):927-941.
191 Aneja B, Khan NS, Khan P, Queen A, Hussain A, Rehman MT, Alajmie MF, El-Seedif
HR, Ali S, Hassan MI, Abid M, (2019) Design and development of Isatin-triazole
hydrazones as potential inhibitors of microtubule affinity-regulating kinase 4 for the 7.08
therapeutic management of cell proliferation and metastasis. European Journal of
Medicinal Chemistry 163:840-852.
190 Khan SH, Prakash A, Pandey P, Lynn AM, Islam A, Hassan MI, Ahmad F. (2019)
Protein folding: Molecular dynamics simulations and in vitro studies for probing
8.02
mechanism of urea- and guanidinium chloride-induced unfolding of horse
cytochrome-c. International Journal of Biological Macromolecules 122:695-704
189 Gulzar M, Syed SB, Khan FI, Khan P, Ali S, Hasan GM, Taneja P, Hassan MI (2019)
Elucidation of interaction mechanism of ellagic acid to the integrin linked kinase. 8.02
International Journal of Biological Macromolecules 122:1297-1304.

36 Hassan’s CV
188 Prakash A, Kumar V, Meena NK, Hassan MI, Lynn AM (2019) Comparative analysis
of thermal unfolding simulations of RNA recognition motifs (RRMs) of TAR DNA-
5.2
binding protein 43 (TDP-43). Journal of Biomolecular Structure & Dynamics
37(1):178-194.
187 Syed SB, Shahbaaz M, Srivastava S, Islam A, Ahmad F and Hassan MI (2019)
Estimation of pH effect on the structure and stability of kinase domain of human 5.2
Integrin linked kinase. Journal of Biomolecular Structure & Dynamics 37(1):156-165.
186 Parray ZA, Ahamad S, Hassan MI, Ahmad F and Islam A (2019) First Evidence of
Formation of Pre-Molten Globule State in Myoglobin: A macromolecular crowding
8.02
approach towards protein folding in vivo. International Journal of Biological
Macromolecules 126:1288-1294.
185 Faizan MI, Naqvi AT, Hassan MI, Abdullah M, Tazeen A, Shafat Z, Hisamuddin
M, Alam A, Ali S, Ali S, Farooqui A, Hamza A, Parveen N, Deeba F, Ahmed A
1.2
and Parveen S (2019) Structure Based Identification of Potential Inhibitors of NS3
Protein of Zika virus, Letters in Drug Design & Discovery 15: 1-14.
184 Beg A, Khan FI, Lobb KA, Islam A, Ahmad F, Hassan MI. (2019) High throughput
screening, docking and molecular dynamics studies to identify potential inhibitors
5.2
of human calcium/calmodulin-dependent protein kinase IV. Journal of Biomolecular
Structure & Dynamics 37(8):2179-2192.
183 Mohammad T, Khan FI, Lobb KA, Islam A, Ahmad F, Hassan MI. (2019)
Identification and evaluation of bioactive natural products as potential inhibitors of
5.2
human microtubule affinity-regulating kinase 4 (MARK4). Journal of Biomolecular
Structure & Dynamics 37(7):1813-1829.
182 Khan, M.S., Agrawal, R., Ubaidullah, M., Hassan, M.I. and Tarannum, N. (2019)
Design, synthesis and validation of anti-microbial coumarin derivatives: An efficient 1.66
green approach. Heliyon 5, e02615.
181 Naqvi AAT, Mohammad T, Hasan GM, Hassan MI. (2018) Advancements in docking
and molecular dynamics simulations towards ligand-receptor interactions and
3.29
structure-function relationships. Current Topics in Medicinal Chemistry 18(20):1755-
1768.
180 Gulzar M, Ali S, Khan FI, Khan P, Taneja P, Hassan MI. (2018) Binding mechanism
of caffeic acid and simvastatin to the integrin linked kinase for therapeutic
5.2
implications: A comparative docking and MD simulation studies. Journal of
Biomolecular Structure & Dynamics 37(16):4327-4337.
179 Amir M, Kumar V, Dohare R, Islam A, Ahmad F, Hassan MI. (2018) Sequence,
structure and evolutionary analysis of cold shock domain proteins, a member of OB 2.41
fold family. Journal of Evolutionary Biology 31(12):1903-1917.
178 Parveen I, Khan P, Alis S, Hassan MI and Ahmad N (2018) Synthesis, Molecular
docking and Inhibition studies of novel 3-N-aryl substituted-2-heteroarylchromones
7.08
targeting Microtubule Affinity Regulating Kinase 4 Inhibitors. European Journal of
Medicinal Chemistry 159:166-177.
177 Khan S, Khan P, Hassan MI, Ahmad F and Islam A (2018) Protein Stability:
Determination of structure and stability of the transmembrane protein Mce4A from
8.02
M. tuberculosis in membrane-like environment. International Journal of Biological
Macromolecules 126:488-495.
176 Khan NS, Khan P, Ansari MF, Srivastava S, Hasan GM, Husain M, Hassan MI. (2018)
Thienopyrimidine-Chalcones Hybrid Molecules Inhibits Fas-activated
4.93
Serine/Threonine Kinase: An Approach to Ameliorates Antiproliferation in Human
Breast Cancer Cells. Molecular Pharmaceutics 15(9):4173-4189.

37 Hassan’s CV
175 Syed SB, Khan FI, Srivastava S, Khan SH, Hasan MG, Lobb KA, Islam A, Ahmad F
and Hassan MI (2018) Unravelling the unfolding mechanism of human integrin
8.02
linked kinase by GdmCl-induced denaturation. International Journal of Biological
Macromolecules 117:1252-1263.
174 Ahamad S, Hassan MI, Dwivedi N. (2018) Designing of phenol-based β-carbonic
anhydrase1 inhibitors through QSAR, molecular docking, and MD simulation 3.73
approach. 3 Biotech. 8(5):256.
173 Queen A, Khan P, Azam A and Hassan MI (2018) Understanding the role and
mechanism of carbonic anhydrase V in obesity and its therapeutic implications. 3.27
Current Protein Peptide Science 19(9):909-923.
172 Prakash A, Kumar V, Pandey P, Bharti DR, Vishwakarma P, Singh R, Hassan MI,
Lynn AM (2018) Solvent sensitivity of protein aggregation in Cu, Zn superoxide
5.2
dismutase: A molecular dynamics simulation study. Journal of Biomolecular
Structure and Dynamics 36(10):2605-2617
171 Queen A, Khan P, Idrees D, Azam A, Hassan MI. Biological evaluation of p-toluene
sulphonylhydrazone as carbonic anhydrase IX inhibitors: An approach to fight
8.02
hypoxia-induced tumors. International Journal of Biological Macromolecules 2018
106:840-850.
170 Ishrat M, Hassan MI, Ahmad F, Islam A. (2018) Sugar osmolytes-induced
stabilization of RNase A in macromolecular crowded cellular environment. 8.02
International Journal of Biological Macromolecules 115:349-357
169 Husain S, Kumar V, Hassan MI. (2018) Phosphorylation-induced changes in the
energetic frustration in human Tank binding kinase 1. Journal of Theoretical Biology 2.69
449:14-22.
168 Kumar V, Prakash A, Pandey P, Lynn AM, Hassan MI (2018) TFE-induced local
unfolding and fibrillation of SOD1: bridging the experiment and simulation studies. 3.87
Biochemical Journal 475(10):1701-1719.
167 Idrees D, Handiwala M, Mahapatra AD, Roy S, Ahamad S, Khan P, Datta B and
Hassan MI (2018) Implication of sulfonylurea derivatives as prospective inhibitors
8.02
of human carbonic anhydrase II. International Journal of Biological Macromolecules
115:961-969.
166 Peerzada MN, Khan P, Ahmad K, Hassan MI, Azam A (2018) Synthesis,
characterization and biological evaluation of tertiary sulfonamide derivatives of
pyridyl-indole based heteroaryl chalcone as potential carbonic anhydrase IX 8.02
inhibitors and anticancer agents. European Journal of Medicinal Chemistry 155:13-
23.
165 Beg I, Islam A, Minton AP, Hassan MI, Ahmad F (2018) Comparison of the thermal
stabilization of proteins by oligosaccharides and monosaccharide mixtures:
2.35
measurement and analysis in the context of excluded volume theory. Biophysical
Chemistry 237:31-37.
164 Syed SB, Khan FI, Srivastava S, Khan SH, Hasan MG, Lobb KA, Islam A, Ahmad F
and Hassan MI (2018) Mechanistic insights into the urea-induced denaturation of
8.02
kinase domain of human integrin linked kinase. International Journal of Biological
Macromolecules 111:208-218.
163 Bansal R, Haque MA, Yadav P, Gupta D, Ethayathulla AS, Hassan MI, Kaur P (2018)
Estimation of structure and stability of MurE ligase from Salmonella enterica serovar 8.02
Typhi. International Journal of Biological Macromolecules 109:375-382.
162 Khan S, Khan FI, Lobb KA, Hasan MG, Islam A, Ahmad F and Hassan MI (2018)
8.02
Exploring molecular insights into the interaction mechanism of cholesterol

38 Hassan’s CV
 derivatives with the Mce4A: A combined spectroscopic and molecular dynamic
simulation studies. International Journal of Biological Macromolecules 111:548-560.
161 Naqvi AAT, Hasan GM, Hassan MI. (2018) Investigating the role of transcription
3.99
factors of pancreas development in pancreatic cancer. Pancreatology 18(2):184-190.
160 Naz F, Khan FI, Khan P, Manzoor S, Hasan MG, Luqman S, Islam A, Lobb K, Ahmad
F and Hassan (2018) Investigation of Molecular Mechanism of Recognition between 8.02
Citral and MARK4: A Newer Therapeutic Approach to Attenuate Cancer Cell
Progression. International Journal of Biological Macromolecules 107(Pt B):2580-
2589.
159 Dar MA, Wahiduzzaman, Islam A, Hassan MI, Ahmad F. (2018) Counteraction of
the deleterious effects of urea on structure and stability of mammalian kidney 8.02
proteins by osmolytes. International Journal of Biological Macromolecules 107(Pt
B):1659-1667.
158 Naz H, Tarique M, Khan P, Luqman S, Ahamad S, Islam A, Ahmad F and Hassan MI
(2018) Evidence of vanillin binding to CAMKIV explains the anticancer mechanism
3.87
in human hepatic carcinoma and neuroblastoma cells. Molecular and Cellular
Biochemistry 438(1-2):35-45.
157 Ansari MF, Idrees D, Hassan MI, Ahmad K, Avecilla F, Azam A. (2018) Design,
synthesis and biological evaluation of novel pyridine-thiazolidinone derivatives as
7.03
anticancer agents: Targeting human carbonic anhydrase IX. European Journal of
Medicinal Chemistry 144:544-556.
156 Kumar V, Hasan GM and Hassan MI (2017) Unraveling the Role of RNA Mediated
5.67
Toxicity of C9orf72 Repeats in C9-FTD/ALS. Frontiers in Neuroscience 11:711.
155 Khan P, Manzoor S, Queen A, Naz F. Rahman S, Kim J, Luqman S, Hasan GM, Islam
A, Ahmad F and Hassan MI (2017) Elucidation of Dietary Polyphenolics as Potential
4.36
Inhibitor of Microtubule Affinity Regulating Kinase 4: In silico and In vitro Studies.
Scientific Reports 7(1):9470.
154 Khan I, Ahmad N, Idrees D, Hassan MI (2017) Synthesis, estrogen receptor binding
affinity and molecular docking of pyrimidine-piperazine-chromene and -quinoline 2.83
conjugates. Bioorganic and Medicinal Chemistry Letters 27(18):4493-4499.
153 Khan FI, Anwer R, Gu K, Wei DQ, Bisetty K, Hassan MI (2017) Structure prediction
and functional analyses of a thermostable lipase obtained from Shewanella 5.2
putrefaciens. Journal of Biomolecular Structure and Dynamics 35 (10): 2123-2135.
152 Nasreen K, Ahmad S, Hassan MI, Ahmad F and Islam A (2017) Macromolecular
crowding induces molten globule state in the native myoglobin at physiological pH. 8.02
International Journal of Biological Macromolecules 106:130-139.
151 Naz H, Shahbaaz M, Haque MA, Bisetty K, Islam A, Ahmad F, Hassan MI. (2017)
Urea-induced denaturation of human calcium-calmodulin dependent protein kinase
5.2
IV: A combined spectroscopic and MD simulation study. Journal of Biomolecular
Structure and Dynamics 35: 463-475.
150 Shahbaaz M, Amir M, Rahman S, Bisetty K, Ravins, Hasan MG, Ahmad F and Hassan
MI (2017) Structural insights into Rab21 GTPase activation mechanism by molecular 2.12
dynamics simulations. Molecular Simulation 44 (3) 179-89.
149 Khan SH, Islam A, Hassan MI, Sharma S, Singh TP and Ahmad F (2017) Effect of
conservative mutations (L94V and L94I) on the structure and stability of horse 4.01
cytochrome c. Archives of Biochemistry and Biophysics 633:40-49.
148 Srivastava S, Begum SS, Kumar V, Islam A, Ahmad F, Hassan, M I (2017), Fas-
1.37
activated serine/threonine kinase: Structure and function. Gene Reports 8: 117-27.

39 Hassan’s CV
147 Khan S, Shhahbaaz M, Bisetty K, Islam A, Ahmad F and Hassan MI (2017)
Classification and functional analyses of putative conserved proteins from
2.23
Chlamydophila pneumoniae CWL029. Interdisciplinary Sciences Computational Life
Sciences 9 (1): 96–106.
146 Dahiya R, Hassan MI. (2017) Studying Host-Virus Alliances using CRISPR Genetics.
0.6
Advances in Biotechnology and Microbiology 3(4): 555621.
145 Idrees D, Rahman S, Shahbaaz M, Haque MA, Islam A, Ahmad F, Hassan MI. (2017)
Estimation of thermodynamic stability of human carbonic anhydrase IX from urea-
8.02
induced denaturation and MD simulation studies. International Journal of
Biological Macromolecules 105(Pt 1):183-189
144 Kumar V, Rahman S, Choudhry H, Zamzami MA, Sarwar Jamal M, Islam A, Ahmad
F, Hassan MI (2017) Computing disease-linked SOD1 mutations: deciphering 4.37
protein stability and patient-phenotype relations. Scientific Reports 7(1):4678.
143 Gupta D, Sachdeva E, Haque MA, Rahman S, Bansal R, Ethayathulla AS, Hassan MI
and Kaur P. (2017) Effect of chemical denaturants on the conformational stability
8.02
GyrB subunit of DNA gyrase from Salmonella enterica serovar Typhi. International
Journal of Biological Macromolecules 103:165-174
142 Rai N, Kumar R, Haque MA, Hassan MI and Dey S (2017) A Study of Recombinant
Human Sestrin 1 and Sestrin 2 Proteins Produced in a Prokaryotic System. Molecular 1.3
Biology 51 (3): 416–425.
141 Ahamad S, Rahman S, Khan FI, Dwivedi N, Ali S, Kim J, Hassan MI. (2017) QSAR
based therapeutic management of M. tuberculosis. Archives of Pharmacal Research 6.06
40(6):676-694.
140 Afreen S, Shamsi TN, Baig MA, Ahmad N, Fatima S, Qureshi MI, Hassan MI, Fatma
T. (2017) A novel multicopper oxidase (laccase) from cyanobacteria: Purification,
3.75
characterization with potential in the decolorization of anthraquinonic dye. PLoS
One 12(4): e0175144.
139 Khan FI, Rahman S, Queen A, Ahamad S, Ali S, Kim J and Hassan MI (2017)
Implications of molecular diversity of chitin and its derivatives. Applied 4.81
Microbiology and Biotechnology 101(9):3513-3536.
138 Parray ZA, Shahid S, Ahmad F, Hassan MI, Islam A. (2017) Characterization of
intermediate state of myoglobin in the presence of PEG 10 under physiological 8.02
conditions. International Journal of Biological Macromolecules 99:241-248
137 Rahman S, Byun Y, Hassan MI, Kim J, Kumar V. (2017) Towards understanding
cellular structure biology: In-cell NMR. Biochim Biophys Acta Proteins & 4.3
Proteomics 1865(5):547-557.
136 Mishra CB, Kumari S, Idrees D, Prakash A, Tiwari M, Hassan MI (2017) Design,
Synthesis, In-Silico and Biological Evaluation of novel 2-(4-(4- substituted piperazin- 2.94
1-yl) benzylidene) hydrazine carboxamides. Molecular Diversity 21(1):163-174.
135 Beg I, Minton AP, Islam A, Hassan MI, Ahmad F. (2017) The pH Dependence of
Saccharides' Influence on Thermal Denaturation of Two Model Proteins Supports an
5.15
Excluded Volume Model for Stabilization Generalized to Allow for Intramolecular
Electrostatic Interactions. Journal of Biological Chemistry 292(2):505-511.
134 Sami N, Rahman S, Kumar V, Zaidi S, Islam A, Ali S, Ahmad F, Hassan MI. (2017)
Protein aggregation, misfolding and consequential human neurodegenerative 2.29
diseases. International Journal of Neuroscience 127(11):1047-1057.
133 Dar MA, Islam A, Hassan MI, Ahmad F (2017) Effect of mammalian kidney
osmolytes on the folding pathway of sheep serum albumin. International Journal of 8.02
Biological Macromolecules 97:625-634.

40 Hassan’s CV
132 Turab Naqvi AA, Rahman S, Rubi, Zeya F, Kumar K, Choudhary H, Jamal MS, Kim
J, Hassan MI (2017) Genome analysis of Chlamydia trachomatis for functional
8.02
characterization of hypothetical proteins to discover novel drug targets.
International Journal of Biological Macromolecules 96:234-240
131 Shahbaaz M, Rahman S, Khan P, Kim J and Hassan MI (2017) Classification and
Structural Analyses of Mutational Landscapes in Hemochromatosis Factor E Protein: 0.37
A Protein Defective in the Hereditary Hemochromatosis. Gene Reports 6: 93–102.
130 Idrees D, Shahbaaz M, Bisetty K, Islam A, Ahmad F, Hassan MI. (2017) Effect of pH
on structure, function, and stability of mitochondrial carbonic anhydrase VA. Journal 3.1
of Biomolecular Structure and Dynamics 35(2):449-461.
129 Rahman S, Ali SA, Islam A, Hassan MI, Ahmad F. (2016) Data on the role of
accessible surface area on osmolytes-induced protein stabilization. Data Brief 10:47- 0.93
56.
128 Naz H, Khan P, Tarique M, Rahman S, Ahamad S, Meena A, Luqman S, Islam A,
Ahmad F and Hassan MI (2017) Binding studies and biological evaluation of β-
8.02
carotene as a potential inhibitor of human calcium/calmodulin-dependent protein
kinase IV. International Journal of Biological Macromolecules 96:161-170
127 Shahid S, Hassan MI, Islam A, Ahmad F. (2017) Size-dependent studies of
macromolecular crowding on the thermodynamic stability, structure and functional
4.77
activity of proteins: in vitro and in silico approaches. Biochimica et Biophysica Acta
(BBA) - General Subjects 1861(2):178-197.
126 Wahiduzzaman, Dar MA, Haque MA, Idrees D, Hassan MI, Islam A, Ahmad F.
(2017) Characterization of folding intermediates during urea-induced denaturation
8.02
of human carbonic anhydrase II, International Journal of Biological Macromolecules
95:881-887.
125 Wahiduzzaman, Dar MA, Haque MA, Idrees D, Islam A, Hassan MI, Ahmad F.
(2017) Purification, preliminary X-ray crystallography and biophysical studies of
8.02
triose phosphate isomerase-β-globin subunit complex. International Journal of
Biological Macromolecules 94(Pt B):746-753.
124 Khan FI, Aamir M, Wei DQ, Ahmad F, Hassan MI. (2017) Molecular mechanism of
Ras-related protein Rab-5A and effect of mutations in the catalytically active 5.2
phosphate-binding loop. Journal of Biomolecular Structure Dynamics 35(1):105-118.
123 Jameel E, Naz H, Khan P, Kumar J, Tarique M, Hoda N, Mumtazuddin S, Ahamad S,
Islam A, Ahmad F and Hassan MI (2016) Design, synthesis and biological evaluation
2.81
of pyrimidine derivatives as potential inhibitors of human CAMKIV. Chemical
Biology & Drug Design 89(5):741-754.
122 Prakash A, Idrees D, Haque MA, Islam A, Ahmad F, Hassan MI. (2017) GdmCl-
induced unfolding studies of human carbonic anhydrase IX: a combined
5.2
spectroscopic and MD simulation approach. Journal of Biomolecular Structure and
Dynamics 35(6):1295-1306.
121 Ahamad S, Islam A, Ahmad F, Dwivedi N, Hassan MI (2018) 2/3D-QSAR, molecular
docking and MD simulation studies of FtsZ protein targeting benzimidazoles 3.87
derivatives. Computational Biology and Chemistry 78:398-413.
120 Zaidi S, Haque MA, Ubaid-Ullah S, Prakash A, Hassan MI, Islam A, Batra JK, Ahmad
F. (2017) Denatured states of yeast cytochrome c induced by heat and guanidinium
5.2
chloride are structurally and thermodynamically different. Journal of Biomolecular
Structure and Dynamics 35(7):1420-1435

41 Hassan’s CV
119 Sami N, Kumar V, Ali, S, Islam A, Ahmad F, Hassan MI. (2017) Exploring Missense
Mutations in Tyrosine Kinases Implicated with Neurodegeneration. Molecular 5.59
Neurobiology 54(7):5085-5106.
118 Khan FI, Gu K, Bisetty K, Singh S, Permaul K, Hassan MI, Wei DQ (2016) Molecular
dynamics simulation of chitinase I from Thermomyces lanuginosus SSBP to ensure 2.17
optimal activity. Molecular Simulation 43(7):480-490
117 Naqvi AA, Anjum F, Khan FI, Islam A, Ahmad F, Hassan MI. (2016) Sequence
Analysis of Hypothetical Proteins from Helicobacter pylori 26695 to Identify Potential --
Virulence Factors. Genomics & Informatics 14(3):125-135.
116 Kumar V, Sami N, Kashav T, Islam A, Ahmad F, Hassan MI. (2016) Protein
aggregation and neurodegenerative diseases: From theory to therapy. European 7.03
Journal of Medicinal Chemistry 124:1105-1120.
115 Kumar V, Kashav T, Islam A, Ahmad F, Hassan MI. (2016) Structural insight into
C9orf72 hexanucleotide repeat expansions: Towards new therapeutic targets in FTD- 3.82
ALS. Neurochemistry International 100:11-20.
114 Khan SH, Kumar A, Prakash A, Taneja B, Islam A, Hassan MI, Ahmad F (2016)
Structural and thermodynamic characterization of L94F mutant of horse cytochrome 8.02
c. International Journal of Biological Macromolecules 92:202-212.
113 Idrees D, Prakash A, Haque MA, Islam A, Hassan MI, Ahmad F. (2016) GdnHCl-
induced unfolding intermediate in mitochondrial carbonic anhydrase VA. 8.02
International Journal of Biological Macromolecules 91:1151-1160.
112 Khan S, Islam A, Hassan MI, Ahmad F. (2016) Purification and Structural
Characterization of Mce4A from Mycobacterium tuberculosis. International Journal of 8.02
Biological Macromolecules 93:235-241.
111 Khan P, Amresh P, Haque MA, Islam A, Ahmad F, Hassan MI. (2016) Structural Basis
of Urea-induced Unfolding: Unraveling the Folding Pathway of Hemochromatosis 8.02
Factor E. International Journal of Biological Macromolecules 91:1051-1061.
110 Kumar V, Islam A, Hassan MI, Ahmad F (2016) Delineating the relationship between
amyotrophic lateral sclerosis and frontotemporal dementia: Sequence and Structure 5.18
based predictions. BBA - Molecular Basis of Disease 1862(9):1742-1754.
109 Dar MA, Wahiduzzaman, Haque MA, Islam A, Hassan MI, Ahmad F. (2016)
Characterizations of molten globule-like state of sheep serum albumin at 8.02
physiological pH. International Journal of Biological Macromolecules 89:605-613.
108 Kumar V, Islam A, Ahmad F and Hassan MI (2016) Therapeutic progress in
amyotrophic lateral sclerosis- beginning to learning. European Journal of Medicinal 8.02
Chemistry 121:903-917.
107 Naz F, Sami N, Naqvi AT, Islam A, Ahmad F, Hassan MI (2016) Evaluation of
Human Microtubule Affinity-Regulating Kinase 4 Inhibitors: Fluorescence Binding
5.2
Studies, Enzyme, and Cell Assays. Journal of Biomolecular Structure and Dynamics
34 (6): 1241-1251.
106 Ali A, Ahmad MM, Khan MA, Gani AA, Kiran U, Prakash A, Hassan MI, Saxena P,
Khan S, Ahlawat S, Abdin MZ (2016). Computational characterization and in vivo
3.3
expression of squalene synthase gene in different tissues of Artemisia annua L. plants.
South African Journal of Botany 105:169-177.
105 Naz F, Sami N, Islam A, Ahmad F, Hassan MI. (2016) Ubiquitin-associated domain
of MARK4 provides stability at physiological pH. International Journal of Biological 8.02
Macromolecules 93(Pt A):1147-1154.

42 Hassan’s CV
104 Khan FI, Bisetty K, Wei DQ, Hassan MI. (2016) A pH based molecular dynamics
simulations of chitinase II isolated from Thermomyces lanuginosus SSBP. Cognet --
Biology 2: 1168336.
103 Naz H, Shahbaaz M, Bisetty K, Islam A, Ahmad F, Hassan MI (2016) Effect of pH on
the structure, function and stability of human calcium/calmodulin-dependent
3.62
protein kinase IV: A combined spectroscopic and MD simulation studies.
Biochemistry and Cell Biology 94(3):221-8.
102 Amir M, Dar MA, Wahiduzzaman, Islam A, Ahmad F, Hassan MI (2016) Purification
and characterization of RGA2, a Rho2 GTPase-activating protein from 3.40
Tinosporacordifolia. 3 Biotech 6(1): 85.
101 Khan S, Jamal MS, Rasool M, Ansari A, Islam A, Ahmad F and Hassan MI (2016)
Functional annotation of putative conserved proteins from Borrelia burgdorferi to find
--
a potential drug target. International Journal of Computational Biology and Drug
Design 9: 295 – 318.
100 Kumari S, Idrees D, Mishra CM, Prakash P, Wahiduzzaman, Ahmad F, Hassan MI,
Tiwari M (2016) Design and synthesis of a novel class of carbonic anhydrase-IX
2.51
inhibitor 1-(3-(phenyl/4-fluorophenyl)-7-imino-3H-[1,2,3]triazolo[4,5d]pyrimidin
6(7H)yl)urea. Journal of Molecular Graphics and Modeling 64:101-109.
99 Naz H, Jameel E, Hoda N, Shandilya A, Khan P, Islam A, Ahmad F, Jayaram B,
Hassan MI (2016) Structure guided design of potential inhibitors of human calcium-
2.83
calmodulin dependent protein kinase IV containing pyrimidine scaffold. Bioorganic
and Medicinal Chemistry Letters 26(3):782-788.
98 Anwer K, Rahman S, Sonani R, Khan FI, Islam A, Madamwar D, Ahmad F and
Hassan MI (2016) Probing pH sensitivity of αC-phycoerythrin and its natural 8.02
truncant: A comparative study. International J. Biological Macromolecule 86:18-27.
97 Naz H, Islam A, Ahmad F, Hassan MI (2016) Calcium/Calmodulin-dependent
protein kinase IV: A multifunctional enzyme and potential therapeutic target. 3.66
Progress in Biophysics and Molecular Biology 121(1):54-65.
96 Idrees D, Kumar D, Rehman SA, Gourinath S, Islam A, Ahmad F and Hassan MI
(2016) Cloning, Expression, Purification of Characterization of Human 3.40
Mitochondrial Carbonic Anhydrase VA. 3Biotech 6 (1), 1-8.
95 Shahbaaz, M., Bisetty K., Ahmad, F., and Hassan, M.I. (2016) Current advances in
the identification and characterization of putative drug and vaccine targets in the 3.29
bacterial genomes. Current Topics in Medicinal Chemistry 16 (9), 1040-1069.
94 Khan FI, Shahbaaz M, Bisetty K, Waheed A, Sly WS, Ahmad F and Hassan MI (2016)
Large scale analysis of the mutational landscape in β-glucuronidase: A major player 3.68
of mucopolysaccharidosis type VII, Gene 576(1 Pt 1):36-44
93 Khan FI, Wei DQ, Gu KR, Hassan MI, Tabrez S (2016) Current updates on computer
aided protein modeling and designing. International Journal of Biological 8.02
Macromolecules 85:48-62.
92 Hassan MI (2016) Recent Advances in the Structure-based Drug design (SBDD) and
3.29
Discovery. Current Topics in Medicinal Chemistry 16 (9), 899-900.
91 Khan P, Parkash A, Islam A, Ahmad F, Hassan MI. (2016) Molecular basis of the
structural stability of hemochromatosis factor E: A combined molecular dynamic 2.50
simulation and GdmCl-induced denaturation study. Biopolymers 105 (3), 133-142.
90 Rahman S, Ali SA, Hassan MI, Islam A and Ahmad F. (2016) Testing the dependence
of stabilizing effect of osmolytes on the fractional increase in the accessible surface
4.01
area on thermal and chemical denaturations of proteins. Archives of Biochemistry
and Biophysics 591:7-17.

43 Hassan’s CV
89 Tasleem M., Ishrat R, Islam A, Ahmad F and Hassan MI (2015) Human Disease
Insight: An integrated knowledge-based platform for disease-gene-drug 7.35
information. Journal of Infection and Public Health 9(3):331-8.
88 Hoda N.; Naz H.; Jameel E.; Shandilya A.; Dey S.; Hassan M.I., Ahmad F; Jayaram B.
(2016) Curcumin Specifically binds to the Human Calcium-calmodulin Dependent
5.2
Protein Kinase IV: Fluorescence and Molecular Dynamics Simulation Studies,
Journal of Biomolecular Structure and Dynamics 34 (3):572-84
87 Naz F, Singh P, Islam A, Ahmad F, Hassan MI. (2016) Human microtubule affinity-
regulating kinase 4 is stable at extremes of pH. Journal of Biomolecular Structure and 5.2
Dynamics 34(6):1241-51
86 Idrees D, Kumar A, Islam A, Ahmad F and Hassan MI (2016) Spectroscopic and MD
simulation studies on unfolding processes of mitochondrial carbonic anhydrase VA 5.2
induced by urea. Journal of Biomolecular Structure and Dynamics 34(9):1987-97.
85 Amir M, Wahiduzzaman, Dar MA, Haque MA, Islam A, Ahmad F and Hassan MI
(2016) Purification and characterization of oligonucleotide binding (OB)-fold protein
5.2
from medicinal plant Tinospora cordifolia. J Chromatography B Analytical Technology
Biomedical Life Sciences 1008:38-44.
84 Amir M, Wahiduzzaman, Dar MA, Haque MA, Islam A, Ahmad F and Hassan MI
(2016) Purification and Characterization of Ras related protein, Rab5a from Tinospora 8.02
Cordifolia. International Journal of Biological Macromolecules 82:471-479.
83 Ishrat M, Hassan MI, Ahmad F, Moosavi-Movahedi AA, Islam A (2016) Effect of
dextran macromolecular crowding on the thermodynamic stability and structure of 2.01
ribonuclease A. Journal of the Iranian Chemical Society 13 (1), 181-189.
82 Naz F, Shahbaaz, M., Bisetty K., Islam A, Ahmad F, Hassan MI. (2015) Designing
new kinase inhibitor derivatives as therapeutics against common complex diseases:
3.87
Structural basis of microtubule affinity-regulating kinase 4 (MARK4) inhibition.
OMICS: Integrative Biology 19(11):700-11
81 Naz F, Shahbaaz, M., Khan S, Bisetty K., Islam A, Ahmad F, Hassan MI. (2015) PKR-
inhibitor binds efficiently with human microtubule affinity-regulating kinase 4. 2.51
Journal of Molecular Graphics and Modeling 62:245-52.
80 Kumar K, Prakash A, Islam A, Ahmad F, Hassan MI. (2015) Identification of
functional candidates amongst hypothetical proteins of Neisseria gonorrhoeae. Letters 1.15
in Drug Design & Discovery 12(2): 101-116.
79 Khan FI, Bisetty K, Singh S and Hassan MI (2015) Chitinases from Thermomyces
2.4
lanuginosus and its biotechnological applications. Extremophiles 19(6):1055-1066.
78 Shahbaaz, M., Bisetty K., Ahmad, F., and Hassan, M.I. (2015) In silico approaches for
the identification of virulence candidates amongst hypothetical proteins of 2.87
Mycoplasma pneumoniae 309. Computational Biology and Chemistry 59(Pt A):67-80.
77 Shahid S, Hassan MI, Ahmad F, Islam A (2015) Relationship between protein
stability and functional activity in the presence of macromolecular crowding agents
4.01
alone and in mixture: an insight into stability-activity trade-off. Archives of
Biochemistry and Biophysics 584:42-50.
76 Naz F, Islam A, Ahmad F, Hassan MI. (2015) Atypical PKC phosphorylates
microtubule affinity-regulating kinase 4 in vitro. Molecular and Cellular 3.87
Biochemistry 410 (1-2): 223-8.
75 Shahbaaz, M., Bisetty K., Ahmad, F., and Hassan, M.I. (2015) Functional Insight into
0.87
Putative Uncharacterized Proteins of Rickettsia rickettsii and its Virulence
Characterization. Current Proteomics 12(2): 101 - 116.

44 Hassan’s CV
74 Aneja B., Irfan M., Hassan M. I., Amresh P., Yadava U., Daniliuc C.G., Azam A;
Zafaryab M; Moshahid RA; Abid M, (2016) Monocyclic β-lactam and unexpected
5.05
oxazinone formation: Synthesis, crystal structure, docking studies and antibacterial
evaluation. Journal of Enzyme Inhibition and Medicinal Chemistry 31(5):834-852.
73 Singh R, Hassan MI, Islam A and Ahmad F. (2015) Cooperative Unfolding of
Residual Structure in Heat Denatured Proteins by Urea and Guanidinium Chloride, 3.75
Plos One 10 (6): e0128740
72 Beg I, Minton AP, Hassan M.I., Islam A, Ahmad F. (2015) Thermal Stabilization of
Proteins by Mono- and Oligosaccharides: Measurement and Analysis in the Context 3.3
of an Excluded Volume Model. Biochemistry 54(23): 3594-603.
71 Shahbaaz, M., Bisetty K., Ahmad, F., and Hassan, M.I. (2015) Functional predication
of putative uncharacterized proteins of Neisseria meningitid MC58 and its virulence 3.87
characterization. OMICS: Integrative Biology 19(7):416-34.
70 Naqvi A.A.T.; Ahmad F.; Hassan M.I. (2015) Identification of functional candidates
amongst hypothetical proteins of Mycobacterium leprae Br4923, a causative agent of 2.13
leprosy; Genome 58(1):25-42.
69 Naqvi AAT, Shahbaaz M, Ahmad F and Hassan MI (2015) Functional annotation of
3.75
hypothetical proteins from Treponema pallidum, Plos ONE 10(4): e0124177
68 Naiyer A.; Hassan M.I.; Islam A.; Sundd M.; Ahmad F. (2015) Structural
characterization of MG and pre-MG states of proteins by MD simulations, NMR, and 5.2
other techniques, Journal of Biomolecular Structure and Dynamics, 33(10):2267-2284
67 Rahaman H.; Khan M.K.A.; Hassan M.I.; Islam A.; Moosavi-Movahedi A.A.; Ahmad
F. (2015) Heterogeneity of Equilibrium Molten Globule State of Cytochrome c
3.75
Induced by Weak Salt Denaturants under Physiological Condition, Plos One
10(4):e0120465
66 Anwer K, Sonani R, Madamwar D, Singh P, Khan F, Bisetty K, IslamA, AhmadF and
Hassan MI (2015) Folding and stability of C-phycoerythrin: Molecular dynamics
5.2
simulation and urea-induced denaturation studies. Journal of Biomolecular
Structure and Dynamics 33, 121-133.
65 Zaidi S.; Hassan M.I.; Islam A.; Ahmad F. (2015) Structural Characteristics of Stable
Folding Intermediates of Yeast Iso-1-Cytochrome-c. Biomacromolecular Journal 1, --
19-45.
64 Mohammad T, Batra S, Dahiya R, Baig MH, Rather IA, Dong JJ, Hassan MI (2019)
Identification of High-Affinity Inhibitors of Cyclin-Dependent Kinase 2 Towards 4.98
Anticancer Therapy. Molecules 24(24).
63 Sinha A.; Ahmad F.; Hassan M. I. (2015) Structure based functional annotation of
putative conserved proteins from Treponema pallidum: search for a potential drug 1.2
target; Letters in Drug Design and Discovery 12, 46-59.
62 Haque M.A.; Ubaid-ullah S.; Zaidi S.; Hassan M.I.; Islam A.; Batra J.K., and Ahmad
F (2015) Characterization of pre-molten globule state of yeast iso-1-cytochrome c and
8.02
its deletants at pH 6.0 and 25° C; International Journal of Biological Macromolecules
72, 1406-18
61 Haque A, Ubaidullah S, Zaidi S, Hassan MI, Islam A, Batra JK and Ahmad F (2015)
In vitro and in silico studies of urea-induced denaturation of yeast iso-1-cytochrome
3.1
c and its deletants at pH 6.0 and 25 °C. Journal of Biomolecular Structure and
Dynamics 33(7):1493-502.
60 Shahbaz M, Ahmad F and Hassan MI (2015) Sequence and Structure Analysis
Putative Conserved Proteins having Lyase Activity from Haemophilus influenzae Rd 3.40
KW20. 3Biotech 5: 317-336.

45 Hassan’s CV
59 Kumar K, Prakash A, Islam A, Ahmad F, Hassan MI (2015) Structure based
Functional Annotation of Hypothetical Proteins from Candida dubliniensis: A Quest 3.40
for Novel Drug Target, 3 Biotech 5:561–576
58 Shahbaaz M.; Ahmad F.; Hassan M.I. (2015) Structure-based function analysis of
putative conserved proteins with isomerase activity from Haemophilus influenzae; 3 3.40
Biotech 5(5): 741–763
57 Tasleem M, Ishrat R, Islam A, Ahmad F and Hassan MI (2015) Structural and
1.2
Functional Analysis of Arg674 Mutation in MyH8 Gene Associated with Trsimus-
Pseudocamptodactyly Syndrome. Letters in Drug Design and Discovery 11, 1177-87.
56 Dar MA, Wahiduzzaman, Hassan MI, Islam A and Ahmad F (2014) Purification and
Characterization of Calreticulin: A Ca2+- binding Chaperone from Sheep Kidney. 3.26
Applied Biochemistry and Biotechnology 174, 1771-83.
55 Devika NT, Prakash A, Hassan MI, Ali BMJ (2014) Molecular modeling and
simulation of human eNOS reductase domain, an enzyme involved in release of 1.81
vascular Nitric Oxide. Journal of Molecular Modeling 20(10):2470.
54 Minakshi R, Padhan K, Rahman S, Hassan MI, Ahmad F (2014) The SARS
Coronavirus 3a protein binds calcium in its cytoplasmic domain, Virus Research 191, 5.35
180-183.
53 Ali SA, Hassan MI, Islam A and Ahmad F (2014) Methods Available to Estimate
Protein Solvent-Accessible Surface Areas in the Folded and Unfolded State. Current 3.1
Protein Peptide Science 15: 456-76.
52 Kumar K, Prakash A, Tasleem M, Islam A, Ahmad F and Hassan MI (2014)
Functional annotation of putative hypothetical proteins from Candida dubliniensis. 3.6
Gene 543(1):93-100.
51 Khan P, Idrees D, Moxley MA, Corbett JA, Ahmad F, von Figura G, Waheed A, Sly
WS and Hassan MI (2014) Luminol based chemiluminescent signals: applications in 3.25
clinical measurements. Applied Biochemistry and Biotechnology 173, 333-55
50 Naz F, Asad M, Malhotra P, Islam A, Ahmad F and Hassan MI (2014) Cloning,
expression, purification and refolding of Microtubule Affinity-Regulating Kinase 4 3.25
expressed in Escherichia coli. Applied Biochem and Biotechnology 172(6):2838-2844.
49 Ubaid-ullah S.; Haque M.A.; Zaidi S.; Hassan M.I.; Islam A.; Batra J.K., Ahmad F.
(2015) Effect of sequential deletion of extra N-terminal residues on the structure and
5.2
stability of yeast iso-1-cytochrome-c; Journal of Biomolecular Structure and
Dynamics 32, 2005-16
48 Anwer K, Rahman S, Parmar A, Sonani R, Madamwar D, Singh P, Islam A, Ahmad
F and Hassan MI (2014) Folding and stability studies on C-PE and its natural N- 4.01
terminal truncant. Archives of Biochemistry and Biophysics 545C:9-21.
47 Thakur P, Prakash A, Fleming RE, Waheed A, Ahmad F and Hassan MI (2014)
Identification of interfacial residues involved in Hepcidin-Ferroprotin interaction 1.2
and their role in Iron Homeostasis. Letters Drug Design &Discovery 11 (3), 363-374.
46 Kumar V, Gupta P and Hassan MI (2019) Mechanism and Implications of Chinese
herbal medicine in Amyotrophic Lateral Sclerosis Therapy. Journal of Proteins and -
Proteomics 10 (2) 131–147.
45 Singh A, Thakur P, Meena M, Kumar D, Bhatnagar S, Dubey AK and Hassan MI
(2014) Interaction between Basic 7S Globulin (Glycine max) and Leginsulin: A 1.2
Structural Insight. Letters in Drug Design and Discovery 11 (2), 231-239.
44 Hassan MI, Kumar P and Gourinath S (2013) Professor Tej Pal Singh: The legend of
--
Indian Macromolecular Crystallography. Journal of Protein and Proteomics 4: 67-81.

46 Hassan’s CV
43 Amresh P, Kumar K, Islam A, Hassan M. I., Ahmad F (2013) Receptor Chemoprint
Derived Pharmacophore Model for Development of CAIX Inhibitors. Journal of --
Carcinogenesis and Mutagenesis S8: 003.
42 Shahbaaz M, Ahmad F and Hassan MI (2013) Functional Annotation of Conserved
3.75
Hypothetical Proteins from Haemophilus influenzae Rd KW20. Plos ONE 8(12): e84263.
41 Hassan MI, Waheed A, Grubb JH, Klei HE, Anumula GR, Korolev S and Sly WS
(2013) High resolution crystal structure of human β-glucuronidase reveals structural 3.75
basis of lysosome targeting. Plos ONE 8(11): e79687.
40 Khan S, Bano Z, Singh LR, Hassan MI, Islam A, Ahmad F (2013) Testing the Ability
of Non-Methylamine Osmolytes Present in Kidney Cells to Counteract the
3.75
Deleterious Effects of Urea on Structure, Stability and Function of Proteins. PLoS
ONE 8(9): e72533
39 Naz H, Islam I. Waheed A, Ahmad F, Sly WS, Hassan MI (2013) Human β-
glucuronidase: Structure, function and application in enzyme replacement therapy. 3.66
Rejuvenation Research 16(5):352-363.
38 Hassan MI, Saji B, Ahmad F, Waheed A and Sly WS (2013) Structure and functions
3.64
of carbonic anhydrases. Bioorganic & Medicinal Chemistry 21(6):1570-82
37 Naz F, Anjum F, Islam A, Ahmad F, Hassan MI. (2013) Microtubule Affinity-
Regulating Kinase 4: Structure, Function, and Regulation. Cell Biochemistry & 2.98
Biophysics. 67(2):485-499.
36 Thakur P, Kumar J, Ray D, Anjum F and Hassan MI (2013) Search of potential
inhibitor against New Delhi metallo-β-lactamase 1 from a series of antibacterial
2.10
natural compounds using docking approach. Journal of Natural Science, Biology
and Medicine 4: 51-56.
35 Hassan MI, Waheed A, Chang Y, Sly WS, Ahmad F. and Fleming RE (2013)
Characterization and Quantization of Hepcidin from Human and Mouse Serum and
--
Secretion Medium from Human Liver Cell Line, Hu.7 by MALDI-TOF MS. Journal
of Protein and Proteomics 4, 9-17.
34 Hassan MI, Ahmad F, Waheed A and van Etten RL (2013) Fluorescent Dye
Conjugates of Rabbit Arylsulfatase A: Application in Immuno-fluorescent Assay,
3.36
Protein-Protein Interaction, and as Biological Tracer for Endocytosis. Applied
Biochemistry and Biotechnology 170(4):972-979.
33 Ahmad F, Jan R, Kannan M, Obser T, Hassan MI, Oyen F, Budde U, Saxena R,
Schneppenheim R. (2013) Characterization of mutations and molecular studies of 5.26
type 2 von Willebrand disease. Thrombosis and Haemostasis 109:39-46.
32 Rahaman H, Khan MKA, Hassan MI, Islam A and Ahmad F. (2013) Evidence of non-
coincidence of normalized sigmoidal curves of two different structural properties for 3.17
two-state protein folding/unfolding. Journal of Chem Thermodynamics 58: 351-358
31 Khan S, Bano Z, Singh LR, Hassan MI, Islam A, Ahmad F (2012) Why is glycine not
1.89
a part of the osmoticum in the urea-rich cells? Protein & Peptide Letters 20:61-70.
30 Hassan MI, Naeem A, Khan MKA, Khan RH, Singh S, Singh TP, Yadav S, (2012)
Protective Effect of Prolactin Induced Protein on Zinc α2-Glycoprotein against --
various Denaturants. Journal of Protein and Proteomics 3: 105-111
29 Ojha H, Mishra K, Hassan MI, Chaudhuri NK (2012) Spectroscopic and isothermal
titration calorimetry studies of binding interaction of ferulic acid with bovine serum 3.11
albumin. Thermochimica Acta, 548: 56-64
28 Kumar V, Yadav VK, Hassan MI, Singh AK, Dey S, Singh S, Singh TP, Yadav S. (2012)
Kinetic and structural studies on the interactions of heparin and proteins of human 1.89
seminal plasma using surface plasmon resonance. Protein Peptide Letters 19:795-803.

47 Hassan’s CV
27 Hassan MI, Saxena A and Ahmad F (2012) Structure and function of VWF, the
Protein That is Deficient and/or Abnormal in Inherited VWD. Blood Coagulation & 1.2
Fibrinolysis 23:11-22
26 Thakur P and Hassan MI (2011) Discovering a Potent Small Molecule Inhibitor for
Gankyrin Using de novo Drug Design Approach. International Journal of -
Computational Biology and Drug Design 4:373-786
25 Rehman MT, Dey P, Hassan MI, Ahmad F, Batra JK. (2011) Functional role of
glutamine 28 and arginine 39 in double stranded RNA cleavage by human pancreatic 3.75
ribonuclease. PLoS One 6: e17159.
24 Khan, K.A., Rahman, M.H., Hassan, M.I., Singh, T.P. and Ahmad, F. (2010),
Conformational and Thermodynamic Characterization of the Premolten Globule
3.86
State Occurring during Unfolding of Molten Globule State of Cytochrome-c by
Lithium Chloride. Journal of Biological Inorganic Chemistry 15(8):1319-1329.
23 Neyaz, M.K., Hussain, S., Hassan, M.I., Das, B.C., Husain, S.A., Bharadwaj, M. (2010)
Novel missense mutation in FHIT gene: interpreting the effect in HPV-mediated 3.87
cervical cancer in Indian women. Molecular and Cellular Biochemistry 335, 53-8.
22 Soni, B.R., Hassan, M.I., Parmar, A. et. al. (2010) Structure of the novel 14 kDa
fragment of α-subunit of phycoerythrin from the starving cyanobacterium 3.25
Phormidium tenue. Journal of Structural Biology 171: 247-55.
21 Hassan, M.I., Aijaz A and Ahmad F. (2010). Structural and Functional Analysis of
Human Prostatic Acid Phosphatase, a Prognostic Biomarker for Prostate Carcinoma. 3.62
Expert Review of Anticancer Therapy 10: 1055-1068.
20 Hassan, M.I., Toor, A., Ahmad, F. (2010) Progastriscin: structure, function, and its
8.18
role in tumor progression. Journal of Molecular Cell Biology 2, 118-27.
19 Hassan, M.I., Naiyer, A., Ahmad, F. Fragile histidine triad protein: structure,
function, and its association with tumorogenesis. Journal of Cancer Research and 4.55
Clinical Oncology 136, 333-50.
18 Khan, K.A., Das, U., Rahman, M.H., Hassan, M. I., Srinivasan, A., Singh, B., Singh, 3.86
T.P. and Ahmad, F. (2009), Disruption of a conserved residue induces molten globule
in cytochrome c. Journal of Biological Inorganic Chemistry 14: 751-760.
17 Ojha, H., Murari, B.M., Anand, S., Hassan, M.I., Ahmad, F., Chaudhury, N.K. (2009)
Interaction of DNA minor groove binder Hoechst 33258 with bovine serum albumin. 1.64
Chemical Pharmaceutical Bulletin (Tokyo) 57, 481-6.
16 Kumar, V., Hassan, M.I., Singh, A.K., Dey, S., Singh, T.P. and Yadav, S. (2009)
Strategy for sensitive and specific detection of molecular forms of PSA based on 2DE
3.78
and kinetic analysis: a step towards diagnosis of prostate cancer. Clinica Chimica
Acta 403: 17-22.
15 Kumar, V., Hassan, M.I., Tomar, A.K., Kashav, T., Nautiyal, J., Singh, S., Singh, T.P.,
Yadav, S. (2009) Proteomic analysis of heparin-binding proteins from human seminal
1.82
plasma: a step towards identification of molecular markers of male fertility. Journal
of Biosciences 34, 899-908.
14 Khan P, Shandilya A, Jayaram B, Islam A, Ahmad F, Hassan MI. (2017) Effect of pH
on the Stability of Hemochromatosis Factor E: A Combined Spectroscopic and
5.2
Molecular Dynamics Simulation Based Study. Journal of Biomolecular Structure
and Dynamics 35(7):1582-1598.
13 Hassan, M. I., Kumar, V., Singh, T.P. and Yadav, S. (2008) Purification and
Characterization of a Novel Complex of Zinc α2-glycoprotein and Prolactin 3.64
Inducible Protein from. Human Seminal Plasma. J Sep Science 31, 2318-2324.2.

48 Hassan’s CV
 12 Atif, S. M ., Salam, N., Ahmad, N., Hassan, M.I., Jamal, H. S., Azevedo, V. And
Owais, M. (2008) Sperm membrane lipid liposomes can evoke an effective immune 4.15
response against encapsulated antigen in BALB/c mice. Vaccine 26, 5874-5882.
11 Rahman, M.H., Khan, K.A., Hassan, M.I., Wahid, M., Singh, B., Singh, T.P., Moosavi-
Movahedi, A.K. and Ahmad F (2008), Sequence and stability of the goat cytochrome 2.35
c. Biophysical Chemistry 138, 23-28.
10 Kumar, V., Hassan, M.I., Singh, T.P. and Yadav, S. (2008) Comparative Studies on
the Aggregation Behavior of HBPs from Human Seminal Plasma by Dynamic Light 1.89
Scattering. Protein & Peptide Letters 15, 633-639.
9 Kumar, V., Hassan, M.I., Singh, T.P. and Yadav, S. (2008) Heparin-binding proteins
of human seminal plasma: Purification and characterization. Molecular 2.8
Reproduction and Development 75, 1767-1774.
8 Waheed, A., Hassan, M. I., van Etten, R.L. and Ahmad, F. (2008) Human Seminal
Proteinase and Prostate-Specific Antigen are the Same Protein. J Biosc 33,195-207. 1.8

7 Hassan, M. I., Waheed, A., Singh, T.P. Yadav, S. and Ahmad F. (2008) Zinc α2-
glycoprotein is a multidisciplinary protein. Molecular Cancer Research 6: 892-906. 5.85

6 Hassan, M. I., Kumar, V., Bilgrami, S., Yadav, S., Kaur, P. And Singh, T.P. (2008)
Crystal structure of a novel complex formed between Zinc α2-glycoprotein (ZAG)
5.46
and Prolactin inducible protein (PIP) from human seminal plasma. Journal of
Molecular Biology 384: 663–672.
5 Hassan, M. I., Kumar, V., Singh, T.P. and Yadav, S. (2008) Proteomic analysis of
human amniotic fluid from Rh– Pregnancy. Prenatal Diagnosis 28, 102–108. 3.05

4 Hassan, M.I., Kumar, V., Somvanshi, R.K., Dey, S., Singh, T.P. and Yadav, S. (2007)
Structure-guided design of peptidic ligand for human prostate specific antigen. 1.90
Journal of Peptide Science 13, 849-855.
3 Hassan, M.I., Kumar, V., Singh, T.P. and Yadav, S. (2007) Structural model of human
2.81
PSA: a target for prostate cancer therapy. Chemical Biol Drug Design 70, 261-267.
2 Hassan, M.I.,Kumar, V., Kashav, T., Alam, N., Singh, T.P. and Yadav, S. (2007)
Proteomic approach for purification of seminal plasma proteins involved in tumor 3.64
proliferation. Journal of Separation Science 30, 1979-1988.
1 Atif, S.M., Hassan, M.I., Ahmad, N., Khan, U. and Owais, M. (2006) Fusogenic
potential of sperm membrane lipids: nature’s wisdom to accomplish targeted gene 5.12
delivery. FEBS Letters 580, 2183-2190.
Publication as Book Chapter
Q 1 Hassan MI and Ahmad F (2011) Structural diversity of class I MHC-like
Molecules and its implications in Binding specificities. Advances in Protein Chemistry
and Structural Biology, Vol. 83: pp. 223-270.
2 Naqvi AAT and Hassan MI (2016) Design Principles, Network Architecture and Their
Analysis Strategies as Applied to Biological Systems. Chapter 3. Systems Biology
Application in Synthetic Biology, 978-81-322-2807-3. Published by Springer
3 Naqvi AAT and Hassan MI (2016) Chapter 2: Methods for Docking and Drug
Designing in Molecular Docking-Based Drug Design and Discovery. Published by IGI
Global.
4 Sami N, Kumar V and Hassan MI (2016) Microtubule Affinity Regulating Kinase-4.
Encyclopedia of Signaling Molecules (DOI: 10.1007/978-1-4614-6438-9_101744-1).

49 Hassan’s CV
 5 Kumar V, Kashav T and Hassan MI (2018) Amyotrophic lateral sclerosis: Current
therapeutic perspectives in Pathology, Prevention and Therapeutics of
Neurodegenerative Disease (ISSN No. 978-981-13-0943-4).
6 Khan P, Queen A, Hassan MI and Ali S (2019) Genetics Ageing and Human Health in
Springer Book titled "Models, Molecules and Mechanisms in Biogerontology" (DOI:
10.1007/978-981-13-3585-3_10).
7 Mohammad T and Hassan MI (2018) Modern Approaches in Synthetic Biology:
Genome Editing, Quorum Sensing, and Microbiome Engineering. In: Singh S. (eds)
Synthetic Biology. Springer, Singapore. ISBN No. 978-981-10-8692-2
8 Mohammad T, Hassan MI (2018) Genome Microbiology for Synthetic Applications. In:
Singh S. (eds) Synthetic Biology. Springer, Singapore. ISBN No. 978-981-10-8692-2
9 Naqvi AAT, Mohammad T and Hassan MI (2019) Discovery of novel drug targets in
microbial pathogens among hypothetical proteins: Methods and significance in the
Book titled Pathogenicity and Drug resistance of Human pathogens -Mechanisms and
Novel approaches Published by Springer. 978-981-329-449-3.
10 Dahiya, R., Mohammad, T., Hassan, M.I. (2020). Role of Genome-Wide Association
Studies in Host Genetics: Toward Understanding of Microbiome Association. In: Singh,
S. (eds) Metagenomic Systems Biology. Springer, Singapore.
https://doi.org/10.1007/978-981-15-8562-3_2
11 Mohammad, T., Dahiya, R., Hassan, M.I. (2020). Implication of Synthetic Biology in
Biotherapeutic Engineering. In: Singh, S. (eds) Systems and Synthetic Immunology.
Springer, Singapore. https://doi.org/10.1007/978-981-15-3350-1_9
12 Naqvi AT, Kiran U, Abdin MZ and Hassan MI (2020) Structural and functional
characterization of proteins using in silico tools in Transgenic Technology for Value
Addition, Plant Biotechnology: Principles and Applications Published by Elsevier.
13 Bashir S, Sami N, Bashir S, Ahmad F, Hassan MI and Islam A (2020) Management of
Insulin Through Co-Solute Engineering: A Therapeutic Approach. Frontiers in Protein
Structure, Function, and Dynamics by Springer Nature (ISBN 978-981-15-5530-5).
14 Shahid S, Hasan I, Ahmad F, Hassan MI and Islam A, (2020) Effect of size of crowder
on protein stabilization in the Recent Research Advances in Biology published by Book
Publisher International.
15 P. Gupta, A. Taiyab, M.I. Hassan, Emerging role of protein kinases in diabetes mellitus:
From mechanism to therapy, in: Advances in Protein Chemistry and Structural
Biology, Academic Press, 2020.
16 Naqvi, A.A.T., Rizvi, S.A.M., Hassan, M.I. (2022). How Machine Learning Has
Revolutionized the Field of Cancer Informatics? In: Singh, S. (eds) Machine Learning
and Systems Biology in Genomics and Health. Springer, Singapore.
https://doi.org/10.1007/978-981-16-5993-5_5
17 Alam, M., Naqvi, A.A.T., Hassan, M.I. (2022). Emerging Role of Structural and Systems
Biology in Anticancer Therapeutics. In: Singh, S. (eds) Systems Biomedicine
Approaches in Cancer Research. Springer, Singapore. https://doi.org/10.1007/978-981-
19-1953-4_5
18 Shamsi, A., Anwar, S., Mohammad, T., Shahwan, M., Hassan, M.I., Islam, A. (2021).
Therapeutic Potential of Polyphenols in Alzheimer’s Therapy: Broad-Spectrum and
Minimal Side Effects as Key Aspects. In: Md Ashraf, G., Alexiou, A. (eds) Autism
Spectrum Disorder and Alzheimer's Disease. Springer, Singapore.
https://doi.org/10.1007/978-981-16-4558-7_7
19 Ali, S., Alam, M., Hassan, M. I., and Noor, S. Chapter 1 - Kinase inhibitors: An
overview, in Protein Kinase Inhibitors, pp 1-22, Academic Press 2022.

50 Hassan’s CV
 20 Shakeel, I., Zaidi, Y., Gupta, V., Badar, S., Khan, M. K. A., Abdullaev, B., Afzal, M.,
Hassan, M. I., and Noor, S. Chapter 6 - Emerging small-molecule inhibitors of ATM
kinase targeting cancer therapy, in Protein Kinase Inhibitors, pp 179-198, Academic
Press 2022.
21 Haque, M. A., Kaur, P., Islam, A., Hassan, M. I., Chapter 14 - Application of circular
dichroism spectroscopy in studying protein folding, stability, and interaction, in
Advances in Protein Molecular and Structural Biology Methods, pp 213-224, Academic
Press 2022. ISBN No. 978-0-323-90264-9
22 Anwar, S., Shamsi, A., Mohammad, T., Islam, A., Hassan, M. I., and Noor, S. Chapter
7 - Targeting pyruvate kinase M2 signaling for development of effective cancer
therapy, in Protein Kinase Inhibitors, pp 199-222, Academic Press 2022.
23 Alam, M., Ali, S., Hassan, M. I., and Noor, S. Chapter 9-Akt inhibitors in cancer therapy,
in Protein Kinase Inhibitors, pp 239-260, Academic Press 2022.
24 Mohammad, T., Hassan, M. I., and Noor, S. Chapter 8 - Serum and glucocorticoid-
regulated kinase 1: A potential target for anticancer therapy, in Protein Kinase
Inhibitors, pp 223-238, Academic Press 2022.
25 Kumar, D., Hassan, M. I., and Noor, S. Chapter 5 - Recent advances in the therapeutic
development of ERK inhibitors, in Protein Kinase Inhibitors, pp 129-178, Academic
Press 2022.
26 Noor, S., Raza, A., and Hassan, M. I. Chapter 19 - Therapeutic targeting of glycogen
synthase kinase-3: Strategy to address neurodegenerative diseases, in Protein Kinase
Inhibitors, pp 535-569, Academic Press 2022.
27 Gupta P, Islam A, Ahmad F and Hassan MI (2023) Applications of Circular Dichroism
Spectroscopy in Studying Protein Folding, Stability, and Interaction in Protein Folding
Dynamics and Stability: Experimental and Computational Methods by Springer
Nature Singapore
28 Hassan MI, Umair M, Mathur Y, Mohammad T, Khan A, Sulaymani N, Alam A and
Islam A (2023) Molecular Dynamics Simulation to Study Thermal Unfolding in
Proteins in Protein Folding Dynamics and Stability: Experimental and Computational
Methods by Springer Nature Singapore
29 Kumar D and Hassan MI (2023) Regulation of receptor tyrosine kinase gene expression
in Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders
published by Academic Press, Elsevier, ISBN: 9780443186776.
30 Alam M, Shamsi A, Hassan MI (2023) Biological Roles and Mechanism of
Phytochemicals in Disease Prevention and Treatment in Ethnobotany and
Ethnopharmacology of Medicinal and Aromatic Plants: Steps Towards Drug Discovery
Published by CRC Press ISBN: 9781032256085
31 Shakeel I, Mohammad T and Hassan MI (2023) Computational phytochemistry in drug
discovery: Databases and Tools in Disease Prevention and Treatment in Ethnobotany
and Ethnopharmacology of Medicinal and Aromatic Plants: Steps Towards Drug
Discovery Published by CRC Press ISBN: 9781032256085.
32 Shakeel I, Rathi A, Taiyab A, Hassan MI (2023) Insights into SARS-CoV-2 structure:
Approaches and action of SARS-CoV-2 Main Protease Inhibitors in Understanding the
Pandemic: Pathophysiology, Transmission, and Treatment of COVID-19 Published by
Academic Press, Elsevier. ISBN: 9780443290046
33 Khan S.; Anwar S.; Choudhury A.; Mohammad T.; Hassan M.I. (2024) Validation of
drug targets using molecular methodologies and enzymatic activity assays for
validation of inhibitory potential in Bacterial Enzymes as Targets for Drug Discovery:
Meeting the Challenges of Antibiotic Resistance 91-112.

51 Hassan’s CV
 34 Shahbaaz M and Hassan MI (2025) Isothermal titration calorimetry in enzymology:
techniques and applications in the new Elsevier series Foundations and Frontiers in
Enzymology.
R Book Edited
1 Md. Imtaiyaz Hassan, Saba Noor (2022) Protein Kinase Inhibitors: From Discovery to
Therapeutics, Published by Academic Press, Elsevier, ISBN: 9780323912877
2 Sufian Badar, Md. Imtaiyaz Hassan, Jawed Ahmad, Nima Razae, Afshar Alam (2023)
COVID-19 Analysis and Diagnosis by Emerging Technologies Published by
Academic Press, Elsevier.
S Abstract Published in Conferences Total 146
T Conference/Seminar Organized as Convener
i. Organizing Secretary, International Interdisciplinary Science Conference 2011 on Bioinformatics:
Interface between Computer Science and Biology held on November 15-17, 2011, organized by
Jamia Millia Islamia, New Delhi.
ii. Organizing Secretary, Interdisciplinary Science Conference 2012 on Protein Folding and Diseases
held on December 8-10, 2012, organized by Jamia Millia Islamia New Delhi.
iii. Convener, National Conference on Recent Trends in Protein Structural Biology held on December
16 to 18, 2013, organized by Jamia Millia Islamia New Delhi.
iv. Convener, National Symposium on Biophysics and Golden Jubilee Meeting of Indian Biophysical
Society held on February 14-17, 2015, at Jamia Millia Islamia, New Delhi.
v. Convener, National conference on Protein Structure and Dynamics in Health and Agriculture,
held during November 3-4, 2017, at Jamia Millia Islamia, New Delhi.
vi. Coordinator, 6th 3-Week Refresher Course in Basic Science (Interdisciplinary) held in Human
Recourse Development Centre, Jamia Millia Islamia held on 26th September to 17th October 2018.
vii. Coordinator, 9th 2-Week Online Refresher Course in Basic Science (Interdisciplinary) held in
Human Recourse Development Centre, Jamia Millia Islamia held on during October 5-21, 2021.

E-content Developed for E-PG Pathshala (4 quadrants)

P-09. Techniques used in molecular biophysics I 6 modules
T P-14. Bioinformatics 4 modules
P-10. Techniques Used in Molecular Biophysics II
26 modules
(Based on Spectroscopy)
Administrative responsibility taken
i. Assistant Dean Students Welfare (2017-2019).
ii. Administrative coordinator of Global Jamia Alumni Network (2017-2021).
iii. Member, Institutional Quality Assurance Cell, Jamia Millia Islamia (2014-2020).
U iv. Warden of Boy’s Hostel of Jamia Millia Islamia (2013-2015).
v. Senior and Residential Warden of Jamia Schools Hostel (2015-till date).
vi. Assistant Incharge, Alumni Connect Cell, Jamia Millia Islamia (2021-till date)
vii. Deputy Provost, Zakir Hussain Hall of Boys, Jamia Millia Islamia (2023-2024).
viii. Deputy Proctor of Jamia Millia Islamia (2023-2024).
Declaration: All the information provided in this resume is true to the best of my knowledge and belief.

(Dr. Md. Imtaiyaz Hassan)

52 Hassan’s CV